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ABSTRACT

As a component of systems biology, proteomics aims to characterize the entire protein
complement of an organism, including qualitative identification of protein types and
quantitative measurement of protein abundance changes as a function of different cellular
states. This dissertation presents an integrated experimental and computational approach
to improve proteomic measurements, including qualitative measurements using Fourier
transform ion cyclotron resonance mass spectrometry (FT-ICR-MS) and quantitative
measurements with statistically derived confidence evaluation.

Although FT-ICR-MS provides high-performance mass measurements, its potential has
not yet been fully explored for proteomics applications. A novel tandem mass
spectrometry method was developed for FT-ICR-MS to obtain sequence tag information
directly from intact proteins in a mixture. The interpretation of FT-ICR tandem mass
spectra for sequence tagging was facilitated with a new graph-theoretical algorithm for
separation of y- and b-ions. To scale FT-ICR-MS for general proteomic characterizations,
low flow-rate liquid chromatography was integrated with FT-ICR-MS. The highperformance MS greatly enhanced the depth and quality of the proteomics measurements.
In total, these studies demonstrated that FT-ICR-MS is of practical value for proteomic
measurements, and that additional experimental and computational developments could
make this into a robust and automated approach.
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Quantitative proteomics based on stable isotope labeling enables global gene expression
profiling at the protein level. However, major challenges remain for extracting reliable
protein quantification information from noisy mass spectrometric data. A principal
component analysis algorithm was developed to accurately estimate peptide abundance
ratios and to provide rigorous scores for their estimation variability and bias. The peptide
quantification results were then processed by a novel profile likelihood algorithm to
estimate protein abundance ratios with confidence interval evaluation. These algorithms
were integrated into a computer program, ProRata, for automated data analysis.
Quantitative proteomic measurements were conducted using ProRata, and integrated with
transcriptomic analysis to study the anaerobic metabolism of p-coumarate in
Rhodopseudomonas palustris. This study yielded a putative cellular pathway for pcoumarate catabolism.

In the research described here, a substantial advancement in both qualitative and
quantitative proteomic measurements was achieved using an integrated experiment and
computational approach. The improved proteomic measurements can help elucidate a
range of biological processes.

v
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Chapter 1
Introduction to Proteomics and its Role in Systems Biology

One of the greatest advances in biology is the establishment of the central dogma of
molecular biology (Figure 1.1) (Astbury, 1961). It was discovered that, for almost all life
forms on the Earth, complete genetic information is encoded in deoxyribonucleic acid
(DNA) molecules (Benfey, 2004). This genetic information can be transmitted
horizontally between different organisms and vertically from parents to progeny through
DNA replication. The functional units of the genetic information are genes. To express a
gene, the DNA sequence of the gene is transcribed to a messenger RNA (mRNA), which
is then translated into a protein. In most cases, the cellular function is carried out by the
final product of gene expression, the protein.

Understanding biological processes at the molecular level has ushered in a new research
paradigm for biology. Previously, biology was largely a descriptive science, where
general principles were deducted from observational data. For example, Charles Darwin
conceived the theory of natural selection from his five-year voyage on the Beagle ship
(Darwin, 1859; Browne, 1996). With the emergence of molecular biology, biologists
have become capable, for the first time, of manipulating life in a directed manner. This
has helped transform biology into a so-called “hypothesis-driven” discipline. A biologist
can propose a hypothesis and then design experiments to test the hypothesis. This
approach has resulted in elucidation of the functions and regulation of thousands of genes,
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Figure 1.1: Research paradigm shift for biology. Molecular
biology based on the central dogma paved the way to systems
biology that takes advantage of different “-omics” technologies
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and has impacted all areas of biology: cell biology, developmental biology, evolutionary
biology, etc.

However, there are at least two challenges in this hypothesis-driven research paradigm.
First, the research is limited by the hypothesis to be tested (Goodman, 1999). The
research documented in scientific journals is often the validation of a reasonable
hypothesis; whereas rejecting a “wrong” hypothesis is rarely considered as scientific
progress. To avoid the risk of formulating a wrong hypothesis in the first place, the
hypotheses to be tested are often logical incremental extensions of known facts. However,
pushing the envelope of knowledge from the known has precluded many biologists from
leaping into uncharted territories in biology.

Second, most conventional molecular biology experiments focus on one gene, one
protein complex, or one pathway at a time. This provides a very narrow view of
biological systems.

In a living organism, there are convoluted protein interactions,

complex regulatory networks, and numerous cellular pathways, which require biologists
to seek answers to their questions in the context of a complex inter-connected system
(Ideker, 2001). A targeted experimental approach becomes insufficient to provide such an
unbiased global perspective about biological systems.

In recent years, the development of high-throughput technologies and corresponding data
analysis algorithms has enabled a variety of “omics” research, including genomics (Cole,
1994; McKusick, 1997), transcriptomics (Bednar, 2000; Harrington, 2000), proteomics
3

(Porubleva, 2000; Yates, 2000), and metabolomics (Fiehn, 2002; Reo, 2002) (Figure 1.1).
Among them, genomics was first to emerge, due to the advent of high-throughput DNA
sequencing technology (Salser, 1974; Martin, 1989). Genomics focuses on determining
and studying the genome of an organism, which encodes for the entire genetic
information of the organism.

The availability of complete genome information enabled the development of
transcriptomics, which is based on high-density microarray technology (Kurian, 1999).
The complete set of all mRNA molecules, or "transcripts", produced in an organism is its
transcriptome. Because the synthesis of a protein requires the presence of its mRNA, the
mRNA abundance change can be used as a surrogate for the protein abundance change.
Thus, the global gene expression profiling became possible at mRNA level with
transcriptomics.

As the next level of the “omics” measurements, proteomics aims to characterize the entire
protein complement of an organism (Blackstock, 1999). Compared with genomics and
transcriptomics, proteomic measurements still demand much effort in methodology
development, due to heterogeneous characteristics of proteins (size, hydrophobicity,
structure, etc). Additionally, the technologies for genomics and transcriptomics are based
on molecular biology tools such as polymerase chain reaction (Erlich, 1989), reverse
transcription, hybridization, etc. However, there are no equivalent tools to manipulate and
amplify proteins.
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A natural extension of proteomics is metabolomics, which focuses on characterization of
the entire metabolite complement of an organism. Metabolomic measurements are even
more technologically challenging and their methodology has not yet been well defined
(Bino, 2004).

The advent of these “-omics” measurements leads to a new research paradigm, termed
“discovery-driven” or “data-driven” research, which is different from the previous
hypothesis-driven research (Goodman, 1999). A biological system can be characterized
by genomics, transcriptomics, proteomics, or any combination of such. Genomics reveals
the “screenplay” of an organism. Transcriptomics and proteomics present molecular
“shows” inside the organism under different scenes to biologists. With these new
technologies, modern biologists can study life by making discoveries from large sets of
data. Free from the confinement of a pre-defined hypothesis, discoveries can now shed
light on the uncharted territories of biology and reveal unknown or even unexpected
mechanisms of biological processes. It has become evident that deducing discoveries
from observational “-omics” data will complement the conventional approach of
validating induced hypotheses (Lastowski, 2000).

Such -omics research has another characteristic distinct from the hypothesis-driven
research – the global view of a biological system. If one considers that the expression of a
gene represents the vertical information flow from one level to another, then genomics,
transcriptomics, proteomics, and metabolomics all aspire to profile the entire horizontal
information landscape at each level. Such a wide-angle perspective on the life processes
5

of an organism allows the development of an understandable model for a biological
system in its entirety. This endeavor has been termed “systems biology” (Anderson, 2000;
Ideker, 2001; Regnier, 2002).

A genome can be completely characterized by determining nucleic acid sequences of all
DNA molecules. The transcript of a gene is the messenger that passes the genetic
information to protein synthesis machinery. The abundance of a transcript is actively
regulated to control the production of a protein. Hence, the measurement of a
transcriptome can be achieved by quantifying the abundance of the transcripts for all
genes. Compared with DNA and mRNA, proteins are, however, dynamic and diverse in
their abundances, chemical modifications, tertiary structures, cellular locations, and
physical interactions. Due to multifaceted characteristics of proteins, the characterization
of the proteome requires the combination of different measurements that focus on
different properties of proteins or different categories of proteins. The different types of
proteomics measurements include, but are not limited to:
•

Structural proteomics: characterization of protein secondary or higher order
structures (Schmid, 2002);

•

Interactomics: identification of physical interactions between proteins (Cesareni,
2005);

•

Amino acid sequence variations: detection of nucleotide polymorphisms, signal
peptide cleavage, and sequence database errors (Gatlin, 2000);
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•

Post-translational

modifications

(PTMs):

determination

of

chemical

modifications to proteins, including phosphorylation, acetylation, methylation,
glycosylation, etc (Cantin, 2004; Jensen, 2004);
•

Sub-cellular proteomics: cataloguing of all proteins in an organelle or a cellular
compartment (Brunet, 2003; Huber, 2003);

•

Whole-cell proteomics: characterization of the entire protein complement of a cell
(Washburn, 2000).

There are multiple challenges in realizing the promises of proteomics (Marko-Varga,
2004; Reinders, 2004; Bertone, 2005). The first challenge is the complexity of proteome
samples. There are thousands of different proteins in a proteome sample. Each of the
proteins may have multiple modification types. The second challenge is the enormous
dynamic range between proteins. Dynamic range is the concentration difference between
the most abundant proteins and the least abundant ones. The dynamic range can reach up
to 106 in a bacterial proteome (Corthals, 2000). The third challenge is the difficulty of
measuring membrane proteins (Santoni, 2000). Membrane proteins play crucial roles in
many cellular activities. But due to their high hydrophobicity and tight association with
lipids, membrane proteins are not very amenable to many experimental methods. In
addition, there are other experimental challenges, such as measurement throughput,
reproducibility, etc.

Different methodologies have been developed to address these challenges in proteomics
measurements. The three main methodologies are two-dimensional gel electrophoresis
7

(Rabilloud, 2002; Watt, 2003), shotgun proteomics (Wolters, 2001; McDonald, 2003),
and top-down proteomics (Kelleher, 2004) (Figure 1.2). They all combine high peakcapacity separation and mass spectrometry (MS) to handle the sample complexity and
dynamic range of proteome samples.

Two-dimensional gel electrophoresis was the first methodology capable of large-scale
proteome measurement. The extracted proteins are first separated by their isoelectric
points with isoelectric focusing and then by their molecular weights with denaturing
sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) (Figure 1.2)
(Bernard, 2004). The 2-dimensional separation resolves most proteins into individual
spots in the gel. The gel spots are excised and digested with protease. The digestion
products are then measured with mass spectrometry, and the proteins are generally
identified by peptide mass fingerprinting (Cottrell, 1994; Pappin, 1997). Twodimensional gel electrophoresis also allows quantitative measurements based on signal
intensities of the gel spots (Watt, 2003). Recently, quantitative proteomics has also been
performed with fluorescence 2-D difference gel electrophoresis (DIGE) (Unlu, 1997),
where proteins from different samples are labeled with different fluorescent dyes and
then mixed together for separation on the same gel.

Two-dimensional gel electrophoresis has been used for a variety of proteomic
applications, including cataloging proteins in proteome samples, measuring protein
abundance changes between cellular conditions, detecting and quantifying posttranslational modifications, etc. For example, many types of PTMs, such as
8
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Figure 1.2: Schemes of three qualitative proteomics methodologies. The
general procedure for protein identification involves three steps: separation,
mass spectrometry measurement and data analysis.
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phosphorylation and glycosylation, can change the isoelectric point of a protein (Banks,
2000). The horizontal migration of the protein’s gel spot to a new pI position would
suggest the presence of these types of PTMs. The comparison between two gel spots of
the protein can yield quantitative information on what percentage of the protein
molecules are modified.

There are certain disadvantages in employing two-dimensional gel electrophoresis
(VerBerkmoes, 2004), including:
•

Bias against membrane proteins and large proteins;

•

Poor recovery rate of low-abundance proteins from the gel;

•

Limited reproducibility;

•

Limited automation available.

There are also at least two challenges for protein quantification with DIGE. First, a gel
spot can have more than one protein, and the fluorescence intensity ratio measured in that
gel spot is a weighted average of abundance ratios of all proteins in that spot. Second,
each protein is quantified with a single data point in one DIGE measurement, which
necessitates extensive replication for reliable error estimation.

Top-down proteomics separates intact proteins with liquid chromatography (LC), –
usually ion exchange LC, C4 reverse phase LC, or their combination (VerBerkmoes,
2002; Wang, 2005). Liquid chromatographic separation obviates the problem of
recovering intact proteins from the gel in two-dimensional gel electrophoresis. The LC
elution can be coupled online with mass spectrometry or offline by fraction collection.
10

Generally, top-down proteomics requires mass spectrometers with high mass
measurement performance to analyze intact proteins (VerBerkmoes, 2002; Bogdanov,
2005). The accurate mass measurement of intact proteins often provides definitive
information on protein identity. Tandem mass spectrometry (MS/MS) can also be
employed to measure the gas-phase fragmentation product ions of the intact proteins to
provide sequence information for more definitive protein identification (Kelleher, 2004).

The main characteristic of top-down proteomics is the direct mass spectrometry
measurement of intact proteins. Two-dimensional gel electrophoresis yields approximate
isoelectric points and masses of the intact proteins from their gel spot positions. However,
mass spectrometry measurement can measure intact protein masses at accuracies that are
orders of magnitude higher than SDS-PAGE, and tandem mass spectrometry provides
protein sequence information. Such measurements make top-down proteomics uniquely
advantageous for characterizing post-translational modifications of proteins. Virtually all
PTMs alter the masses of proteins, and the measured mass shift for a protein allows the
inference of the number and the types of all PTMs on the protein. Top-down proteomics
has been used for whole-cell proteomics to detect the presence of methylation,
acetylation, phosphorylation, N-terminal truncation, etc (VerBerkmoes, 2002; Kelleher,
2004; Strader, 2004).

Although significant progress has been made in top-down proteomics, this methodology
has the following limitations to be addressed:
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•

Molecular mass cannot be measured accurately for proteins larger than 100,000
Daltons;

•

Liquid chromatography is not straightforward for large proteins or membrane
proteins;

•

The gas-phase fragmentation of intact proteins is not very robust or extensive;

•

Many low-abundance proteins are not detected.

Overcoming these limitations requires further development of intact protein liquid
chromatography, high performance mass spectrometry instrumentation, and data analysis
algorithms.

Both two-dimensional gel electrophoresis and top-down proteomics process proteins
from a proteome sample in their intact forms. Many aforementioned disadvantages of the
two methodologies stem from the challenges in the separation and the MS analysis of
intact proteins. Instead, shotgun proteomics analyzes proteolysis-derived peptides
(Wolters, 2001). A protein mixture is first treated with protease, which cleaves all
proteins into peptides. The peptides are then measured with liquid chromatographytandem mass spectrometry (LC-MS/MS). Shotgun proteomics has been shown to be the
methodology most comprehensive in cataloging proteins in a complex protein mixture
(VerBerkmoes, 2004). With shotgun proteomics, thousands of proteins have been
identified in whole-cell lysates from a wide range of organisms (Jungblut, 1999; Cash,
2003; Lilley, 2003). Mitochondria, lysosomes and chloroplasts have been purified, and
their protein constituents have been characterized with shotgun proteomics (Brunet, 2003;
Huber, 2003). Proteins carrying specific PTMs, such as phosphorylation (Gronborg, 2002;
12

MacCoss, 2002) and ubiquitination (Peng, 2003), have been enriched with biochemical
methods and identified with shotgun proteomics.

Shotgun proteomics has also been coupled with a variety of stable isotope labeling
techniques for measuring relative abundances of proteins between different proteome
samples (Tao, 2003). The combination of LC-MS measurements with stable isotope
labeling for quantification has been used in isotope dilution mass spectrometry (IDMS)
for decades (Bjorkhem, 1980). An isotopic analogue of identical structure as the analyte
to be quantified is synthesized and mixed with the sample. The analogue becomes the
internal standard in known abundance; and the ratio between the ion currents of the
analyte and the internal standard measured by LC-MS reflects the ratio of their
abundances. The same strategy is employed in quantitative shotgun proteomics. As it is
impractical to synthesize isotopic analogue for every protein, a wide range of stable
isotope labeling techniques have been developed, including 15N or 13C metabolic labeling
(Oda, 1999), stable isotope labeling with amino acids in cell culture (SILAC) (Ong,
2002), H218O digestion (Yao, 2001), and isotope-coded affinity tags (ICAT) (Gygi, 1999).
With these stable isotope labeling techniques, quantitative shotgun proteomics allows
accurate relative quantification of thousands of proteins in a high-throughput manner.

Compared with two-dimensional gel electrophoresis and top-down proteomics, a
disadvantage of current shotgun proteomics measurements is the lack of information on
the full sequence of a protein. Proteins are digested into peptides during the first step of
shotgun proteomics. The existing LC-MS/MS technology can generally measure a subset
13

of peptides in the peptide mixture, and the measured peptides for the majority of proteins
can only cover a portion of amino acid sequences. Although the detection of a portion of
a protein generally presents a sufficient evidence for the presence of the intact protein,
there is little information about the undetected portion of the protein sequence, such as
the presence or absence of an amino acid sequence variation, N-terminus truncation,
chemical modification, etc.

The field of proteomics rests on four cornerstones, namely, protein chemistry, mass
spectrometry, informatics, and biology (Figure 1.3):
•

Protein chemistry: Extraction of proteins from cells and preparation of proteome
samples.

•

Mass spectrometry: Comprehensive measurement of the proteome samples with
suitable analytical platforms.

•

Informatics: Processing of mass spectral data to yield information, such as protein
identification, chemical modification detection, and quantification.

•

Biology: Interpretation of proteomic results to generate knowledge to further the
understanding of a biological system.

The methodology development for proteomics often requires devoting coordinated effort
in the four cornerstones.

The major goal of this dissertation is to develop new proteomics methodologies for
confident protein identification and quantification. Two main research directions have
been pursued: The first direction is development and prototyping of various high14
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Knowledge

Protein chemistry

Proteomes

Mass spectrometry

Biology

Proteomics

MS data

Results

Informatics

Figure 1.3: Cornerstones of proteomics. Proteomics is based upon
four cornerstones: protein chemistry, mass spectrometry, informatics and
biology.
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performance methodologies based on Fourier transform ion cyclotron resonance (FT-ICR)
mass spectrometry (Hendrickson, 1999). The conventional analytical platform for
shotgun proteomics is primarily based on quadrupole ion trap (QIT) MS, because QITMS is a robust medium-cost instrument with exquisite capabilities for high-throughput
tandem mass spectrometry measurement (Brancia, 2006). However, QIT-MS provides
mass measurements of only moderate accuracy and resolution. We believe that the nextgeneration analytical platform for proteomics will be based on high-performance mass
spectrometers, such as FT-ICR. The exceptional accuracy, resolution, and dynamic range
in mass measurement offered by FT-ICR could revolutionize proteomics. However, there
was insufficient prior research work on methodology development based on FT-ICR. A
focus of this dissertation is to explore the potential of FT-ICR for various proteomics
measurements, including direct sequence tagging from intact proteins, de novo
sequencing of peptides, and high confidence peptide identification. Each of these studies
demonstrated the unique advantages of high performance MS instruments for proteomics.
Although not yet suitable for proteomics laboratories operating in a “pipeline”
measurement mode, these prototype methodologies represented pioneering development
of proteomics methodology. In fact, with the recent introduction of two commercial
hybrid high-performance instruments, the ThermoFinnigan LTQ-FTMS (Peterman, 2005)
and LTQ-Orbitrap (Erickson, 2006), we believe that the transition to high-performance
instruments has began, and the value of our pioneering work in this area will become
more evident.
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The second research direction focuses on quantitative shotgun proteomics with advanced
data analysis algorithms. Shotgun proteomics was developed initially to catalogue
proteins in a proteome. However, the detection of a protein’s presence in a proteome is
not as informative about its function as quantification of the protein’s abundance change
between different cellular states. Quantitative proteomics has been developed to
determine the abundance changes of thousands of proteins. Quantitative proteomics
results are equivalent to transcriptomics results: both provide global gene expression
profiles, one at mRNA level and the other at protein level. For quantitative shotgun
proteomics measurement, the critical step in protein chemistry is stable isotope labeling
of proteins, and the key in mass spectrometry analysis is acquisition of high-quality full
scan mass spectra in LC-MS/MS measurement.

A variety of stable isotope labeling methods have been developed for quantitative
proteomics. However, the informatics for quantitative proteomics has greatly lagged
behind. Algorithms are required to estimate the relative abundances of peptides from full
scan data and then to estimate the abundance ratios of proteins by assembling their
peptides together. As quantitative shotgun proteomics measurements yield selected ion
chromatograms at highly variable signal-to-noise ratios for tens of thousands of peptides,
we developed algorithms that not only robustly estimate the abundance ratios of different
peptides but also rigorously score each abundance ratio for the expected estimation bias
and variability. A profile likelihood algorithm was then used for maximum likelihood
point estimation and profile likelihood confidence interval estimation of protein
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abundance ratios. The confidence interval estimation provides an “error bar” for each
protein abundance ratio that reflects its estimation precision and statistical uncertainty.

Echoing a systems biology theme of integrating multiple “-omics” technologies, we have
combined genomics, transcriptomics, and quantitative proteomics to study anaerobic pcoumarate degradation in Rhodopseudomonas palustris. Multiple genes in the
hypothesized p-coumarate pathway were identified by sequence similarity and expression
change. The global gene expression profiles at both mRNA level and protein level
showed the coordinated responses from a multitude of related cellular pathways to pcoumarate degradation. The discoveries made in this study have showcased how systems
biology can further our understanding of a biological system in a high-throughput and
comprehensive manner.

The research conducted under this dissertation project is discussed by first highlighting
the fundamental experimental and computational work and then applying them to explore
biological applications.

Thus, the dissertation is organized as follows: Chapter 2

describes the mass spectrometry technology for proteomic measurements. Chapter 3
introduces a novel MS3 tandem mass spectrometry analysis with FT-ICR for deriving
sequence tags from intact proteins. Chapter 4 details a graph-theoretical algorithm for
interpreting the high-resolution FT-ICR tandem mass spectra. Chapter 5 describes our
effort in interfacing FT-ICR with an LC system. The next three chapters focus on
quantitative shotgun proteomics. Chapter 6 describes novel algorithms for peptide
quantification. Chapter 7 details both a protein quantification algorithm and the
18

benchmark results of quantitative proteomics measurements. Chapter 8 shows a study of
p-coumarate degradation in Rhodopseudomonas palustris. Chapter 9 concludes the
described research work and discusses the future directions of proteomics and systems
biology.
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Chapter 2
Mass Spectrometry as a Foundation Technology for Proteomics

BACKGROUND

This chapter describes general technology background for proteomics measurements. The
studies described in Chapters 3, 4, and 5 are based on FT-ICR technology for prototyping
high performance proteomics methodologies. The studies presented in Chapters 6, 7, and
8 are based on shotgun proteomics with quadrupole ion trap technology for quantitative
proteomics development and application. Although the exact methods used in these
studies vary to some extent and are detailed in the MATERIALS AND METHODS
section of each chapter, this chapter presents a general background on the fundamental
mass spectrometry technology, the shotgun proteomics methodology, and the biological
system of interest.

Principles of mass spectrometric ion manipulation and measurement

All mass spectrometers have three fundamental components, namely the ion source, the
mass analyzer, and the detector (Hoffmann, 2001). In the ion source, the analytes in a
sample are transformed into gas-phase ions, which are then transferred through a series of
ion optics into the mass analyzer. The process of generating gas-phase ions of the
analytes is called ionization. The ions are then resolved according to their mass-to-charge
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ratio (m/z) in the mass analyzer. Finally, the detector measures the signal intensities of
ion species occurring at different mass-to-charge ratios.

A variety of mass analyzers have been developed, including three-dimensional
quadrupole ion traps, linear quadrupole ion traps, triple quadrupoles,

time-of-flight

(TOF), sectors, Fourier transform ion cyclotron resonance (FT-ICR), and Orbitrap
(Hoffmann, 2001; Erickson, 2006). The performance of these different mass analyzers
can be measured in terms of different figures-of-merit, including:
•

Mass accuracy: the mass error divided by the expected mass. For modern mass
spectrometers, this is generally much less than 1% and is commonly measured in
parts per million (ppm).

•

Resolution: the ability to separate a mass spectral peak from other closelypositioned ones. This is measured by the expected mass divided by the peak width
at half height.

•

Dynamic range: the ion signal ratio between the most abundant detected species
and the least abundant detected species.

•

Sensitivity: the increase of mass spectrometric signal intensity from a unit
increase of the analyte concentration.

•

Detection limit: the minimum concentration of the analyte that can be detected
with a signal-to-noise ratio of three.

•

Upper mass limit: the maximum mass-to-charge ratio that can be measured.
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The figures-of-merit for different mass analyzers are compared in Table 2.1. The mass
spectrometers with higher performance, such as Orbitrap and FT-ICR, are also more
expensive than the other mass spectrometers.

Ionization methods for biomolecules

Two soft ionization methods used in the ion source are matrix assisted laser desorption
ionization (MALDI) (Hillenkamp, 1990) and electrospray ionization (ESI) (Fenn, 1989).
MALDI ionizes samples from a crystallized form. An aqueous sample is mixed with a
matrix solution, spotted to an arrayed plate, and crystallized by air-drying. Ions from the
sample can be generated by bombarding the crystals at the spot with a focused laser beam.
The matrix assists the ionization of analyte molecules and protects them from the
disruptive energy of the laser. In contrast, ESI transports preformed ions directly from the
liquid phase to the gas phase. A continuous stream of sample solution is sprayed through
a needle to a counter-electrode, which is electrically biased with a few thousands of volts
potential difference. The analyte ions are released from the droplets in the spray plume
and desolvated by the heated gas. Because the continuous solution stream can be the
eluent of an LC system, ESI enables placing mass spectrometer online with LC. The
integrated platform is called LC-MS. Both top-down proteomics and shotgun proteomics
employ ESI in their LC-MS measurement.

During electrospray ionization, a sample is pumped at a low flow rate (10 nL/min–10
µL/min) through a capillary needle biased to a positive high potential relative to the
22

Table 2.1: Figures-of-merit of different mass analyzers.
Mass analyzer

Mass accuracy

Resolution

Dynamic range

QIT 1

20 ppm

1k ― 2k

100

TOF 2

2 ― 5 ppm

2k ― 10k

1000

Sectors

< 1 ppm

5k ― 100k

10,000

Orbitrap

2 ― 5 ppm

5k ― 50k

5,000

FT-ICR 3

< 1 ppm

5k ― 1000k

10,000

1 Quadrupole

ion trap
Time-of-flight
3 Fourier transform ion cyclotron resonance
2
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orifice of mass spectrometer in the positive ion mode (Figure 2.1). The capillary needle,
whose inner diameter should match with the flow rate, is referred to as ESI emitter. Often
ESI is referred to as nanospray if its flow rate is below a few hundred nL/min and as
microspray if its flow rate is between 1 µL/min and 10 µL/min. As the solution reaches
the capillary tip, where a strong electric field is present, the liquid emerges out of the tip
to form Taylor cone and then streams out as a jet, which is subsequently dispersed into a
plume of charged fine droplets. Note that stream and plume are formed as a result of the
strong electric field, not the fluidic pressure. Through the orifice and a differential
pumping system, these droplets are transferred from atmospheric pressure into the
vacuum of the mass analyzer, and free ions are released from the shrinking droplets.

The process of transferring analytes from liquid phase to gas phase is thermodynamically
unfavorable in itself, due to the loss of their solvation energy. Currently the electrospray
process is thought to consist of three steps: (1) generation of charged droplets; (2) a
cascade of uneven fission of charged droplets; and (3) release of ions into gas phase from
fine charged droplets (Hager, 1994; Kebarle, 1999). The strong electric field at the needle
tip attracts cations to the surface of Taylor cone, while repulsing anions away to highvoltage anode to be oxidized to neutral species. The electric force of drawing excess
cations away from anions in bulk liquid can eventually overcome the liquid surface
tension and a fine jet of liquid is ejected. This jet subsequently disintegrates into charged
droplets with a surplus of cations. Due to solvent evaporation from heating, the charged
droplets shrink in size, approaching the so-called “Rayleigh limit”, which is the
maximum charge a spherical droplet can hold before the Coulomb repulsion overcomes
24

Figure 2.1: Image of a stable electrospray. A stable
electrospray consists of Taylor cone, jet and plume. A portion of
the charged fine droplets in the plume are admitted into mass
spectrometer through an orifice in the right (not shown). (Image
from www.NewObjective.com.)
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the surface tension (Taflin, 1989). Once the Rayleigh limit is reached, the droplets eject
about 20 offspring droplets, which carry away about 15% of the charge (excess cations)
and about 2% of the mass from the initial droplet. This process is called uneven fission.
The mechanism for the third step is still under debate. The charge residue model assumes
that cycles of solvent evaporation and uneven fission continue to occur in the offspring
droplets until the droplets contain only one ion, which is released after the solvent
evaporates (Dole, 1968). A competing model, the ion evaporation model, assumes that
ions “evaporate” directly from offspring droplets of 10-nm diameter (Iribarne, 1976).

Ion Trapping Mass Spectrometry

FT-ICR-MS has been the most widely used mass spectrometer for top down proteomics,
because of its high performance in mass measurement (VerBerkmoes, 2002; Kelleher,
2004). In FT-ICR MS, the mass-to-charge ratios of ions are determined based on their
cyclotron frequencies in a magnetic field (Marshall, 1998). The simplified relationship
between the angular cyclotron frequency (ωc) and the mass to charge ratio (m/z) is given
by:

ωc =

B
,
m/ z

(2.1)

where B is the magnetic field strength. Thus, the m/z of an ion can be determined by
measuring its cyclotron frequency in a static magnetic field. For an m/z range of 100–
2500 and a magnetic field of 9.4 Tesla, the cyclotron frequencies span the kHz to MHz
radiofrequency range. Within this radiofrequency range, frequency can be measured with
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excellent precision, and therefore the m/z of ions can be determined with ultrahigh
resolution (Marshall, 1985).

The ions are trapped in the FT-ICR cell radially by the magnetic field and axially by two
electrostatic trapping plates. The trapped ions are excited by a resonantly oscillating
electric field which matches the ions natural cyclotron frequencies to generate a phasecoherent composite cyclotron motion at a large radius (Figure 2.2). The coherently
orbiting ion packet induces an image current on the detection plates, which is recorded as
a time-dependent transient. The detected signal is a superposition of sine waves from ion
packets with different m/z, and can be converted to the frequency domain by fast Fourier
transformation. The cyclotron frequencies of the ion packets can be used to calculate their
mass-to-charge ratios according to Equation 2.1. Therefore, compared with quadrupole
ion trap, time-of-flight and sector instruments, FT-ICR is unique in that all ions are
simultaneously detected and then resolved in the frequency domain. The longer in time
that the image current can be recorded, the better defined the cyclotron resonance
frequency will be, and thus the higher resolution the mass measurement will be.

In the studies described here, all FT-ICR experiments were conducted with an IonSpec
HiResESI FT-ICR instrument (IonSpec, Lake Forest, CA) equipped with a 9.4 Tesla
magnet (Cryomagnetics Inc., Oak Ridge, TN). Samples were introduced to an
electrospray ionization source (Analytica of Branford, CT). The continuously generated
ions were accumulated in an external hexapole gated axially by the skimmer cone and an
exit lens. At the end of the accumulation time period, the ion packet was transferred into
27
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Figure 2.2: Ion cyclotron excitation and detection in FT-ICR cell. A
radiofrequency electric field is generated by the two excitation plates to
accelerate ions to a spatially coherent packet at detectable orbital radius.
Then the ion cyclotron orbital motion is detected by measuring the image
current induced in the two detection plates.
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an rf-only quadrupole ion transfer device and down to the FT-ICR cell for mass analysis.
Usually multiple transients were acquired and co-added to yield a mass spectrum. In
sustained off resonance irradiation collision-activated dissociation (SORI-CAD)
experiments (Gauthier, 1991), a stored-waveform inverse Fourier transform (SWIFT)
pulse was used to isolate a parent ion species from the accumulated ion packet. The
isolated parent ions were excited with an rf pulse (1-4 v p-p, 1s) at a frequency 1 kHz
lower than the parent ion cyclotron frequency. At the same time, a pulse of nitrogen gas
was admitted into FT-ICR cell as collisional gas (maximum pressure of ~ 3 x 10-6 Torr).
After an 8 – 10 second pump-down delay to re-establish the pressure to ~ 3 x 10-10 Torr,
the tandem mass spectrum was acquired.

The FT-ICR instrument was routinely

calibrated with ubiquitin for mass accuracies of ± 5 ppm and mass resolutions of 150,000
(FWHM).

Quadrupole ion traps (QIT) have become the most widely used mass spectrometers for
shotgun proteomics measurements, because of their high-throughput and high-dynamicrange tandem mass spectrometry capabilities. QIT-MS is also an ion trapping instrument.
However, the QIT-MS traps ions with a dynamic electric field but no magnetic field.
QIT-MS has two configurations: three-dimensional form and two-dimensional form.

Three-dimensional QIT consists of two hyperbolic endcap electrodes and a hyperbolic
ring electrode between the two endcap electrodes (Figure 2.3A) (Schwartz, 1996). The
electric field between the three electrodes is composed of an rf field oscillating at ~1MHz
(fundamental rf) and a static electric field. Under this dynamic electric field, the shape of
29

(A)

(B)

Figure 2.3: Three-dimensional quadrupole ion trap. (A)
Schematic drawing of a quadrupole ion trap. The ions are trapped
in the space surrounded by the ring electrode and the two endcap
electrodes. (B) Stability diagram of ions. The shadowed area
shows the theoretical region with both radical stability and axial
stability. (Images from www.MatrixScience.com)
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the ion ensemble oscillates between a spindle axially pulled towards the two endcap
electrode and a disk radially pulled towards the ring electrode. To be trapped in the trap,
ions must have axial stability (z stability) and radical stability (r stability) (Figure 2.3B).
The complex ion trajectories inside the trap are determined by two parameters, az and qz,
which are the x-axis and y-axis, respectively, of the stability diagram. Ions with az and qz
values within the stability region are trapped inside QIT. The value of az is generally zero
in most commercial QIT instruments. The value of qz is determined by the mass-tocharge ratios of ions (m/z), the radial size of the ion trap (r), and the frequency of the
fundamental rf (w) and the amplitude of the voltage on the ring electrode (V), as shown in
equation 2.2:
qz =

4V
m 2 2
⋅r ⋅w
z

,

(2.2)

Ions can be manipulated by changing the electric field inside the ion trap. By scanning
the amplitude of the fundamental rf voltage, ions can be ejected sequentially from low
m/z to high m/z through the holes in the endcap electrode. Detection of the ejected ions
with a conversion dynode and an electron multiplier system during the m/z scanning
yields a mass spectrum. To perform collision-activated dissociation, ions within an m/z
window are isolated by ejecting other ions in the trap, and then kinetic energy is
deposited into the isolated ions by resonance excitation. The collisions between the
excited ions and the helium gas molecules result in fragmentation.

Two-dimensional QIT has a quadrupole made of four hyperbolic cross-sectional rods.
The ions are trapped in an axial fashion in the quadrupole. Similar to three-dimensional
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QIT, two-dimensional QIT acquires mass spectra by ejecting ions out sequentially by
their m/z. A recent commercial implementation of two-dimensional QIT is
ThermoFinnigan LTQ-MS. LTQ-MS achieved many functional enhancements over
three-dimensional QIT, including 15X higher ion capacity, 3X faster scan rate, and 14X
higher trapping efficiency (Schwartz, 2002).

Tandem mass spectrometry

Besides measuring molecular masses, mass spectrometers are capable of interrogating the
structure of an isolated analyte with gas-phase fragmentation. The typical procedure for
tandem mass spectrometry measurement is illustrated in Figure 2.4. In a full scan mass
spectrum, m/z and intensities of all ions species are measured. Different mass
spectrometers can then use different mechanisms to isolate an ion species at a specific
m/z window. The isolated ion species is called the parent ion. Fragmentation is then
induced on the isolated ion ensemble by a variety of different techniques, such as
collision-activated dissociation (CAD) (Senko, 1994), electron capture dissociation
(Zubarev, 1998), electron transfer dissociation (Syka, 2004), infrared multiphoton
dissociation (Little, 1994), black-body infrared radiative dissociation (Price, 1996), etc.
Finally, the product ions are measured by the mass analyzer. As two successive stages of
mass spectrometric analysis, the first one for the parent ions and the second one for the
product ions, are used, this process is called tandem mass spectrometry (MS/MS). The
product ion species are largely determined by the amino acid sequence of peptides or
proteins. For example, when peptides are fragmented with CAD, the major product ions
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Figure 2.4: Tandem mass spectrometry. The four steps for tandem
mass spectrometry are (1) full scan; (2) ion isolation; (3) fragmentation;
and (4) MS/MS scan. The green arrow in the full scan indicates the ion
species to be isolated. When CAD is used for fragmentation, the probable
product ions can be predicted from the peptide sequence. The cleavage
usually occurs on the peptide bond between two residues. The two major
ion series, y ions and b ions, are shown in blue and red, respectively. The
product ions are measured in the MS/MS scan. The mass spectral peaks
corresponding to the predicted y and b ions are highlighted in blue and
red, respectively.
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are y ions and b ions, generated from the cleavage of the peptide bond (Hunt, 1981).
Therefore, the observed product ions of a peptide can be used to infer peptide sequence,
often with a computer algorithm for high throughput identifications.
Although the quadrupole ion traps have limited performance in mass measurement (i.e.
moderate mass accuracy and resolution), this technique excels in fast and automated
tandem mass spectrometry. A three-dimensional quadrupole ion trap can acquire ~15
MS2 scans in a minute, and a linear quadrupole ion trap can acquire ~60 MS2 scans in a
minute. The fast scan rate of MS2 allows examination of more peptides at a given
retention time window in HPLC-MS measurements. The tandem mass spectrometry in
QIT is also highly automated for data-dependent LC-MS/MS analysis; 3 – 5 most
abundant peaks on a full scan are selected for MS2 analysis and then pushed into a rolling
exclusion list to prevent repeated MS2 scans within their chromatographic peaks. The
dynamic gain control feature of QIT also gives this instrument superior sensitivity and
dynamic range for tandem mass spectrometry. To achieve this feature, the QIT varies the
accumulation time of the isolated ions to fill the ion trap with the same amount of ions for
every fragmentation. As the less abundant ions are accumulated for a longer time, high
quality MS2 scans can be acquired from the most abundant ions to the least abundant
ions in a full scan. This is critical for handling the wide dynamic range of a proteome
sample. The large number of MS2 scans acquired in a proteomics measurement
necessitates an automated data analysis procedure. The two representative algorithms for
peptide identification from tandem mass spectrometry are SEQUEST (Eng, 1994) and
MASCOT (Perkins, 1999), which match experimental tandem mass spectra against the
theoretical tandem mass spectra predicted from peptide sequence databases.
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Shotgun proteomics measurement

Shotgun proteomics is the foundation for the studies presented in Chapters 6, 7 and 8. A
shotgun proteomics measurement can be described as a pipeline shown in Figure 2.5. A
proteome is extracted from the pellet of cells grown under conditions of interest. The
proteome can be fractionated to reduce the sample complexity. The obtained protein
mixture is treated with protease, which cleaves all proteins into peptides. The resulting
peptide mixture is then analyzed with liquid chromatography-tandem mass spectrometry
(LC-MS/MS). Trypsin is the most commonly used protease. Trypsin specifically cleaves
at the carboxyl side of the basic amino acids, lysine, and arginine, except when these two
residues are followed by proline. Tryptic peptides generally carry a positive charge on
both the N-terminus and C-terminus and can be ionized efficiently by electrospray
ionization (ESI) and be fragmented readily by tandem mass spectrometry to yield rich
sequence information. Tryptic peptides can also be readily separated at very high
resolution by a variety of liquid chromatography techniques.

As proteolysis greatly increases the sample complexity by turning every protein into
multiple peptides, two-dimensional separation is generally employed in shotgun
proteomics. A number of other liquid chromatography methods have also been coupled
with reverse phase LC to generate two-dimensional liquid chromatography separation for
the peptides. As strong cation exchange (SCX) LC separates peptides based on their
charge and reverse phase (RP) LC separates peptides based on their hydrophobicity, the
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Cell Growth
Cell pellet
Proteome Extraction
Protein mixture
Proteolysis
Peptide mixture
LC-MS/MS
MS data
Peptide Identification
Peptide IDs
Protein Identification
Protein IDs
Figure 2.5: Process pipeline of shotgun proteomic measurement.
Each step of the pipeline is shown in the grey blocks. The first four steps
are experimental steps and the last two steps are computational steps.
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common two-dimensional separation is SCX LC as the first dimension separation and RP
LC as the second dimension separation. In this dissertation, the multidimensional protein
identification technology (MudPIT) has been used for 2-dimensional LC separation (Link,
1999; MacCoss, 2002; McDonald, 2002).

Reverse phase LC is generally interfaced directly with a mass spectrometer via
electrospray ionization in order to minimize post-column peak broadening and to increase
analysis throughput. Peptides are automatically selected for the tandem mass
spectrometry measurement, and the fragmentation product ions of peptides can yield
sequence information needed for computer algorithms to definitively identify peptides.
Finally, the identified peptides are computationally assembled into proteins, using a
protein sequence database. Here, the computer programs, SEQUEST (Eng, 1994) and
DTASelect (Tabb, 2002), are used for peptide identification and protein identification,
respectively.

The metabolically versatile bacterium Rhodopseudomonas palustris

R. palustris is a purple non-sulfur phototrophic bacterium (Figure 2.6). It has been
recognized as one of the most metabolically versatile bacteria. R. palustris is capable of
utilizing three energy sources (light, inorganic compounds, and organic compounds), two
carbon sources (wood-derived compounds and carbon dioxide), and three electron donor
sources (oxygen, carbon, and nitrogen) in response to different growth conditions
(Larimer, 2004). Because of its extraordinary adaptability to different environmental
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(A)

(B)

Figure 2.6: Rhodopseudomonas palustris. (A) The clustered bacterial
cells under microscope. (B) batch growth in laboratory under the
anaerobic photoheterotrophic state. Figure courtesy of Dr. Dale A.
Pelletier.
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conditions, R. palustris is widely distributed in nature, including soil, aquifers, aquatic
sediments, underground water, pond water, etc (Oda, 2003). This bacterium grows under
all the four types of metabolism: photoautotrophic (energy from light and carbon from
carbon dioxide), photoheterotrophic (energy from light and carbon from organic
compounds), chemoheterotrophic (energy and carbon from organic compounds), and
chemoautotrophic (energy from inorganic compounds and carbon from carbon dioxide)
(Larimer, 2004). The respiration mode of R. palustris can be switched between anaerobic
growth and aerobic growth according to oxygen availability (Harwood, 1988). Hence, R.
palustris is used as a model organism to study how a biological system responds to
changes in carbon, nitrogen, electron, and energy sources by adjusting its gene expression
profile and metabolic network.

R. palustris also has the remarkable capability to degrade diverse aromatic compounds
under anoxic environments (Dutton, 1967). Biodegradation of aromatic compounds is a
vital link in the carbon cycle of our ecological system. Recycling of lignin, perhaps the
second most abundant carbon polymer on Earth, requires degradation of its phenolic
monomers (Kirk, 1984). The large quantities of industrially-generated aromatic
contaminants in the environment necessitates remediation, and one possible remedy
appears to be biodegradation (Xu, 1996). These aromatic compounds are often released
into anoxic environments. Although many bacteria can catabolize aromatic compounds
with oxygen (Zylstra, 1991), R. palustris is one of a few bacteria capable of disrupting
benzene rings by a reduction reaction without using oxygen (Harwood, 1999). Thus, R.
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palustris is a model bacterium to understand anaerobic aromatic compound degradation
pathways and their regulation.

R. palustris also draws tremendous interest because of its potential to be engineered for
generating hydrogen as biofuel (Barbosa, 2001). Although there are other bacteria that
can produce hydrogen using hydrogenase, the reaction is reversible, which prevents
significant hydrogen accumulation in a closed chamber (Hilhorst, 1982). R. palustris
possesses three nitrogenases for fixing dinitrogen gas and generating hydrogen (Oda,
2005). Although the nitrogenase activity requires large amount of ATP, the reaction is
largely irreversible. Thanks to the metabolic diversity of R. palustris, it can collect ample
energy from sunlight through photosynthesis and derive copious reducing equivalents
through aromatic compound degradation.

Because of these interesting features of R. palustris, its genome was sequenced in 2004
(Larimer, 2004). The genome consists of a circular chromosome with 5,459,213 base
pairs and a plasmid with 8,427 base pairs. A total of 4,836 genes are predicted from the R.
palustris chromosome. Its metabolic versatility is conferred by the large number of genes
involved in cellular metabolism, which account for 31% of the predicted genes. R.
palustris harbors 451 potential regulatory and signaling genes to sense the environment
for different resources and regulate the metabolism genes for optimal growth. While most
bacteria devote 5–6% of genes in their genome to transportation, R. palustris has 325
transport systems comprising at least 700 genes, which sum up to about 15% of the
genome. Many of the transport systems are hypothesized to be responsible for aromatic
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compound trans-membrane transportation. All the studies described in this dissertation
focus on R. palustris as a model organism for methodology development and biological
application.
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Chapter 3
Multipole-Storage Assisted Dissociation for Characterization of Large
Proteins and Protein Mixtures

All of the data presented below has been published as
C. Pan, R.L. Hettich. Multipole-Storage-Assisted Dissociation for the Characterization of
Large Proteins and Simple Protein Mixtures by ESI-FTICR-MS. Analytical Chemistry
2005, 78, 3072-3082.
C. Pan’s primary contributions include experimental design, FT-ICR measurement and
data interpretation.
INTRODUCTION

High-resolution MS experiments with Fourier transform ion cyclotron resonance (FTICR) mass spectrometry provide exquisite information about the molecular masses of
intact proteins. However, for unambiguous identifications, it is advantageous to
supplement these measurements with ion fragmentation experiments to obtain in-depth
information on protein sequence, post-translational modifications, and even higher order
structure (Kelleher, 1999). For example, a wide range of dissociation techniques for
intact proteins have been implemented in the analyzer cell of FT-ICR mass spectrometers,
including sustained off resonance irradiation collision-activated dissociation (SORI-CAD)
(Senko, 1994), electron capture dissociation (ECD) (Zubarev, 1998), infrared
multiphoton dissociation (IRMPD) (Little, 1994), and black-body infrared radiative
dissociation (BIRD) (Price, 1996). The most common procedure for conducting these ion
43

dissociation methods involves isolating an ensemble of parent ions at a given mass-tocharge ratio (m/z) inside the analyzer cell, and then activating the trapped parent ions by
these different methods to achieve fragmentation. While these dissociation methods have
proven to be quite valuable, they have severe limitations for very large proteins and for
the high-throughput investigation of protein mixtures.

Most current FT-ICR mass spectrometers also utilize a second ion-trapping/
accumulation device: an external rf-only hexapole or octapole bounded by electrostatic
elements (Senko, 1997). Electrosprayed ions traverse the skimmer cone and are
accumulated in the rf-only linear multipole storage trap by employing a dc-controllable
gate electrode at the exit end of the multipole, as illustrated in Figure 3.1. The voltage
and timing of this gate provides the ability to accumulate ions for a desired period of time,
after which they can be transported out of the multipole and down to the FTICR analyzer
cell for mass/charge measurement. Because electrospray ionization (ESI) is continuous,
the multipole functions as a linear ion trap to admit and accumulate a sufficient ion
population for eventual FT-ICR ion detection. New fragmentation techniques for FTICRMS have been developed by exploiting ion dissociation in this linear ion trap, with either
gas phase collisional activation accomplished with multipole-storage assisted dissociation
or MSAD (Sannes-Lowery, 1998; Hakansson, 2000; Palmblad, 2000; Sannes-Lowery,
2000; McDonnell, 2002; Keller, 2004), “ion thrashing” (McFarland, 2004) or photoninduced dissociation (termed external IRMPD) (Hofstadler, 1999; Hofstadler, 2003)
While these approaches may seem to be a minor variation of the established CAD
techniques listed above, in fact these multipole dissociation methods afford a number of
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Ion acc. voltage +20V
MSAD voltage +20V
Ion Inj. voltage +20V
heated capillary skimmer

-3.5V
-7.0V
-7.0V
hexapole

+5V
+5V
+0V
exit lens quadrupole

MSAD
External IRMPD
Ion thrashing

FTICR cell

SORI-CAD
ECD
IRMPD

Figure 3.1: Ion optics of FT-ICR mass spectrometer (not drawn to scale). During the ion accumulation
stage, ions flow through skimmer and are trapped in hexapole, confined radially by the rf voltage of the rods
and axially by the skimmer voltage, exit lens voltage and hexapole dc offset voltage. MSAD, ion threshing,
and external IRMPD can be accomplished in this stage at the location indicated. During ion injection stage,
ions are transferred through quadrupole and are trapped in FT-ICR cell primarily by the magnetic field.
Conventional CAD, IRMPD, ECD etc. can be induced at this stage inside FTICR cell. Voltage settings are
listed directly above the appropriate electrostatic component.
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advantages, including eliminating the need for a collision gas in the high vacuum region
of the FTICR instrument, and the ability to conduct multiplexed fragmentation at
relatively high energies.

MSAD was first observed by accumulating ions in the multipole for an extended
timeframe (Sannes-Lowery, 1998). It was postulated that once the ion density reaches
the space charge limit in the multipole, the Coulomb force will push the ion ensemble to
spread out radially, enabling the ions to oscillate at higher amplitude. This would allow
coupling of the rf energy in the hexapole rods to the ions, effectively accelerating them to
higher kinetic energy (Hakansson, 2000; Sannes-Lowery, 2000; Belov, 2001).
Fragmentation then would result from the collisions of excited ions with the background
gas molecules in the hexapole (typically air at ~10-5 Torr), and thus is generally regarded
as a form of CAD. Like nozzle-skimmer collisional activated dissociation, MSAD is also
an in-source fragmentation. Compared with SORI-CAD, MSAD obviates the need for
introduction of collisional gas into the analyzer cell and subsequent pump-down.
However, in an rf-only multipole, no parent ion selection is possible; thus MSAD
fragments all species present, which limits its use in a targeted fragmentation experiment.

We have undertaken a systematic investigation of ways to control the collision energy
and fragmentation pattern for intact proteins to evaluate this MSAD process.

In

particular, we have focused on examination of the hexapole dc offset voltage and
accumulation time, which are the two key parameters in controlling the ion population.
Seven representative proteins covering a molecular mass range of 8-116 kDa were
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employed to study the fragmentation pattern of intact proteins under a variety of MSAD
conditions. In addition, the ability to conduct MSAD experiments on protein mixtures
was also investigated.

To extend the capabilities of MSAD, we have devised an experimental method in which
selected MSAD fragment ions were subjected to a further stage of tandem mass
spectrometry in the FTICR analyzer cell. This MS3 type experiment enables coupling of
the efficient, relatively high-energy MSAD process with the more selective SORI-CAD.
The goal of this approach was to generate sequence tag information by dissociation of the
MSAD fragment peptide for protein identification, in a manner analogous to generating
sequence tags by dissociation of peptides from enzymatic digestion (Mann, 1994).
McLafferty and coworkers have employed a similar approach to directly generate
sequence tag from intact proteins (Mortz, 1996; Horn, 2000a). They have shown that a
sequence tag and an intact protein mass were sufficient to identify a protein from a
protein database. Although this approach appears to be quite promising, there are at least
three major challenges that complicate this method. First, the fragments of intact proteins
are usually very large and exhibit a wide isotopic package. When comparing the masses
of two adjacent fragment ions in an effort to identify the residual amino acid, the
difficulty in accurately choosing the correct isotopic mass in each packet can lead to the
so-called ‘1 Da error’ (Horn, 2000b). Because these high-resolution measurements do
not directly determine the average molecular masses, transposing the measured isotopic
masses into an average value has some inherent uncertainty due to the variation in peak
height abundances (which can skew the calculated average mass value and thus degrade
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the resolution of the mass measurement). Either way of calculating the mass difference
will compromise the reliability of obtaining sequence tag information from an unknown
protein. Second, due to the large size of intact proteins and their residual tertiary
structures, it is very difficult to establish a standard dissociation energy that can induce
substantial fragmentation at multiple consecutive peptide bonds, which prevents
implementing this approach in a robust fashion to most proteins. Third, the standard
dissociation techniques (SORI-CAD, ECD, IRMPD) are virtually ineffective for
dissociating very large proteins (Mr > 100 kDa). In contrast, obtaining sequence tag
information from peptides that are generated by proteolytic digestion is relatively
straight-forward to measure and interpret. In fact, the MS3 approach consisting of an insource dissociation step and a conventional dissociation step has been used for deriving
sequence information from oligonucleotides, oligosaccharides, peptides, and intact
proteins (Chen, 2001a; Raska, 2002; Suckau, 2003; Ginter, 2004). Recently, a new
sequence tagging approach for intact protein with in-source dissociation has been shown
by using a class of "mass defect" tags incorporating the element 35Br (Hall, 2003). While
the objectives of this study are similar to those aforementioned techniques, we feel that
the capabilities of the MSAD technique, in particular for efficient high-energy
dissociation, make this uniquely suited for this approach. We propose that MSAD can be
used to efficiently generate small fragment ions from intact proteins with molecular
masses exceeding 100 kDa, and these fragment ions can be further dissociated to give
sequence tag information.
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MATERIALS AND METHODS

All protein standards were acquired from Sigma-Aldrich (St. Louis, MO) and used as
received with no additional purification. Samples for mass spectrometry were prepared at
formal concentrations of 520 µM in 50:50 (v/v) acetonitrile:water, with 0.1% acetic acid
added. All mass spectrometry experiments were conducted with a HiResESI Fouriertransform ion cyclotron resonance mass spectrometer (IonSpec, Lake Forest, CA)
equipped with a 9.4T magnet (Cryomagnetics Inc., Oak Ridge, TN). Samples were
introduced to an electrospray source (Analytica of Branford, CT) by direct infusion at 2–
3 µl/min. Ions were accumulated in an external hexapole situated between the skimmer
cone on one end and an exit lens and mechanical shutter (Figure 3.1) on the other. The
static pressure in this region of the instrument was typically around 2 x 10-5 Torr. At the
end of the accumulation time period, the exit lens voltage was dropped to zero and a
mechanical shutter was pulsed open to allow ion transfer into an rf-only quadrupole ion
transfer device and down to the ICR cell. In SORI-CAD experiments, ion accumulation
(typically 0.5 to 3 s) was followed by ion isolation, which was accomplished with a
SWIFT pulse. Off-resonance ion excitation was achieved with an rf pulse (1-4 v p-p, 1s)
at a frequency 1 kHz lower than the parent ion cyclotron frequency, in the presence of
nitrogen which was admitted with a pulsed valve to a transient pressure of 5 x 10-6 Torr.
An 8-10 s pump-down delay was inserted to allow the base pressure to re-establish (~ 3 x
10-10 Torr) prior to ion detection.

For normal ESI-FTICR-MS experiments, ion

accumulation was usually performed for 0.5 to 3 s at a hexapole dc offset voltage of –3.5
v, as shown in the top line of Figure 3.1. This yielded multiply-charged molecular ions
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with virtually no fragmentation. To achieve MSAD, ion accumulation/ activation was
accomplished by lengthening the accumulation times (2–8 sec) and adjusting the
hexapole dc offset voltage (–7 to –12 v). This condition creates a deeper axial potential
well than the standard offset setting (–3.5 v) and promotes ion fragmentation during the
accumulation period. Discrete parent ion isolation and collision gas pump-down delay
times were not necessary, so overall scan times for MSAD were determined solely by the
accumulation times (~2–6 s per scan). Each spectrum was comprised of ten co-added
scans acquired at 512K data points/transient, and external calibration was performed with
ubiquitin; these conditions typically result in mass accuracy of ± 5 ppm and resolutions of
150,000 (FWHM) for intact proteins. Product ion spectra were deconvoluted to zero
charge state with the IonSpec software deconvolution tool. Sequence tags were identified
by manual inspection of the deconvoluted spectra in following steps. First, the mass
difference between two fragment ions masses and between fragment ion and parent ion
mass were calculated and an amino acid was assigned if this mass difference
corresponded to an amino acid mass, denoted by |Å Æ| in the tandem mass spectra.
Second, the mass differences between the parent ion mass and the sum of two fragment
ion masses were calculated. If the two fragments are complementary ion types (e.g. y
and b ion type) and have an amino acid between them, then the mass difference
calculated would give the identity of this amino acid, denoted by Æ| |Å in tandem mass
spectra. If this mass difference corresponded to an amino acid mass, these two fragments
may have arisen from two complementary ion fragment species (e.g. y or b ions) with
this amino acid situated between them. Third, contiguous identified amino acids
constituted a sequence tag.
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RESULTS AND DISCUSSION

Experimental Parameters for Controlling MSAD in a Hexapole Storage Trap

In order to optimize the MSAD technique, a systematic examination of the experimental
parameters governing this dissociation method was undertaken. The two key factors
involved in MSAD (at similar protein concentrations) were observed to be the ion
accumulation time in the hexapole and dc offset voltage.

The dependencies on

accumulation time, rf amplitude, skimmer and exit lens voltages, and target gas pressure
in hexapole have been discussed previously (Hakansson, 2000; Sannes-Lowery, 2000),
but the effect of the dc offset voltage has not been reported in literature.

The dc offset voltage controls the depth of the electrostatic axial well. To probe the
effect of dc offset voltage on fragmentation, we examined the MSAD of the protein
apomyoglobin with the accumulation time maintained at 4 seconds and all other
parameters kept constant. When dc voltage is between -3.5 v and -6 v, mass spectra
revealed no fragmentation for most protein ions, as shown in Figure 3.2A for
apomyoglobin. A sharp threshold for dissociation is observed at dc offset voltages
between –6 v and –7 v. For example, at –6.5 v, apomyoglobin dissociates into two types
of fragments; a few abundant multiply-charged fragments and many low-abundance
singly-charged fragments (Figure 3.2B). At –7 v, low-mass, singly-charged fragments
dominate the mass spectra (Figure 3.2C). From –7 v to –11 v, no noticeable differences in
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Figure 3.2: Apomyoglobin MS2 from MSAD. The ion
accumulation time and hexapole dc offset voltage offset
respectively are at 4 sec and –6.0 v (A), 4 sec and –6.5 v (B), 4 sec
and –7 v (C) and 1.4 sec and –10 v (D). A sharp threshold of
hexapole dc offset voltage for MSAD from no dissociation (A) to
extensive sequential dissociation (C) was observed. Similar
fragmentation can be achieved by long accumulation time and high
dc offset voltage (A) or short accumulation time and very high dc
offset voltage (D). The intermediate condition for MSAD yielded
two distinctive population of fragments, singly charged small
fragments and highly charged large fragments (B).
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(A)

(B)

Figure 3.2: Continued.
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(C)

(D)

Figure 3.2: Continued.
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fragment ion species are observed. However, a more negative dc voltage will induce
fragmentation at a much shorter accumulation times (Figure 3.2D). These results indicate
that even at a fixed ion accumulation time in the hexapole, the magnitude of the dc offset
voltage has a dramatic effect on ion fragmentation.

The information obtained above suggests that a combination of dc offset voltage and ion
accumulation time can be used to effectively control the degree of fragmentation in a
MSAD experiment. Empirically, the lower boundary for fragmentation to occur involves
accumulation times of at least 1200 ms and for dc voltages of at least -6.5 v for the
protein samples (~uM concentration) that were examined in this study.

The ion storage/accumulation capability of a hexapole is controlled by the confining
forces of the multipole device. In particular, the electrostatic potential created by the rfonly mode of operation of a hexapole provides extensive ion confinement in the x-y
direction (i.e. perpendicular to the hexapole rods), and somewhat more limited ion
confinement in the z-direction (parallel to the hexapole rods). By employing electrostatic
voltage confinement at the ends of the hexapole, it is possible to accumulate and store
ions for an extended period of time in the hexapole device. Previous reports have
suggested that extended ion accumulation results in a sufficiently large ion population for
which space charge pushes the ions outward radially and allows energy coupling with the
rf-only hexapole rods. However, our experiments on the dc offset voltage and previous
reports on the skimmer and exit lens voltage (Sannes-Lowery, 2000; Belov, 2001) have
revealed that the depth of axial potential well is critically important, and can induce
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fragmentation. These results suggest an alternative fragmentation process. Because the
voltage at the entrance of the hexapole is static (usually held at 25 v in our experiments),
the lowering of the dc offset on the hexapole to more negative voltages will induce a
translational energy component to the ions as they enter the hexapole. Since the ions are
confined in the hexapole in a multiple pass configuration along z-direction, even a
modest amount of translational energy added as the ions enter the multipole device will
result in substantial fragmentation. Note that the higher charged parent ions will pick up
a proportionately higher translational energy as they enter the multipole. Therefore,
while we cannot rule out the possibility of rf-coupling with the hexapole rods as the
energy source for fragmentation, we believe that we have identified an additional MSAD
fragmentation mechanism, in which a translation energy component can be exploited to
produce substantial ion fragmentation in the multipole device. Note that MSAD is a
single excitation process; whereas ion thrashing is multiple excitation process that can be
tuned somewhat (McFarland, 2004).

Although variation of sample concentration, rf amplitude, skimmer and exit lens voltages
and collision gas pressure in the hexapole undoubtedly would also affect the MSAD
experiment, those parameters were not examined in this study. Control of the collisional
energy was based only on the dc offset voltage and accumulation time.
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Single Protein MSAD: Identification of Fragmentation Extent and Ion Types

A range of proteins were examined with MSAD, to determine the general utility of the
technique as well as investigate any sequence dependent fragmentation. Previously, only
limited research had been conducted on pure small to medium sized proteins over a
narrow low energy range.

In this study, we have conducted MSAD over a wide

collisional energy range on seven individual proteins whose molecular masses range from
8-115

kDa

(ubiquitin,

lysozyme,

apomyoglobin,

ß-lactoglobulin

B,

carbonic

dehydrogenase, serum albumin, and ß-galatosidase). The proteins examined in this study
exhibit substantial diversity in their amino acid sequence, molecular weight, and number
of disulfide bonds present, and thus should represent a general case for other proteins. All
protein samples were prepared by directly solubilizing the protein into the ESI solution
(see MATERIALS AND METHODS section). Due to the preservation of disulfide
bonds and the gentle experimental conditions, these proteins may have a large amount of
residual tertiary structure.

It has been demonstrated that proteins have similar fragmentation behavior in low energy
MSAD experiments and in SORI-CAD experiments (Hakansson, 2000). We also have
verified this trend under our experimental conditions (Uchiki, 2002; Keller, 2004). In our
study, MSAD with accumulation times ranging from 2000 – 3000 ms, and dc voltages
ranging from -6.0 to -6.5 v were regarded as low energy conditions. This rather empirical
range is defined as low energy based on the experimental observation of a small amount
of fairly large fragment ions for most of the proteins examined. In these typical low
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energy MSAD experiments, the mass spectra consisted of a few large y- and b-type ions
derived from the parent molecular species. The observed fragmentation is less extensive
in low energy MSAD experiments than in SORI-CAD experiments. However, the types
of fragment ions common to MSAD (i.e, y- and b-type species) are quite similar to
SORI-CAD experiments and differ substantially from ECD (which is predominantly cand z-type ions). In particular, both MSAD and SORI-CAD not only reveal similar types
of fragment ions (Keller, 2004), but also a common preference for dissociation at
residues such as proline, asparatic acid, and glutamic acid in some cases. These results
verify that MSAD is a gas-phase collisional activated dissociation process, and may serve
as a higher duty cycle experiment than SORI-CAD (provided that ion isolation is not
required). A large amount of undissociated parent ion is present in the low energy
MSAD experiment, which indicates there is no clear cutoff between the normal MS
experiment and the low energy MSAD experiment.

Even though low energy MSAD is attractive due to its similar fragmentation with SORICAD, high-energy dissociation makes MSAD unique among SORI-CAD and nozzleskimmer CAD in terms of the amount of collisional energy that can be put into protein
ions. High-energy collisions can be achieved simply by elongating the accumulation
time and/or adjusting the magnitude of the dc offset voltage. In this study, we found 4-sec
accumulation time and -7 v dc offset is a generic high energy MSAD condition that can
be employed to dissociate most proteins.
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This MSAD process technique is illustrated for the protein beta-lactoglobulin B in Figure
3.3. “Normal” electrospray mass spectra can be acquired easily with a modest
accumulation time (2 sec) and dc offset (-3.5 v), and reveal multiply-charged ions
corresponding to the protonated molecule with no fragmentation (Figure 3.3A). The inset
reveals the isotopic resolution of the deconvoluted molecular ion region, illustrating the
high resolution capabilities of the FTICR-MS technique. By altering the hexapole
conditions to those listed above for high-energy MSAD (i.e. 4 sec accumulation time
with -7 v dc offset), it was possible to completely dissociate the protein into small,
singly-charged fragment ions, as shown in Figure 3.3B. Similar fragmentation results
from high-energy MSAD experiment were observed in all other examined proteins. The
MSAD fragments are generally small, singly charged, abundant, and quite distinct for
different proteins. When longer accumulation times and more negative dc offset voltages
were used, the types of fragment ions remain basically the same, although their relative
abundances vary and the overall signal/noise for the spectra decreases. The small size of
the fragments suggests they may come from sequential fragmentation. This is further
supported by the identity of fragments determined by the sequence tag technique, as will
be discussed below. Thus these MSAD fragments correspond to not only classical
terminal fragment species such as y- and b- ions, but also internal fragment species such
as y/b ions from parent ion. In our proposed MSAD mechanism, the sequential
fragmentation may be a result of ions’ multiple pass in the z-direction in hexapole.
Alternatively, this could be explained with the space-charge repulsion mechanism by
considering the continuous deposition of energy through rf-coupling with the hexapole.
Thus high-energy MSAD tandem mass spectra for large proteins, while complex, are not
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(A)

Figure 3.3: Examination of ß-lactoglobulin B MS3 by MSAD/SORI-CAD.
A sequence tagging experiment consists of normal MS (A) for determining
molecular weight of intact protein, MS2 (B) from MSAD for identifying
fragments and MS3 (C) from MSAD/SORI-CAD for acquiring sequence tag
from a MSAD fragment. The deconvoluted mass spectrum and protein
sequence is show in (A) inset. The MSAD fragment indicated with an arrow in
(B) is isolated and fragmented, as shown in (C). This fragment is highlighted
in the protein sequence with sequence tag underlined. Most ions in MS3 can be
identified using the general rules of peptide CAD fragmentation.
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(B)

(C)

Figure 3.3: Continued.
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completely intractable. Many of the initial fragment ions are not stable enough to survive
the multiple high-energy collisions. The most stable fragments, corresponding to the
abundant peaks in the spectrum, are undoubtedly dictated by their sequence, the sequence
surrounding them, the residual protein tertiary structure, and the distribution of positive
charges. Because the stable fragments are fairly characteristic for each protein (due to
the complex factors involved), we refer to them as “MSAD signature”, which potentially
could provide identification of a protein.

As a remarkable demonstration of the high collisional energy, MSAD was used to
fragment ß-galatosidase, which has a molecular mass of 116,351 Da (Figure 3.4A). Note
that because the translational energy gained scales proportionally to the protein’s charge
state, the accumulation time and dc offset voltage of the MSAD experiments for ßgalatosidase are identical with those for smaller proteins. To our knowledge this may be
the most extensive fragmentation of a protein whose molecular mass is over 100 kDa.
With conventional CAD, IRMPD or ECD experiments, even if fragmentation could be
achieved, the fragments of this protein most likely would still be too large to be easily
resolved in FTICR-MS. In contrast, the sequential fragmentation under MSAD was able
to dissociate the intact protein to fragment ions that are easily measured.

Under “normal” hexapole ion accumulation conditions, no fragmentation occurs. In low
energy MSAD, limited dissociation occurs to generate large fragment ions. In high
energy MSAD, sequential fragmentation occurs until only small singly- or doublycharged fragments remain. This leaves one to speculate about a protein’s fragmentation
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Figure 3.4: Examination of ß-galatosidase MS3 by MSAD/SORICAD. Despite this protein’s large size (~116 kDa), MSAD with 4 sec.
ion accumulation and –7.0 v dc offset voltage generated a complex
pattern of small fragments (A). Its MSAD condition and fragmentation
pattern were similar to other medium-sized proteins. Sequence tag
information was then derived (B) with MSAD/SORI-CAD from a
MSAD fragment. This fragment is a y/b ion resulted from sequential
fragmentation during MSAD.
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(A)

(B)
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behavior in the intermediate energy MSAD experiment. By definition, intermediate
energy MSAD should give medium size fragments with multiple charges (more than
three). When using experimental conditions intermediate between high energy MSAD
and low energy MSAD, the simultaneous coexistence of large fragments and small
fragments, instead of medium size fragments, was observed (Figure 3.2B). Such a sharp
transition between high and low energy MSAD suggests that intermediate energy MSAD
may be difficult to achieve. This is probably because once sufficient collisional energy
conditions are achieved in an MSAD experiment, the sequential fragmentation process
will continue to reduce mid-sized fragment ions to the smaller, more stable species.

Sequencing MSAD Fragment Ions by Subsequent SORI-CAD

High-energy MSAD is a very efficient way to generate small-sized, singly charged
peptides. When subjected to SORI-CAD experiment, many of these fragment peptides
produce an easily interpretable tandem mass spectrum that often yields a sequence tag for
the protein. This MS3 experiment is illustrated with ß-lactoglobulin B in Figure 3.3. The
accurate mass of the multiply charged intact protein is first measured with a normal mass
spectrum (Figure 3.3A). Then the accumulation time is extended to 4 s and the dc offset
voltage is decreased to –7 v to acquire this protein’s MSAD tandem mass spectrum
(Figure 3.3B). Now the high complexity of the fragmentation products is actually
advantageous for offering a wide range of peptide fragments for SORI-CAD
interrogation. The SORI-CAD tandem mass spectrum of an abundant fragment ion
species of m/z 986.6 is shown in Figure 3.3C. A sequence tag [VEE] can be found and the
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parent ion of m/z 986.6 can be identified from ß-lactoglobulin B sequence as y126b43,
which is shown in boldface in protein sequence in Figure 3.3C’s inset with the sequence
tag underlined. This is direct evidence of the identities of high-energy MSAD fragments
to be internal fragments. Most of the fragment ions of the y126b43 parent ion can be
readily attributed to common y-, b- and a-type ions, along with internal fragments and
ions resulting from loss of water or ammonia. MS3 experiments from MSAD/SORI-CAD
have a comparable S/N level to MS2 experiments from SORI-CAD alone. This is
probably because the dissociation and fragment ion collection efficiencies in the MSAD
experiment are very high.

Identification of large intact proteins (>100kDa) has been a challenge, as large proteins
can neither be easily measured in mass nor be dissociated to give informative tandem
mass spectra. We have shown the extensive dissociation of ß-galatosidase with high
energy MSAD (Figure 3.4A). Once large proteins are dissociated into small peptide
fragments, these ions are no different from those of small proteins. Thus we conducted
MSAD/SORI-CAD experiment on the ß-galatosidase MSAD fragment ion of m/z 1042.6
with identical MSAD and SORI-CAD conditions as ones for ß-lactoglobulin B. Two
sequence tags from both ends of this fragment are identified (Figure 3.4B), verifying that
this fragment ion is a y232b801 ion. Although only two-residues long, the two sequence
tags along their parent peptide’s mass provide enough information to identify this protein
from SWISS-PROT database. Thus MSAD/SORI-CAD presents a unique way to
characterizing large proteins.
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Table 3.1 summarizes the information on the sequence tags and their parent MSAD
fragments from different proteins. Most of those MSAD fragments are small singlycharged y/b ions with high abundance in MSAD tandem mass spectra. They are often the
fragmentation products of cleavage next to P or D. The sequence tags generally arise
from the cleavage of two or three peptide bonds next to the peptide termini. For all of
these sequence tag measurements, a 4-second accumulation time and -7-v dc offset
voltage were used for MSAD, and 3.7 v excitation voltage was used for SORI-CAD.
SORI-CAD tandem mass spectra were interpreted and sequenced manually as described
in experimental section. High confidence sequence tag determination can be achieved
from the accurate mass measurement of FT-ICRMS, the simple isotopic envelope, the
small size of parent ion, and the sparse fragment ions in the tandem mass spectra. In
addition to peaks that contribute to the sequence tag, there are other, less informative
peaks coming from loss of water, ammonia, a-type ions, or other internal fragmentation.
A fraction of MSAD fragments do not generate sequence tags because of limited
fragmentation of parent ion due to their small size or amino acid sequences. Because the
standardized MSAD/CAD conditions yield a rich diversity of fragment ions, many
MSAD ions can be evaluated with reasonable effort and time. In this study, SORI-CAD
was conducted only on a few major MSAD fragments. In our initial survey, we were
unable to obtain sequence tags from major MSAD fragments of lysozyme and carbonic
dehydrogenase; however, there may be other less abundant MSAD fragment ions from
these proteins that could yield such information.
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Table 3.1: Summary of the proteins examined with MSAD/SORI-CAD.

Protein

a

MW

Sequence tag

Parent ion
1+

y42u118

I.IHVLHSK.H

1+

y126b43

A.PLRVYVEE.L

1+

y472b118

D.LPKLKPD.P

y232b801

N.DIGVSEATRI.D

X2 ( I/L )( K/Q )( K/Q ) E Xn

699.8

Myoglobin

16,951

( I/L ) H V ( I/L ) H X2

784.5

Lactoglobulin

18,281

Xn V E E

986.6

Serum albumin
Galatosidase

66,433
116,351

( I/L ) P ( K/Q )( I/L )( K/Q ) P D

792.5

1+

D ( I/L ) Xn R ( I/L )

Sequence

y18

8564

Ubiquitin

Identity

3+

1042.5

D.YNIQKESTLHLVLRLRGG

a. Lysozyme (14kDa) and carbonic dehydrogenase (35kDa) were not included since we were unable to
generate sequence tags from the major fragment ions of these two proteins.
b. The cleavage type at the C-terminus of this peptide is nonstandard and is denoted by "u" to indicate a
fragment 31.0 Da less than that from b-ion type cleavage, possibly due to side chain cleavages.
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There are three unique advantages for this MSAD/SORI-CAD method that make it most
promising to be applied in a high-throughput manner for obtaining sequence tags. First,
unlike other fragmentation methods, MSAD/SORI-CAD has no discrimination against
large proteins or certain types of proteins. As demonstrated with several different
representative proteins here, MSAD dissociates proteins regardless of their heterogeneity
into uniform small peptides, which can then be fragmented to yield sequence tags.
Secondly, generic experimental conditions for MSAD/SORI-CAD experiments work for
most proteins. The automation of tandem mass spectra processing is also straightforward
due to the high interpretability of the peptide tandem mass spectra and the continued
development of computational tools for processing peptide CAD spectra. Third, MSAD
of any protein yields a large number of MSAD fragments that can be surveyed by an
additional step of SORI-CAD. This might provide a versatile method for investigation of
sequence tag information from proteins.

The main disadvantage of this MSAD/SORI-CAD method is that the success of obtaining
sequence tag from a given MSAD fragment is variable. This is probably because both
MSAD and SORI-CAD are induced by collisions with gas molecules. The fragments that
could survive MSAD are less likely to be fragmented easily by SORI-CAD again. A
possible solution to this is to employ other dissociation methods such as IRMPD to
dissociate MSAD fragments.
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Simple Protein Mixture MSAD: Identification of Protein Components

Despite the inability of MSAD to isolate a parent ion for subsequent fragmentation, two
methods were attempted to identify proteins from mixtures up to four components:
inspection of the MSAD signature for each protein and MS3 to obtain sequence tag
information. Experimental approaches that provide multiplexed tandem mass
spectrometry capabilities are beginning to appear (Masselon, 2000; Meng, 2001; Purvine,
2003) and provide the potential for high-throughput measurements of complex mixtures.
Even without parent ion selection, MSAD can be employed for generating multiplexed
tandem mass spectra for protein mixtures. The challenge for the application of MSAD in
this case, much like the other multiplexed CAD techniques, is the interpretation of the
complex fragmentation patterns. Because of the high degree of internal fragmentation for
MSAD, it appears that the spectra interpretation for this method will be formidable,
especially for de novo sequencing or correlation-related computational techniques to
identify proteins. However, the abundant MSAD fragments are quite characteristic for
each protein, and, at high resolution and high mass accuracy, could be used to generate a
protein's MSAD signature. Thus a protein's presence in a mixture could be suggested by
its high-resolution, accurate fragment ion mass MSAD signature. A protein mixture with
four components at equal ratio was examined with high-energy MSAD. The tandem mass
spectrum was then compared with the previously acquired MSAD tandem mass spectra
of each of the proteins. Most of major fragments were confidently attributed to one and
only one component protein due to the high mass accuracy and the uniqueness of their
MSAD signature (Figure 3.5A). Thus, ubiquitin, apomyoglobin, and serum albumin can
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(A)

Figure 3.5: MSAD MS3 of a four-protein equimolar mixture. The mixture
consists of ubiquitin, Apomyoglobin, Lactoglobulin and serum albumin (A). The
origin of fragments were determined by matching with individual protein’s
MSAD fragments and labeled with protein name’s initial in the spectrum. The
MSAD fragments can be then used to generate sequence tag of the component
proteins (B, C). Note that a pair of single-headed arrows pointing each other
(
) denotes that the mass differences between the parent ion mass and
the sum of two fragment ion masses corresponds to an amino acid, which wraps
sequence tag from y ion series to b ion series or vice versa. .
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(B)

(C)

Figure 3.5: Continued.
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be identified by their MSAD signature. However, lactoglobin's MSAD signature is not
discernible in this mixture, probably due to the discrimination against lactoglubin by
electrospray ionization and/or MSAD. In general, we estimate that the dynamic range for
protein identification by MSAD in mixtures might range to at least 1:10. This should be
tempered with the knowledge that ionization suppression in the ESI source may suppress
the observed signal of some species, even before the MSAD process is conducted.
The second identification method attempted is sequence tagging of the component
proteins by MSAD/SORI-CAD experiments. Similar to what enzymatic digestion does in
solution, MSAD transforms a gas-phase protein mixture into a more complex gas-phase
peptide mixture. Yet complex peptide mixtures are amenable for sequential examination
of constituents with ion isolation. Peptides from MSAD fragmentation of 4-component
mixture were surveyed (Figure 3.5A) and sequentially examined with SORI-CAD.
Tandem mass spectra of fragment y42u118(*) from apomyoglobin and fragment y472b118
from serum albumin are shown in Figure 3.5B and 3.5C respectively, both of which yield
sequence tags for the originating proteins. (* the cleavage type at the C-terminus of this
peptide is non-standard and is denoted by “u” to indicate a fragment 31.0 Da less than
that from b-ion type cleavage possibly due to side-chain cleavages). For comparison we
attempted direct SORI-CAD on the intact proteins in an effort to obtain sequence tag
information. However we were unable to successfully dissociate large proteins such as
serum albumin to give informative fragment ions, much less sequence tag information.

The results obtained above indicate that proteins in mixture can be identified by these two
methods. Identification of a protein by its MSAD signature is fast and parallel, but
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requires prior information on the protein’s MSAD signature, which would be suitable for
prompt detection of targeted proteins. This can be done in a selected reaction monitor
(SRM) mode in an LC-MS experiment. However, identification by sequence tagging
would be suitable for singling out proteins from a sequence database in the application
such as top-down proteomics. Exploiting MSAD’s capability of dissociating large
proteins enables both methods to identify large proteins from mixture in a robust and
standardized manner.

CONCLUSIONS

MSAD is a new in-source fragmentation method, initially attributed to hexapole rfcoupling induced by extended accumulation time. In this report, we provide evidence that
dc offset voltage of the hexapole can be used to induced fragmentation even at short
accumulation times, thus providing a method of conducting MSAD on more rapid
timescales, such as those compatible with on-line chromatography FTICRMS. The data
obtained with the dc offset voltage suggested an alternate dissociation mechanism based
on ion kinetic energy excitation due to the increased potential difference between
skimmer and hexapole.

A variety of proteins were examined with MSAD at a range of collisional energies
measured by accumulation time and dc offset voltage. While low-energy MSAD yields y
and b ions similar to SORI-CAD, high-energy MSAD can fragment proteins up to
116kDa into small singly charged ions, which are characteristic to the protein and can be
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referred to as its MSAD signature. This MSAD signature was used as an identification
method to identify a protein’s presence in a mixture.

The protein fragments from high-energy MSAD can be dissociated further by SORICAD (MSAD/SORI-CAD), analogous to enzymatic digestion followed by CAD. From
such MS3 spectra, sequence tags were obtained for five proteins whose sizes range from
8kDa to 116kDa. This sequence tagging technique was extended to proteins in a mixture,
showing the potential of being applied in top-down proteomics. Its advantages include
standardized experimental conditions, readily interpretable peptide fragmentation mass
spectra, and applicability to large proteins.
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Chapter 4
Graph-theoretical Approach to Separation of y- and b- Ions in High
Resolution Tandem Mass Spectra

All of the data presented below has been published as
B. Yan, C. Pan, V.N. Olman, R.L. Hettich and Y. Xu. A graph-theoretic approach for the
separation of b and y ions in tandem mass spectra. Bioinformatics 2005 21(5):563-574
As co-first author, C. Pan’s primary contributions include problem formulation, graph
theoretical algorithm development, and FT-ICR data acquisition. B. Yan is responsible
for dynamic programming and simulation results (data not shown).
INTRODUCTION

Tandem mass spectrometry (MS/MS) has become a dominant technique for proteomics
due to its ability to identify peptides in a high-throughput manner (Aebersold, 2003). In a
typical liquid chromatography (LC)/MS/MS experiment, a protein mixture of interest is
digested with proteases, and the resulting peptides are separated by one- or multidimensional LC. When eluted from the LC column, peptides are transported into the gas
phase as positively charged ions using electrospray ionization and then introduced into a
mass spectrometer. After measuring the mass/charge ratios (m/z) of all ions, MS can
precisely isolate each peptide by its m/z and fragment the peptide through collisionalactivated dissociation (CAD). The resultant fragments from this peptide are then
measured. This process involves two sequential mass spectrometric measurements for a
peptide (the full scan and the MS/MS scan), thus called tandem mass spectrometry
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(MS/MS). Modern mass spectrometers can acquire thousands of high-resolution MS/MS
spectra per day. Interpretation of such high-throughput mass spectral data in a reliable
and efficient manner represents a highly challenging computational problem.

MS/MS spectra are informative about the composition and the order of amino acids in a
peptide sequence, as it can reveal the molecular masses of the peptide’s fragment
products. Several bonds along the backbone of a peptide can be broken with the gas-phase
collisional process. If the charge is retained on the N-terminal fragment, the ion is
classified as a, b or c, and if the charge is retained on the C-terminal, the ion is classified
as x, y or z. It has been observed that in a typical MS/MS spectral dataset, the majority of
the N- and C-terminal ions are b and y ions, respectively, and each of these ion types
contains the derivatives of neutral loss of water or ammonia (Dancik, 1999; Tabb, 2003).
Note that the sum of any two complementary ion masses should be equal to the mass of
the parent ion and the mass difference between two consecutive ions of the same type is
exactly the mass of an amino acid residue.

There are two popular approaches to interpret tandem mass spectra data for protein
identification: the ‘database search’ and ‘de novo sequencing’ methods. The database
search method compares experimental tandem spectra with theoretical tandem mass
spectra of each peptide derived from a protein sequence database, such as Swiss-Prot
(Boeckmann, 2003) and reports the best match or matches (Eng, 1994; Mann, 1994;
Clauser, 1999; Perkins, 1999; Fenyo, 2000) assuming that the query peptides exist in the
protein sequence database. This approach is highly effective and has been used
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successfully in several proteomics projects on organisms with well-studied genomes
(Washburn, 2001; Ho, 2002; Lasonder, 2002; Andersen, 2003). However, it is not
applicable when a target sequence is not present in the protein database. This can happen
for a number of reasons, including novel proteins, protein mutations, post-translational
modifications (PTMs), and protein sequence database errors. Since the database search
method usually generates high-false-positive recognition rates, it remains an open
problem as how to validate database search results (Nesvizhskii, 2004).

De novo sequencing methods attempt to derive a protein sequence directly from tandem
mass spectra (Taylor, 1997; Dancik, 1999; Pevzner, 2000; Chen, 2001b; Taylor, 2001; Lu,
2003; Ma, 2003). Theoretically, a full-length peptide sequence could be derived from an
ideal tandem mass spectrum by computing the differences in mass between adjacent
fragment ions of the same ion type in a complete series of fragment ions. The de novo
methodology generally employs a graph-theoretic approach in which the tandem mass
spectrum is represented as a graph. Each spectral peak is represented as a vertex, and a
pair of spectral peaks that differ precisely by the mass of one amino acid is represented as
an edge, which is referred to as type-1 edge in this study. The partial sequence of a target
peptide is predicted by finding one or a set of longest directed paths in the spectrum graph.
In this method, no special attempt was made to distinguish ion types and only the
information on type-1 edges was used. However as shown in Figure 4.1, type-1 edges
could be created to connect different types of ions by mistake. That is, although the
difference in mass between any two ions of the same type is always equal to the total
mass of an amino acid, the converse is not necessarily true. Since a tandem mass
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Figure 4.1: Conditional probability profile showing two ions being of
the same type at a given mass difference. The values were derived from
the statistical analysis of the simulated tandem mass spectra of all tryptic
peptides with a mass range of [800 Da, 4000 Da], digested from proteins
in Yeast genome. (A) Only b and y ions were considered. (B) b, y ions and
their loss of water or ammonia were considered. (C) The combination of
(A) and (B) in the information-rich zone. Only the points of interest were
plotted and labeled.

79

spectrum generally mixes up various ions of different types, such a kind of misconnection
decreases the accuracy of de novo sequencing. Furthermore, currently available de novo
sequencing programs are computationally intensive and require high-quality MS/MS data.
Owing to these difficulties, the de novo sequencing approach has not widely been used. In
this study, we solve the problem of ion-type identification separately from the problem of
de novo sequencing. We developed a novel graph-theoretic approach to the identification
of ion types in a set of high-quality MS/MS data. Since the majority of MS/MS spectral
peaks are either b or y ions [e.g. as observed in ion trap instruments (Dancik, 1999; Tabb,
2003)], our algorithm attempted to separate a set of MS/MS peaks into: (1) b ions and
their variants (i.e. loss of water or ammonia), (2) y ions and their variants, and (3) the
other ion types. We used a spectrum graph to represent a given set of spectral peaks in a
similar fashion to some of the previous works (Taylor, 1997; Dancik, 1999; Pevzner,
2000; Chen, 2001b; Taylor, 2001; Lu, 2003; Ma, 2003). The main difference in our graph
representation is that we considered two types of edges, one representing the connection
between a pair of peaks suspected to be of the same ion type (type-1 edge) and the other
representing the connection between a pair of peaks suspected to be of different ion types
(type-2 edge). This is based on the observations that the mass difference between any two
ions of the same type must be equal to the combination of some amino acids; and if the
mass difference is not equal to the mass of any amino acid, it must arise from different
type ions. Edge weights were assigned based on the estimated probabilities of whether the
edges truly connect ions of the same or different types of ions. We formulated the iontype identification problem as a graph partition problem, which is to partition the graph
into three subgraphs, B, Y and U, respectively, to maximize the total weight of type-1
80

edges while minimizing the total weight of type-2 edges within each subgroup. This
problem has been rigorously and efficiently solved using a dynamic programming
algorithm, with a running time of O(∑i=1 3|Si −1|+|Si | ) in the worst case, where i is the
L

distance from the root in a breadth-first tree (BFT) of the spectrum graph, L is the depth
of the BFT and |Si | is the number of vertices on the i-th level of the BFT. For a spectrum
graph, |Si | is generally small in value. We have systematically tested our algorithm on
114,851 simulated tandem mass spectra data derived from tryptic digested peptides of
proteins in the Yeast genome, and have achieved an accuracy level of >90% for the
separation of b and y ions. The tests on 19 sets of high-quality experimental Fourier
transform ion cyclotron resonance (FT-ICR) tandem mass spectra indicate an average
accuracy of 88%. On a typical dataset with 40 spectral peaks, our identification program
PRIME (PaRtition of Ion types in tandem Mass spEctra) generally finds the globally
optimal partition within 1 second, on a Dell Workstation with Pentium 4 (2.1 GHz).

MATERIALS AND METHODS

Spectrum graph representation.

Let S = {s1 , s2 ,L sk } be a set of tandem mass spectral data with k peaks s j = {M j , I j } ,

where Mj and Ij denote the neutral mass and intensity of the peak sj . Throughout this
Chapter, we assume that ion masses are already derived from their m/z ratios based on the
analysis of the isotope peaks. We define the zero mass peak as s0 = {0, I k +1} and parent
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mass peak as sk +1 = {M , I k +1} , where I k +1 = max{I j ,1 ≤ j ≤ k} and M is the neutral mass
of the parent peptide. Theoretically, each ion has a complementary ion (e.g. the
complementary ion of a b ion is a y ion) in the same spectrum. That is for any ion with a
mass X, there should be an ion with a mass Y such that X + Y = M. In an experimental
spectrum dataset, some ions may have their complementary ions missing because of
various reasons. In such cases, we add their complementary ions back. That is for any j, 1
≤ j ≤ k, if there is no peak {M i , I i } with Mi + Mj =M, we add a peak {M − M j , I j } to the
spectrum. Note that the masses of expanded spectrum S are distributed symmetrically
around half of the parent mass.

We shall proceed to examine the mass differences between pairs of spectra peaks. First,
we note that the mass difference between two ions of the same type (b or y or others) is
always equal to the combination of some amino acids, whereas if the mass difference is
not equal to the combination of any amino acid, it must be from different type ions. Our
algorithm separates ions into different ion types primarily based on this property.
However, two ions with a mass difference of the combined mass of some amino acids do
not necessarily belong to the same ion type. To estimate the probability of a given mass
difference to be from two ions of the same type, we conducted a simulation of tandem
mass spectrometry experiment in silico using tryptic digested peptides from proteins
derived from the Yeast genome in Swiss-Prot database (version of March 14, 2004). Each
peptide was theoretically fragmented into b, y ions and their chemical variants (i.e. loss of
water for the first present residue S, T, E, D or loss of ammonia for the first present
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residue R, K, Q, N). The mass differences between the ions of the same type and between
ions of different types were calculated and tabulated (we treated b ions and their variants
as the same group and so for y ions and their variants). The conditional probability that a
given mass difference δ is from two ions of the same type was then estimated by the ratio
of the counts of δ between two ions of the same type to the total occurrences of δ. The
results are shown in Figure 4.1. Apparently, mass differences that do not correspond to
the total mass of some amino acids must arise from ions of different types, while mass
differences arising from one or two amino acids are highly probable to come from ions of
the same type (see the information rich zone, 0–200 Da in Figure 4.1).

We used the following procedure to construct the spectrum graph. Each peak of tandem
mass spectrum is represented as a vertex. To capture two distinct relationships between
two vertices, two kinds of edges, type-1 and type-2 edges are considered. A pair of peaks
is connected by a type-1 edge if their mass difference is the same as the mass of a single
amino acid (suggesting that they are most probably of the same ion type), or by a type-2
edge if their mass difference is not equal to the combination of any amino acids
(indicating that they definitely belong to different ion types). In the interest of reducing
the complexity of the graph, we currently use the following more conservative definition
that keeps the number of type-2 edges small. A pair of peaks is connected by a type-2
edge only if their mass difference is ≤35 Da (which is smaller than the mass of any amino
acid) and not equal to 1, 17 or 18 Da (which correspond to masses of H2O–NH3, water
loss and ammonia loss, respectively). We named this threshold as δ2. To make the
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calculations more efficient, if a vertex had only type-2 edges, we discarded all these type2 edges. We call this graph G = (V, E) a spectrum graph, with V and E being the vertex
and edge set, respectively.

Each type-1 edge has an assigned weight, representing the possibility that the two peaks
involved are of the same ion type. The weight of a type-1 edge E(Vm ,Vn ) is defined as
follows:
W1 ( E ) = ln( I m ⋅ I n ) + ln[Pr(δ mn )] − α ⋅ | m(aai ) − δ mn | + ln( Fi ), 1 ≤ i ≤ 20 ,

(4.1)

where Im, In in (0, 1] are the relative intensities of ions m and n; Pr (δmn ) is the conditional
probability that ions m and n are of the same type, given the mass difference δmn = |Mn –
Mm |; aai is an amino acid type that has the smallest |m(aai ) –δmn | value and satisfies the
condition |m(aa i ) –δmn | ≤ δ1 (δ1= 0.01 Da for simulated tandem mass spectra or 0.05 Da
for experimental FT-ICR data), and m(aai ) is the mass of aai; Fi is the relative frequency
of amino acid, aai, in the target genome. The scaling factor α > 0 is determined
empirically. This definition validates the observation that a good type-1 edge usually has
a small mass deviance, connects two peaks with high intensities, and has a high
probability to arise from the same type ions. Since the type-2 edges generally connect
different type ions based on the above conservative definition, the weight of a type-2 edge
E(Vm ,Vn ) is simply defined as:
W2 ( E ) = ln( I m ⋅ I n )
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(4.2)

Problem formulation.

If we imagine that type-1 edges carry attractive force and type-2 edges repulsive force,
then the vertices of the same ion type in a spectrum graph should naturally cluster
together, whereas vertices of different ion types repel away. Noise can be disconnected or
attached by false type-1 edges to b or y ions. The separation of b and y ions can then be
achieved by optimally cutting all the type-2 edges and false type-1 edges.
Let Ω be the set of all possible tri-partitions of vertices set V of a spectrum graph G.
Without loss of generality, we assume that G is a connected graph; otherwise G will be an
individual connected component. We define the scoring function Score(P,G) for any tripartition P = {VB ,VY ,VU } ∈ Ω as:
Score( P, G ) = Q1 ⋅ [W1 (VY ,VY ) + W1 (VB ,VB ) − W1 (VY ,VB )]
+ Q ⋅ [W2 (VY ,VB ) − W2 (VY ,VY ) − W2 (VB ,VB )],

(4.3)

where Wi (A,B) represents the total weight of type-i edges between vertices of subsets A, B
⊆ V, Qi is a positive factor, i = 1, 2. Our goal is to find the optimal partition Popt ∈ Ω such
that
Score( P opt , G ) = max{Score( P, G ) | P ∈ Ω} ,

(4.4)

Algorithm.

We now present a dynamic programming algorithm for solving the optimization problem
defined above. For a carefully chosen vertex v0 ∈ V (see below), we construct a BFT(v0)
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of the spectral graph G, with v0 being the root (Cormen et al., 2001). Let Si be a set of
vertices at the i-th level of BFT(v0) (hence, their distance to the root is i), where i = 0, 1,
2, ..., L and L is the length of the longest path. We have S 0 = {v0 } and V = U iL=0 Si . We
define a set of subgraphs Gi = (Vi , Ei ) such that Vi = U ij =0 S j consists of edges connecting
vertices of Vi , i = 0, 1, 2, ...,L. Note that in BFT(v0), there is no edge between Vi and Sj for
any j > i+1. The definition is illustrated in Figure 4.2. For each partition Pi of vertices of
Si , let Ω/P i be a subset of Ω satisfying Pi . We define the conditional optimal partition of
vertices Vi of Gi , P opt (Pi ) ∈ Ω/P i , as
Score[ P opt ( Pi ), Gi ] = max{Score( P, Gi ), P ∈ Ω / Pi } ,

(4.5)

The following theorem relates the conditional optimal partition of the whole graph with
the conditional optimal partitions of its subgraphs. It enables us to divide the problem into
smaller segments, to tackle one by one, without compromising the global optimality of
the final solution.

THEOREM: For any subgraph Gi of G and any partition Pi ∈ Ωi where Ωi is a set of all

possible partitions of Si , the conditional optimal partition of vertices Vi of Gi can be
decomposed into a conditional optimal partition of vertices Vi – 1 of Gi – 1 and a particular
partition of Si , i = 1, 2, ...,L:
Score[ P opt ( Pi ), Gi ] = max{Score[ P opt ( Pi−1 ), Gi−1 ] + Score( Pi−1 ⊗ Pi , g i ), Pi−1 ∈ Ωi−1} , (4.6)
where gi is a subgraph of G formed by a vertex set Si ∪Si – 1 connected by edges Ei – Ei – 1,
and Pi – 1⊗Pi presents the virtual union of Pi – 1 and Pi (Figure 4.2).
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Figure 4.2: Scheme of the graph partition algorithm. A breadth-first search
tree is constructed from the spectrum graph. A dynamic programming algorithm
is then used to identify the optimal partition of vertices.

87

PROOF: Because the scoring function (Equation 4.3) is additive in terms of the weights of

edges, and subgraphs Gi–1 and gi do not have any common edges based on their
definitions, we always have:
Score( P, Gi ) = Score( P, Gi−1 ) + Score( P, g i ) ,

(4.7)

By combining Equations 4.5 and 4.7 with the decomposition Ω / Pi = U Ω /( Pi−1 ⊗ Pi ) ,
Ω / Pi = U Ω /( Pi−1 ⊗ Pi ) , Pi−1 ∈ Ω i−1 , we have:

Score[ P opt ( Pi ), Gi ]
= max{Score( P, Gi ), P ∈ Ω / Pi }

(4.8)

= max{Score( P, Gi−1 ) + Score( P, g i ), P ∈ Ω / Pi }
= max{Score( P, Gi−1 ) + Score( P, g i ), P ∈ U {Ω / Pi−1 ⊗ Pi , Pi−1 ∈ Ωi−1}}

However, (P, Gi–1) is independent of Pi , and Score(P, gi ) depends only on Pi–1 and Pi .
Thus, we have
max{Score( P, Gi −1 ) + Score( Pi −1 ⊗ Pi , g i ), P ∈ Ω / Pi −1 , Pi −1 ∈ Ω i −1 }
= max{Score( P opt ( Pi −1 ), Gi −1 ) + Score( Pi −1 ⊗ Pi , g i ), Pi −1 ∈ Ω i −1 }

,

(4.9)

This completes the proof of the theorem.

Implementation.

The following pseudo-code describes the dynamic programming algorithm for solving the
optimal partition problem defined by Equation 4.6.
1. Select v0 from G based on a specific rule (see below);
2. Build a BFT(v0) of G;
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3. For each partition P0 ∈ Ω0 of S0 Do Score(P opt (P0),G0)Å0;
4. For i = 1 To L Step 1 Do
5.

For each tri-partition Pi ∈ Ωi of Si Do

6.

max_scoreÅ0;

7.

For each tri-partition Pi – 1 ∈ Ωi–1 of Si–1 Do

8.

If max_score>Score < (Popt (Pi–1), Gi–1 ) + (Pi–1⊗Pi ,gi ) Do

9.

max_scoreÅ(Popt(Pi–1), Gi–1)+ (Pi–1 ⊗ Pi, gi );

10.

Popt (Pi ) ÅPopt (Pi–1) ⊗Pi ;

11. Select the partition Popt (PL ) with the maximal (Popt (PL ),GL ) value as the final
optimal partition of G;
12. Determine the ion types of the partitioned vertices as follows.
The dynamic programming algorithm classifies all the spectrum peaks into three classes,
B, Y and U. These three groups are really two large groups of ions of the same type (i.e.
B or Y), plus a smaller set for the remaining ions (i.e. U). In the algorithm, we did not
specifically use properties that are directly associated with b ions or y ions. Therefore, B
may actually be y ions and Y may be b ions. To further determine whether B set contains
b ions or y ions (the same for Y set), we need additional information. We used two
properties of tandem mass spectra to decide which group contains the b ion set or the y
ion set. (1) The b ion group should include a vertex with a mass of 0 and a vertex with a
mass of peptide parent mass -18 Da (i.e. [M-H2O]), while the y ion group should include
a vertex with a mass of 18 Da (the complementary ion of [M-H2O]) and a vertex with
parent mass. (2) Statistical analysis of tandem mass spectra has shown that the average
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intensity of y ions is typically more than twice as much as that of b ions, although the
numbers of ions are almost the same (Dancik, 1999; Tabb, 2003). Based on such
information, PRIME reports the ion type of each ion as output.

Computational complexity.

Let C(G) be the computational complexity for calculating the optimal partition of a
spectrum graph G defined by Equation 4.6 and define C(G) as the number of function
(P,G) calls. The computational complexity of our dynamic programming algorithm can be
derived from the lines 4, 5 and 7 of the pseudo-code directly,
C (G ) ≤ O (∑i=1 3|Si−1|+|Si | ) ,
L

(4.10)

where i is the distance from the root v0 of the (v0), L is the length of the longest path of the
(v0) and |Si | is the number of vertices on the i-th level of (v0). To make C(G) as small as
possible, we exhaustively searched through all vertices to find the root v0 that gave the
smallest argument of O in (10) before starting the partition procedure.

Generalized algorithm—considering chemical variants.

Neutral losses from fragment ions are common in tandem mass spectra. A loss of water or
ammonia will reduce fragment ion masses by 18 or 17 Da. In addition, protein PTMs, a
common and important phenomenon in cell functioning, also change the patterns of mass
spectra by shifting a portion of peaks by specific masses. To detect and deal with such
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variants, we introduced a new type of pseudo amino acid with the specific mass for each
suspected chemical variant, and treated the resulting ions the same way as we did with b
or y ions. For example, for water loss, we added a pseudo amino acid, namely ‘water’,
with a mass of –18.011 Da to the amino acid library. Since it is difficult to estimate the
frequency of each possible pseudo amino acid occurring in tandem mass spectra in
advance, we used a simplified Equation 4.1 to calculate the weight of type-1 edge
involving these new residue types,
W1 ( E ) = ln( I m ⋅ I n ) − α ⋅ | m(aai ) − δ mn | ,

(4.11)

By doing so, virtually no change is needed in our partition algorithm for dealing with
chemical variants. In addition, by introducing a pseudo amino acid for each suspected
PTM, we prevented the exhaustive combinatorial search for all possible mass
modifications, in which even a small set of modification types will lead to a large
combinatorial problem (Yates et al., 1995). Finally, the generalized algorithm can deal
with the special case where the neutral loss ions of a spectrum are so prominent, and the
base b or y ions are sufficiently small that only the neutral loss ions survive the spectral
pre-processing procedure. Since we treated b ions and their variants as the same group
and dealt with them independently (similar approach for y ions and their variants), the
absence of base b or y ions does not cause major problems.

RESULTS

Our algorithm was implemented as a computer program PRIME using C++ programming
language. PRIME was tested on 19 sets of high-quality experimental FT-ICR-MS data
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from synthetic peptides as well as tryptic peptides obtained from digestion of horse
myoglobin, bovine serum albumin and lysozyme. All mass spectra were acquired with an
IonSpec (Lake Forest, CA) 9.4-Tesla HiRes electrospray ESI-FTICR-MS. Ions were
generated with a low-flow rate dynamic electrospray source (flow rate of ~400–500
nl/min), accumulated in an external hexapole, transferred into the high-vacuum region
with a quadrupole lens system, and then detected in the cylindrical analyzer cell of the
mass spectrometer. Because ion detection was achieved in an ultra-low vacuum regime
(~2 x 10–10 Torr), broadband mass resolutions of about 200,000 (full width of peak at half
maximum) at m/z 1,000 were possible. Calibration was accomplished by using standard
proteins (such as ubiquitin and myoglobin), and provided mass accuracies within a few
milli-mass units. Low-energy fragmentation via ion collisional dissociation was
accomplished with an FT-ICR-MS instrument. This method of collisional fragmentation
was conducted by isolating an ion of interest (either a peptide or a protein) within the
analyzer cell of the mass spectrometer, and then accelerating the ion into a nitrogen target
gas under sustained off-resonance irradiation collision-activated dissociation (SORICAD). Energetic collisions between the accelerated ion and the target gas generated ionic
fragment ions and could be measured at high resolution.

Data preprocessing

For each precursor mass, the raw profile data of its corresponding mass spectrum was
loaded using the manufacturer’s software IonSpec99. The molecular mass/intensity list
was then tabulated using the View function and saved into a text file (noise was filtered
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with the default threshold). The resulting file was fed to an in-house software for further
isotopic peak reduction. We found that a few isotopic peaks were not identified and
consequently their charges were not determined correctly by IonSpec99. This problem
was fixed by re-analyzing isotopic peaks carefully, i.e. checking the consecutive peaks
with uniform intervals (1.000 Da for +1, 0.500 Da for +2 and 0.333 Da for +3 and so on,
with the mass tolerance of 0.005 Da). Such isotopic peaks were removed and their
intensities were added to the monoisotopic peaks. This pre-processing resulted in a
number of ions in each spectrum which varied from 22 to 50, covering 25–90% of
hypothetical b and y ions. PRIME was then used to determine the ion type of each
individual peak. The thresholds δ1=0.05 Da and δ2=15 Da were used to build type-1 edges
and type-2 edges, respectively. In most cases, the calculations were done within 1 second
on a Dell workstation with Pentium 4 (2.1 GHz). The prediction results are summarized
in Table 4.1.

Overall performance.

As shown in Table 4.1 for each of the 19 test spectra, our partition program identified
most of the b and y ions and their chemical variants (i.e. loss of water or ammonia)
correctly. Among the 19 datasets, 7 were identified with 100% accuracy. The partition
accuracy for each individual spectrum ranged from 57 to 100%, with an average accuracy
of 88%. In the ‘sequence’ column of Table 4.1 the b and y ions that were correctly
differentiated were labeled with underlines (b ions) and overlines (y ions), respectively.
We observed that the experimental tandem mass spectra with good coverage of b and y
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Table 4.1: The test results on 19 sets of experimental FT-ICR tandem mass spectra

a b,

y ions correctly identified were labeled with underline (b ions) or overline (y ions), respectively.
The numerator indicates the number of the correctly identified b or y ions and their chemical variants, i.e.
loss of water or ammonia, while the denominator represents that of observed in experimental spectrum.
c The unit of CPU time measured in seconds.
d The precursor ions of these peptides were triply charged, while the rest were doubly charged.
e The synthesized peptide LVFFAEDVGSNK was acetylated.
b
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ions always had high identification accuracy (e.g. the peptide with 100% accuracy), while
those with poor fragmentation resulted in relatively lower partition accuracy. We also
observed that most induced sequences covered only a portion of the target peptide
sequence. However, those accurately determined subsequences with enough length might
be appropriate to perform homology-based sequence database search through homology
search tools like PSI-BLAST (Altschul, 1997; Taylor, 1997).

The part A and part C of Figure 4.3 show the FT-ICR tandem mass spectrum of two
peptides and their partition results. Several interesting results can be observed from
Figure 4.3. (1) All the b, y ions and their variants (loss of water here is denoted by X)
were identified correctly. (2) The full-length peptide sequences except for the first two
residues can be readily derived from either b ion series or y ion series (no distinction
between the amino acids L and I). The first di-peptide was assigned to tryptophan, since
neither b1 nor y12 was observed in the spectrum and coincidently the mass of Trp is equal
to the sum of Asp and Ala. It was also clearly shown that adding back of the
complementary ions (denoted by open symbols) greatly improved the completeness of
spectra for de novo sequencing. (3) There existed a second continuous mass ladder
(572.27, 719.34, 832.43, 995.50, 1124.55, 1287.63, 1374.67 and 1530.74) that apparently
corresponds to b-H2O ion series starting from position 6 of the peptide. This evidence
strongly indicates that Ser-6 lost water during fragmentation. This kind of secondary mass
ladder information should be highly useful in future applications for detecting the types
and sites of protein PTMs, since X could be any other specified neutral mass losses of
PTMs, for example, –98 Da for loss of H3PO4 from phosphopeptides. (4) Three false
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Figure 4.3: Partition of two FT-ICR tandem mass spectra. The b ions (red
circles) and y ions (blue squares) were partitioned into two subgraphs, where
vertices were connected through type-1 edges (thin red or blue lines) within
each subgraph and through type-2 edges (thick black lines) between the two
subgraphs. Thin dashed lines represent the false type-1 edges while the thick
dashed lines denote the discarded type-2 edges. Noises were labeled with
diamonds. The closed symbols represent the ions observed in experimental
spectrum while the open symbols denote the added complementary ions.
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(A)

(B)

Figure 4.3: Continued.
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(C)

(D)

Figure 4.3: Continued.
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type-1 edges (labeled with thick teal lines) were formed between b and y ions. Our
algorithm recognized all of them correctly based on the global optimization.

DISCUSSION

Methods for accurate identification of ion types provided the basis for many mass
spectrometry data interpretation problems, including (1) de novo sequencing, (2)
identification of PTMs, and (3) validation of database search results. Compared to
previous de novo sequencing methods (Taylor, 1997; Dancik, 1999; Pevzner, 2000; Chen,
2001b; Taylor, 2001; Lu, 2003; Ma, 2003) the uniqueness of our approach is that we treat
the problem of ion-type identification separately from the problem of de novo sequencing.
By decoupling the two problems, we arrived at a conceptually clearer framework for
solving the two problems separately rather than having them tangled together.

In addition, among these published papers on de novo sequencing algorithms and
applications (Taylor, 1997; Dancik, 1999; Pevzner, 2000; Chen, 2001b; Taylor, 2001; Lu,
2003; Ma, 2003) only the information similar to what we call type-1 edges was utilized.
As shown in Figure 4.1, false type-1 edges could arise from different types of ions by
accident. To recognize this kind of false connections and to partition ions into correct
classes, we introduced a new type of connection, the type-2 edges, which connect two
peaks of possibly different ion types; and include the probability that a given mass
difference between two ions corresponds to an amino acid into the objective function.
Since we use a very conservative definition in the construction of type-2 edges, the
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probability of having a false type-2 edge is intrinsically much lower than that of having a
false type-1 edge. These facts imply that our algorithm does utilize more informational
context of a given MS/MS experimental data and might describe the real spectrum more
completely. The systematic tests of our approach on 114,851 simulated tandem mass
spectra derived from Yeast genome and on the 19 sets of experimental FT-ICR data
showed that the type-2 edges were powerful. The inclusion of a few sparse type-2 edges
can make the partition correctly.

Protein PTMs generate tremendous diversity, complexity and heterogeneity of gene
products, and are involved in many important cell functioning and regulation processes
(Gooley, 1997). To date, there are over 340 entries reported in Delta Mass
(http://www.abrf.org/index.cfm/dm.home?AvgMass=all), a database of protein PTMs.
Therefore, the verification of PTMs raises a major challenging problem after the human
genome was completely sequenced (Mann, 2003). The capacity for detecting the types
and sites of PTMs efficiently should be a key feature of a good de novo sequencing
algorithm. We have shown that our algorithm can be easily extended to consider chemical
variants, i.e. loss of water or ammonia, or PTMs, by introducing a new type of pseudo
amino acid with the specified mass for each suspected chemical variants, without
increasing the computational complexity.

Several de novo sequencing algorithms and software packages, such as Lutefisk (Taylor,
1997; Taylor, 2001) and PEAKS (Ma, 2003) were reported to perform de novo
sequencing successfully, and the latter also employed a dynamic programming algorithm.
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However as we discussed above, the basis of these approaches are quite different from
ours: no special attempt was made to distinguish ion types, and solely the information of
type-1 edges was used to construct the spectrum graph representation. Since our effort in
this study has been to identify the ion type of each individual peak (a first stage of de
novo sequencing), no comparison was made to evaluate the performance of our algorithm
with others. However, the tests on the simulated and experimental tandem mass spectra
showed that PRIME achieved an accuracy of ~90% for the separation of b and y ions.
Once the ions are partitioned into correct classes, the de novo sequencing should be easily
derivable from one single ion series. Work on extending this algorithm to deal with the de
novo sequencing problems by using more robust data and exploring its potential
applications in detecting PTMs is on-going and will be presented in the future
publications.

CONCLUSIONS

Ion-type identification is a fundamental problem in computational proteomics. Methods
for accurate identification of ion types provide the basis for many mass spectrometry data
interpretation problems, including (a) de novo sequencing, (b) identification of posttranslational modifications and mutations, and (c) validation of database search results.

Here we present a novel graph-theoretic approach to solve the problem of separating b
ions from y ions in a set of tandem mass spectra. We represent each spectral peak as a
node and consider two types of edges: type-1 edge connecting two peaks probably of the
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same ion types and type-2 edge connecting two peaks probably of different ion types. The
problem of ion-separation is formulated and solved as a graph partition problem, which is
to partition the graph into three subgraphs, representing b, y and others ions, respectively,
through maximizing the total weight of type-1 edges while minimizing the total weight of
type-2 edges within each partitioned subgraph. We have developed a dynamic
programming algorithm for rigorously solving this graph partition problem and
implemented it as a computer program PRIME (PaRtition of Ion types in tandem Mass
spEctra).
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Chapter 5
Integration of Nanoscale Liquid Chromatography with Fourier
Transform Ion Cyclotron Resonance Mass Spectrometer

Part of the data presented below has been published as
M.B. Strader, D.L. Tabb, W.J. Hervey, C. Pan, and G.B. Hurst. Efficient and Specific
Trypsin Digestion of Microgram to Nanogram Quantities of Proteins in Organic-Aqueous
Solvent Systems. Analytical Chemistry 2006, 78, 125 -134,
C. Pan’s contributions to this manuscript include all LC-FT-MS measurements,
nanospray ionization optimization, and associated data analysis.
INTRODUCTION

FT-ICR mass spectrometers combine high mass accuracy, superb resolution, and
excellent dynamic range with versatile tandem mass spectrometry capability (Marshall,
1998). In the previous chapters, we have demonstrated novel uses of FT-ICR with
standard samples in direct infusion mode. However, MS measurements in direct infusion
mode are not sufficient for analysis of a typical sample from shotgun proteomics, because
of at least the following reasons.

First, many peptides in a typical proteome digest cannot be completely resolved by their
mass-to-charge ratios. It is common for a bacterial proteome to contain more than 3000
proteins, which are transformed into greater than 30,000 peptides by proteolysis in a
shotgun proteomics measurement (Hochstrasser, 2002). Most of the tryptic peptides have
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a mass-to-charge ratio between 400 and 3000 and a charge state between +1 and +3. In
such a dense mass spectrum, it is difficult to completely resolve all the peptides from
each other, even using a high-resolution mass spectrometer.

Second, the dynamic range of a typical proteome digest is far larger than the dynamic
range of FT-ICR. The proteins in a proteome exist in vastly different abundance. The
concentration difference between the high-abundance proteins and the low-abundance
proteins can reach 106 (Corthals, 2000); whereas the dynamic range of FT-ICR is ~
10,000. The orders of magnitude of difference between the desired dynamic range and
the attainable dynamic range in FT-ICR would result in the selected detection of only the
most abundant proteins in a proteome.

Third, electrospray of a large diversity of peptides in a single sample leads to the limited
ionization of only a subset of peptides. In the electrospray ionization process, peptides
have to compete for a fixed number of positive charges. The characteristics of a peptide,
including proton affinity, hydrophobicity, size, etc., determine how well the peptide can
be ionized (Avery, 2003). The ionization of a peptide can be partially or even completely
suppressed in the presence of many other competing peptides. This ionization
suppression effect leads to the selected detection of a few peptides that can be well
ionized from a complex peptide mixture.

To address these challenges, mass spectrometry has been coupled with liquid
chromatography as an integrated analytical platform (Link, 1999; Washburn, 2001). The
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peptides are separated in time with liquid chromatography, and the LC eluent is directly
electrosprayed into mass spectrometers. The mass spectrometer becomes an online
detector of the LC by measuring the m/z and ion intensity of the co-eluting peptides.
Since LC retention time and m/z value are two orthogonal properties of peptides, the LCMS system multiplies the peak capacity of mass spectrometer with the peak capacity of
liquid chromatograph. Therefore, the complex peptide mixture can be well resolved with
LC-MS. The dynamic range limitation of mass spectrometers and ionization suppression
of the electrospray are also mitigated, because different sets of peptides are eluted off
sequentially, and, at a given retention time, only a small set of peptides are electrosprayed
and analyzed by the mass spectrometer.

In this chapter, we describe the development of an LC-MS system integrating reverse
phase LC with FT-ICR MS. Our FT-ICR instrument is equipped with an electrospray
source from Analytica of Branford Inc. This electrospray source was originally designed
for microspray (flow rate between 1 µL/min and 10 µL/min) in the direct infusion mode,
as demonstrated in the previous chapters. Here we have focused a significant amount of
effort on incorporating nanospray (flow ratio between 50 nL/min and 300 nL/min) with
the Analytica source, because of the following two advantages of nanospray ionization.

First, the electrospray of aqueous solvent is more stable at lower flow rates in nL/min
range. As the LC eluent is directly electrosprayed into the mass spectrometer, the
electrospray solvent changes from highly aqueous (95% H2O and 5% ACN) to
moderately organic (50% H2O and 50% ACN) with the progression of the LC gradient.
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Microspray often fails to form a stable electrospray plume with highly aqueous solvent,
which compromises the MS measurement of peptides eluting off early in the LC gradient.
Nanospray is able to more effectively ionize peptides throughout the LC gradient.

Second, nanospray can be coupled with the nanoscale LC to provide higher sensitivity
than capillary LC. Nanoscale LC typically uses a column with inner diameter less than
100 µm. The flow rate is 100–300 nL/min for both LC elution and electrospray.
Ultimately, the use of the nanoscale LC reduces the amount of proteome sample needed
for an LC-MS measurement.

With the implementation of nanospray on our FT-ICR instrument, the high-performance
LC-MS measurements were demonstrated with bacterial proteome digest samples.
However, since our FT-ICR MS lacked the capability to perform data-dependent tandem
mass spectrometry, we proposed to combine the accurate mass measurement of FT-ICR
and the automated tandem mass spectrometry of a three-dimensional quadrupole ion trap
(QIT) to achieve confident identification of peptides. By using an identical LC setup for
LC-FT-MS and LC-QIT-MS, the peptides measured in the two LC-MS platforms were
correlated computationally by their retention time. Here, we present development of the
LC-FT-MS platform and the computational tools for data integration.
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MATERIALS AND METHODS

Materials.

All proteins, salts, buffers, dithiothreitol (DTT), guanidine hydrochloride, trifluoroacetic
acid, diethyl pyrocarbonate, phenylmethanesulfonyl fluoride (PMSF), sucrose, and
RNase-free DNase I were obtained from Sigma Chemical Co. (St. Louis, MO). RNase
Away was obtained from Molecular BioProducts (San Diego, CA). Sequencing-grade
trypsin was purchased from Promega (Madison, WI). Formic acid was obtained from EM
Science (affiliate of Merck KgaA, Darmstadt, Germany). HPLC grade acetonitrile and
water were used for all LC-MS analyses (Burdick & Jackson, Muskegon, MI). Ultrapure
18-MΩ water obtained from a Millipore Milli-Q system (Bedford, MA) was used for
sample buffers. Fused-silica capillary tubing was purchased from Polymicro
Technologies (Phoenix, AZ). BCA assay reagent and standards were obtained from
Pierce Chemical Co. (Rockford, IL).

Construction of Protein Standard Mixture.

Protein standard mixtures were generated using six proteins: bovine serum albumin (MW
69 kDa), yeast alcohol dehydrogenase I (MW 37 kDa), bovine carbonic anhydrase II
(MW 29 kDa), horse myoglobin (MW 17 kDa), bovine hemoglobin (MW 15 kDa), and
chicken egg lysozyme C (MW 14 kDa). Hemoglobin includes α- and β- polypeptides, and
the isomer yeast alcohol dehydrogenase II was found to be a component of yeast alcohol
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dehydrogenase I, giving a total of eight polypeptides in the mixture. Mixtures contained
equal concentration of each protein. The proteins were dissolved in 50 mM Tris-HCl/10
mM CaCl2 (pH 7.6) and then combined in equal concentration.

Proteolytic Digestion.

For the trypsin digestion study, the protein mixture digestion was performed using two
different protocols for comparison: (A) overnight digestion in aqueous buffer; and (B) 1hour digestion in 80% acetonitrile buffer. In both digestion experiments, 200 ng of
trypsin were added to the 1-μg sample to yield an enzyme-to-substrate ratio (w/w) of 1:5,
and the digestion was performed at 37oC with shaking. After digestion, all peptide
samples were treated with DTT (20 mM) for 1 h at 37oC to reduce disulfide bonds. The
reduced peptides were lyophilized and resuspended in 100 μL of 95% H2O/5%
acetonitrile/0.1% formic acid. To further inhibit trypsin activity, 2 μL of 10% formic acid
was added to each resuspended sample.

For the nanoLC-FT-MS platform development, the protein standard mixture sample and
an Rhodopseudomonas palustris proteome sample were digested using the manufacturer's
protocol for the trypsin used in these experiments, which included denaturation in 6 M
guanidine hydrochloride/50 mM Tris-HCl/10 mM CaCl2 (pH 7.6) for 45 min followed by
dilution to 0.5 M guanidine hydrochloride and overnight digestion with 200 ng of trypsin
at 37oC. The samples were then treated with 20 mM DTT for 1 hour at 60oC as a final
reduction step. The resultant peptides from this control digestion were desalted using
108

solid-phase extraction (C18 Zip-Tip, Millipore, Billerica, MA) and solvent exchanged into
0.1% formic acid in water by centrifugal evaporation.

1D capillary LC-FT-MS Analysis.

1D capillary LC-FT-MS experiments were performed with an Ultimate HPLC system
(Dionex) coupled with a HiResESI Fourier transform ion cyclotron resonance mass
spectrometer equipped with a 9.4-T magnet. Samples were separated with a Vydac C18
column (300 μm i.d. × 15 cm, 300-Å pore size, 5-μm particles) at a flow rate of 4 μL/min
and directly introduced to the FTICR MS with an electrospray source (Analytica,
Branford, CT).

1D nanoLC-FT-MS Analysis.

For nanoLC-FT-MS analysis, samples were separated using a nanobore Vydac C18
column (750 μm i.d. × 15 cm, 300-Å pore size, 5-μm particles). The LC operation was
automated with a Famos/Switchos/Ultimate HPLC System (Dionex, Sunnyvale, CA)
(Figure 5.1). The sample is automatically loaded into a 50-μL loop from a vial with the
auto-sampler Famos and then pumped through a pre-concentration column (300 μm i.d. ×
5 mm C18 PepMap) on the switching system Switchos. After the pre-concentration
column is switched online with the analytical nanobore C18 column, the peptides are
resolved and eluted at the flow rate of 200 nL/min. The LC eluent ran through a grounded
metal union and electrosprayed into FTICR MS using a 10 μm i.d. emitter (PicoTip, New
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Figure 5.1: Famos/Switchos/Ultimate nanobore HPLC system. This system
consists of an auto-sampler, Famos, a switching system, Switchos, and an HPLC
pump, Ultimate. The sample is injected into the pre-concentration column on the
Switchos and then resolved on the 25-cm nanobore column. (Figure courtesy of Dr.
Gregory B. Hurst)
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Objective, Woburn, MA). The emitter and the counter-electrode were 3 mm apart with
1800 volts potential difference. The FT-ICR MS measurement used 2 second hexapole
ion accumulation, 256K data points analog-to-digital conversion at 1Mhz, and 2-scan
signal averaging.

1D LC-QIT-MS/MS Analysis.

For all peptide samples, one-dimensional LC-QIT-MS/MS experiments were performed
with a Famos/Switchos/Ultimate HPLC System coupled to an LCQ-DECA XP Plus
quadrupole ion trap mass spectrometer (Thermo Finnigan, San Jose, CA) equipped with a
nanospray source as previously described. The reverse-phase HPLC was run at a flow
rate of 200 nL/min using a Vydac C18 column (75 μm i.d. × 15 cm, 300-Å pore size, 5μm particles). For all 1D LC-MS/MS data acquisition, the LCQ was operated in the datadependent mode with dynamic exclusion enabled (repeat count 2), where the four most
abundant peaks in every MS scan were subjected to MS-MS analysis. Data-dependent
LC-MS/MS was performed over a parent m/z range of 400-2000.

Protein Identification from QIT MS/MS Data Analysis.

The SEQUEST algorithm (Eng, 1994) was used to match experimental MS-MS spectra
with their counterparts predicted from a protein sequence database. An unconstrained
database search was employed so that peptides resulting from cleavage at residues other
than lysine or arginine at one end (semitryptic peptides) or both ends (nontryptic) could
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be identified. The sequence database used for searches in this study consisted of two
major elements. The 4833 ORFs of the published R. palustris protein sequence database
(Larimer, 2004) were search targets for the R. palustris proteome searches but acted as
distractors (indicators of false positive identifications) during the protein standard
mixture searches. Sequences for the eight proteins in the standard mixture were also
included in the database; we added the sequence for alcohol dehydrogenase II, because
this protein was observed as a component in the alcohol dehydrogenase I standard.

DTASelect was used to assemble, filter, and compare the identifications from SEQUEST
searches on all data sets (Tabb, 2002). This software sorts peptide identifications by the
proteins that contain them. A protein in the mixture was considered successfully
identified if at least two component peptides passed DTASelect's default SEQUEST
score cutoffs. Spectra from singly charged peptides were required to exceed 1.8 in the
SEQUEST parameter XCorr, while XCorr values for doubly- and triply-charged peptides
were required to exceed 2.5 and 3.5, respectively. The best matching sequence for each
spectrum was required to have an XCorr at least 8% greater than the second best (DeltCN
> 0.08).

Correlation of LC-QIT-MS/MS Data and LC-FT-MS Data.

The LC-FT-MS data were processed with the IonSpec FTdoc program. The processing
steps include charge state determination, deconvolution of isotopic clusters into
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monoisotopic peaks, and filtering of noise peaks. The monoisotopic masses, retention
times, and intensities were exported to ACSII files.

The peptide data points from the LC-FT-MS measurement were correlated with the
peptide identification from the LC-QIT-MS measurement. The retention time of the LCQIT-MS measurement was normalized as follows. The confident peptide identifications
from the QIT data were obtained by filtering the SEQUEST results with the conservative
Xcorr cutoff as described above. These peptides were matched against all peptide data
points measured in the FT-ICR data without retention time constraint. If the mass error
between a QIT peptide identification and a FT-MS data point was less than 0.05 Da, this
peptide was considered as positively correlated between the two measurements. A linear
regression model was constructed between the two retention time points for all correlated
data points: one from LC-QIT-MS measurement and the other one from LC-FT-MS
measurement. The retention time for the peptide data points from LC-FT-MS was
normalized with this linear function.

The LC-FT-MS measurement was then used to validate peptide identifications with lower
Xcorr scores. Filtering of peptide identifications were performed with Xcorr cutoff
(Xcorr (+1) > 1.3, (+2) > 2.0, (+3) > 3.0). A peptide identification is considered as being
validated by the LC-FT-MS measurement if there is a peptide data point found with less
than 0.05 Da mass measurement error and 3 minutes retention time shift. Each validated
peptide identification was marked by a flag in the DTASelect result files. The data
correlation and peptide identification validation were performed with Perl scripts.
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RESULTS AND DISCUSSION

Comparison of the Proteolysis Results of Two Digestion Protocols with capillary
LC-FT-MS

Protein complexes can be isolated with tandem affinity purification (TAP) in a highthroughput manner. The subunits of an isolated protein complex can then be identified
with shotgun proteomics measurements. However, the isolation of protein complexes by
TAP often yields samples with less than 100 ng of total protein. This complicates
enzymatic digestion and peptide identification, as protein concentrations less than 10
ng/μL are unsuitable for efficient enzymatic digestion with the conventional protocols. In
this study, a new digestion protocol was proposed that uses 80% acetonitrile in the
digestion buffer. This 80% acetonitrile digestion was compared with conventional
aqueous buffer for trypsin digestion. The digestion products with the two protocols were
measured with capillary LC-FT-MS (Figure 5.2).

FT-ICR-MS allows isotopic resolution of multiply charged ions, allowing the
determination of molecular mass to better than 10 ppm accuracy. By knowing the
accurate molecular masses, we were able to characterize the dense patch of late-eluting
unidentified ions in the LC-QIT-MS/MS results. Most of those ions are intact undigested
proteins or partially digested protein fragments with charge states too high to be
identified by SEQUEST. Figure 5.2 shows the LC-FTICR total ion chromatograms of the
mixture digested overnight in aqueous buffer and digested for 1 h in 80% acetonitrile.
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Figure 5.2: Capillary LC-FT-MS total ion chromatograms of the
1-ug mixture. The blue trace is from overnight digestion in aqueous
buffer; the red trace is from a 1-h digestion in 80% acetonitrile. The
insets illustrate the isotopic resolution of nominal masses
representing undigested myoglobin and hemoglobin chain.
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The C18 reverse-phase column, LC instrumentation, and gradients used for these
experiments were identical to those used for the LC-QIT-MS/MS analyses. As illustrated
in the insets in Figure 5.2, intact myoglobin (most abundant isotope mass [MAIM]
measured 16,950.954 Da, calculated MAIM 16,950.993 Da, mass error 2.3 ppm) and
hemoglobin α chain (measured MAIM 15,052.891 Da, calculated MAIM 15,052.929 Da,
mass error 2.5 ppm) were identified in the 75–82-min retention time window for the
overnight aqueous digestion. In addition, several unidentified species, probably partially
digested protein fragments, in the 27–29 kDa range were observed (data not shown). We
did not identify any intact proteins in the 75–82-min retention time window for the 80%
acetonitrile digestion shown in Figure 5.2, and overall ion signal was lower in this
retention time window. These data show that trypsin cuts more efficiently in the 80%
acetonitrile digestion.

Development of nanoLC-FT-MS Platform for Shotgun Proteomics Measurement

The original ionization source on our FT-ICR instrument was designed for microspray at
the flow rate between 1 μl/min to 10 μl/min. The electrospray emitter is a grounded metal
needle with ~ 100 μm i.d. To perform nanospray, the metal needle was replaced by a
commercial nanospray emitter – PicoTip from New Objective. Since the PicoTip is made
of fused silica, it had to be connected to a metal union to provide electric contact for the
nanospray. The main factors that can affect the ionization efficiency and stability of
nanospray include:
•

The i.d. of the nanospray emitter;
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•

The potential difference between the emitter and the counter-electrode; and

•

The distance from the emitter to the counter-electrode.

We optimized the three factors with an aqueous solution of 1 μM ubiquitin in direct
infusion mode. The combination of a 10 μm i.d. emitter, 1800 volt potential difference,
and 3 mm distance was found to provide a stable and intense signal.

This nanospray setup was then connected to a Famos/Switchos/Ultimate HPLC System.
This system fully automated sample injection and gradient elution for the HPLC analysis.
During LC elution, the full scan mass spectra were continuously acquired at a rate of 6
scans per min with the FT-ICR instrument. The LC-FT-MS platform was first tested with
a protein standard mixture digest (Figure 5.3). A linear gradient (shown as red lines in
Figure 5.3A) was used for the reverse phase LC elution. The total ion chromatogram
shows many resolved chromatographic peaks (Figure 5.3A). The peak width of these
chromatographic peaks indicates high LC separation resolution. The MS measurement
with FT-ICR gives accurate mass measurement of peptides. A full scan acquired at a
retention time 40 minute is shown in Figure 5.3B. The isotopic envelope of individual
peptides was resolved, which allowed the determination of the peptides’ charge states.
The high sensitivity and excellent dynamic range of FT-ICR enabled the detection of
many low-abundance peptides. The low-abundance peptides measured in the 614–632
m/z window at this full scan are shown in the inset of Figure 5.3B.

The LC-FT-MS platform was then used to measure an R. palustris proteome sample
(Figure 5.4). As opposed to the protein standard mixture that contains 6 proteins at equal
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Figure 5.3: nanoLC-FT-MS measurement of a protein standard
mixture digest. (A) Total ion chromatogram. The red line shows the
LC gradient. (B) The full scan at the retention time 40 minute. The inset
shows the zoom-in of an m/z region.
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Figure 5.4: nanoLC-FT-MS measurement of an R. palustris
proteome. (A) Total ion chromatogram. The red line shows the LC
gradient. (B) The full scan at the retention time 21 minute.
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abundance, the proteome sample contained thousands of proteins at vastly different
abundance. Due to this daunting complexity, many peptides were eluted off the LC
column at any retention time point and no individual chromatographic peak can be
identified in the total ion chromatogram. A full scan at the retention time of 21 minute is
shown in Figure 5.4B, which yielded the accurate mass measurement for many peptides
at different intensities. Although trypsin digestion is expected to generate peptides with
one, two or three positive charges, many peptides with charge state higher than three
were observed. These peptides are generally ignored in the data analysis of LC-QIT- MS
measurement, as all peptides are assumed to be singly, doubly or triply charged for
MS/MS database searching. As the charge states of peptides were experimentally
determined in the FT-ICR MS measurement, the mass spectra showing mass-to-charge
ratios of peptides can be deconvoluted into the mass spectra showing the neutral mass of
those peptides. The deconvolution can greatly simplify the data analysis procedure for
LC-FT-MS measurement.

Integration

of

LC-FT-MS

with

LC-QIT-MS/MS

for

Confident

Peptide

Identification

Shotgun proteomics generally uses the MS/MS data from LC-QIT-MS/MS measurement
for peptide identification. The best match between an MS/MS scan and a peptide
sequence is scored and, if the score exceeds a threshold, the peptide is considered being
identified from this MS/MS scan. However, many true peptide identifications can score
lower than the threshold and, conversely, many spurious peptide identifications can score
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higher than the threshold. Here, we propose to use the accurate mass measurement from
LC-FT-MS to improve both the false positive rate and the false negative rate of peptide
identification in shotgun proteomics by measuring the protein standard mixture digest
with both LC-FT-MS and LC-QIT-MS/MS. The peptide identifications were filtered with
a reduced threshold, which reduced the false negative rate at the expense of increasing
the false positive rate. Then, the peptide identifications were filtered with the LC-FT-MS
data to remove the false peptide identifications that passed the threshold.

To filter the peptide identifications with LC-FT-MS data, we first normalized the
retention time of LC-FT-MS measurement (Figure 5.5). 5496 ion species were observed
in the LC-FT-MS experiment, which were displayed in a 2-dimensional ion map with
their retention time and measured monoisotopic mass (Figure 5.5A). 301 peptides were
identified by the LC-QIT-MS/MS experiment, which were also displayed in a 2dimensional ion map with their retention time and monoisotopic mass calculated from the
peptides’ sequence (Figure 5.5B). Data points in the two ion maps were matched if their
monoisotopic masses have less than 0.05 Da difference. All matched data points were
plotted into a scatter-plot with the two observed retention times: one from the LC-FT-MS
experiment and the other from the LC-QIT-MS/MS experiment (Figure 5.5C). A linear
model was fitted into the data points for retention time normalization:
RTQIT = 0.9669 ⋅ RTFT − 11.5872 ,
where RTQIT is the retention time of a peptide in the LC-QIT-MS/MS experiment and
RTFT is the retention time of this peptide in the LC-FT-MS experiment. The intercept of
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Figure 5.5: Integration of LC-FT-MS data and LC-QIT-MS/MS
data from the protein standard mixture digest. (A) Ion map from
LC-FT-MS measurement. (B) Ion map from LC-QIT-MS/MS
measurement. The monoisotopic masses were calculated from peptide
sequences. (C) Correlation of retention times between LC-QIT-MS/MS
and LC-FT-MS
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this linear function indicates an 11.6-second retention time shift between the two LC
elutions, which can arise from different sample injection times or different dead volumes.
The slope of this linear function is approximately 1, which indicates that the retention
time scale is not stretched or compressed between the two LC elutions. The correlation
coefficient of the data points was 0.94, indicating good reproducibility of the peptides’
retention time. The retention time for all data points from the LC-FT-MS experiments
was normalized with this linear function.

Next, the peptide identification results from the LC-QIT-MS/MS experiment were refiltered with a lowered threshold using DTASelect. A peptide identification is marked as
being validated by the accurate mass measurement, if a mass spectral peak is observed in
the LC-FT-MS experiment with less than 0.05 Da mass difference and less than 3 min
retention time difference. To facilitate result interpretation, the manual validation flag in
the DTASelect result file was used to indicate the validation by the LC-FT-MS data.
Figure 5.6 shows the identification results of the alcohol dehydrogenase. Note that many
true peptides that would have been discarded according to their Xcorr score were
validated by the accurate mass measurement using the LC-FT-MS data. This indicates
that integration of LC-FT-MS measurement and LC-QIT-MS/MS measurement can
improve both the sensitivity and the confidence of peptide identification in shotgun
proteomics.
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Figure 5.6: Validation of MS/MS peptide identifications with LC-FT-MS
data. The peptide identifications validated by the LC-FT-MS data are marked
with a green “Y” in the first column.
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CONCLUSIONS

FT-ICR mass spectrometry has to be coupled with liquid chromatography to provide
adequate peak capacity and dynamic range for analyzing a proteome digest sample. With
an integrated LC-FT-MS system, peptides are first separated by liquid chromatography
and then analyzed by the FT-ICR mass spectrometry. We first demonstrated the use of a
capillary LC-FT-MS system to compare the digestion results of two proteolysis protocols.
Undigested proteins were detected with the conventional aqueous digestion protocol and
were not detected with the new 80% acetonitrile digestion protocol, which indicates the
superior digestion efficiency of the new protocol. To provide better ionization of aqueous
solution and higher measurement sensitivity, a nanospray ionization source was
developed for our FT-ICR instrument, and a fully automated nanoLC-FT-MS system was
constructed. The nanoLC-FT-MS was tested with the protein standard mixture and a
Rhodopseudomonas palustris proteome. Finally, the accurate mass measurement with
nanoLC-FT-MS was integrated with the tandem mass spectrometry measurement with
LC-QIT-MS/MS. The integration improved the confidence and sensitivity of peptide
identification for shotgun proteomics.
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Chapter 6
Robust Estimation of Peptide Abundance Ratios and Rigorous Scoring
of Their Variability and Bias in Quantitative Shotgun Proteomics

All of the data presented below has been published as
C. Pan, G. Kora, D.L. Tabb, D.A. Pelletier, W.H. McDonald, G.B. Hurst, R.L. Hettich,
and N.F. Samatova1, Robust Estimation of Peptide Abundance Ratios and Rigorous
Scoring of Their Variability and Bias in Quantitative Shotgun Proteomics Analytical
Chemistry 2006 (In press)
As first author, C. Pan’s contributions to this article include algorithm development and
MS data acquisition and interpretation.
INTRODUCTION

In quantitative shotgun proteomics, proteolysis-derived peptides are measured with liquid
chromatography–tandem mass spectrometry (LC–MS/MS) and used as surrogates of their
parent proteins for relative quantification. In a label free approach, the proteomes under
comparison are analyzed separately in standardized LC-MS/MS runs. Alternatively, by
employing stable isotope labeling, the proteomes under comparison are mixed and
analyzed in one LC-MS/MS run, which eliminates the variability in sample processing
steps after mixing and LC-MS/MS analysis. The common stable isotope labeling methods
include 15N or 13C metabolic labeling (Oda, 1999), SILAC (Ong, 2002), H218O digestion
(Yao, 2001) and ICAT (Gygi, 1999). Each peptide in the mixture of two isotopically
labeled proteomes has two mass-different isotopic variants, the light isotopologue from
one proteome and the heavy isotopologue from the other. Here we consider algorithms
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for peptide relative quantification using mass-different stable isotope labeling. Note that
the algorithms discussed here are not applicable to the isobaric labeling method iTRAQ
(Ross, 2004), which generates specific reporter ions in tandem mass spectra for
quantification.

Figure 6.1 illustrates the general computational procedure for estimating the abundance
ratio between the light isotopologue and the heavy isotopologue of a peptide. The
sequence of the peptide is identified from an MS/MS scan of one of its isotopologues
(Figure 6.1A). The full scan that triggered this MS/MS scan is shown in Figure 6.1B, in
which the mass spectral peaks of the two isotopologues are highlighted. Selected ion
chromatograms for the two isotopologues are then extracted, and peak detection is
performed to define front and back boundaries of the two isotopologues’
chromatographic peaks (Figure 6.1C). Finally, the abundance ratio of the peptide is
evaluated from the two chromatographic peaks. In this study, we developed novel
algorithms for peak detection and for peptide abundance ratio evaluation.

Normally, peak detection is performed in the selected ion chromatograms. However, a
large fraction of chromatographic peaks have a very low chromatographic signal-to-noise
ratio (S/N) that results in incorrect assignments of their peak boundaries. We have
improved the robustness of peak detection by employing a parallel paired covariance
algorithm, which was developed based on sequential paired covariance algorithm
originally devised for rapid component identification from ion electropherograms
(Muddiman, 1995; Muddiman, 1997). The parallel paired covariance algorithm integrates
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Figure 6.1: Estimation of peptide abundance ratios in quantitative shotgun
proteomics. (A) The sequence of a peptide is identified from an MS/MS scan.
(B) The peak pair in the full scan for the two isotopologues of this peptide is
identified. (C) The selected ion chromatograms of the light isotopologue (red)
and the heavy isotopologue (blue) are extracted from the full scans. The brown
vertical line indicates the MS/MS scan. The chromatographic peaks of the
isotopologue pair are detected as between the two vertical green lines. The
abundance ratio between the two isotopologues can be estimated as the ratio of
the peak areas. (D) The abundance ratio is estimated from a peak profile. The
blue data points represent the ion intensities of the two isotopologues measured
in the full scans within the chromatographic peak. The red line has the minimum
total squared perpendicular offset to the data points, whose slope is an
abundance ratio estimator.
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the two selected ion chromatograms and reconstructs a covariance chromatogram of
improved chromatographic S/N for peak detection.

Estimation of the peptide abundance ratios from the detected chromatographic peaks can
be accomplished with several existing algorithms. A common algorithm is based on peak
area. First, the selected ion chromatograms are smoothed to remove random noise. Then,
the background is subtracted from the chromatograms. Finally, the area under the two
chromatographic peaks is calculated by integration. The ratio between the two peak areas
is considered as the abundance ratio of a peptide. The peak area algorithm has been used
in quantitative proteomics programs XPRESS (Han, 2001), ASAPratio (Li, 2003), and
MSQuant (Schulze, 2004). The accuracy of the peak area calculation highly depends on
two empirical steps – chromatogram smoothing and background subtraction. MacCoss et
al argued that background subtraction is difficult to optimize for thousands of different
chromatographic peaks measured in a proteomics experiment and leads to less reliable
abundance ratio estimation (MacCoss, 2003). In their program RelEx, a correlation
algorithm based on peak profiles is used to calculate peptide abundance ratios (Lawson,
1980; MacCoss, 2003). A peak profile is a scatter plot of ion intensities of the two
isotopologues detected in each full scan within the chromatographic peaks (Figure 6.1D).
The correlation algorithm fits a straight line that has the minimum total squared
perpendicular offset to the data points in the peak profile (Figure 6.1D). The slope of the
fitted line is an estimator of the peptide abundance ratio.
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The existing algorithms that evaluate peptide abundance ratios do not formally “score”
the abundance ratio estimates for their expected bias and variability. In quantitative
shotgun proteomics, the abundance ratios for tens of thousands of identified peptides can
be estimated, but with dramatically varying error. We propose to use a principal
component analysis algorithm to not only estimate the abundance ratio of a peptide from
its peak profile but also score the estimation with a signal-to-noise ratio measure of its
peak profile (profile S/N). We show that the profile S/N is inversely correlated with both
the standard deviation and the bias of the abundance ratio estimation. Thus, the profile
S/N allows stratification of the peptide abundance ratios into those with greater or lesser
estimation accuracy and precision. As a result, it becomes possible to statistically
evaluate every peptide abundance ratio in the subsequent protein abundance ratio
estimation (Pan, 2006a).

Here we describe both the parallel paired covariance algorithm for peak detection and the
principal component analysis algorithm for peptide abundance ratio estimation and
scoring. These two algorithms have been assembled into a computer program, termed
ProRata (Pan, 2006a). ProRata automates the entire data analysis pipeline for quantitative
proteomics with stable isotope labeling, incorporating selected ion chromatogram
extraction and peptide abundance ratio evaluation for the ultimate goal of protein
abundance ratio estimation. The graphical user interface of ProRata also allows manual
data

interrogation

for

result

validation.

www.MSProRata.org.
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ProRata

is

freely

available

at

MATERIALS AND METHODS

Standard Isotopically Labeled Proteome Mixture Preparation.

Wild type Rhodopseudomonas palustris CGA0010 strain was grown anaerobically in
light on defined minimal growth media to mid-log phase at 30°C. (NH4)2SO4 was the
only nitrogen source available for bacterial assimilation, provided as (14NH4)2SO4 for the
unlabeled culture and as (15NH4)2SO4 for the

15

N-labeled culture (>98 atom percentage

excess, Sigma-Aldrich, St. Louis, MO). The 15N-enriched nitrogen from (NH4)2SO4 was
incorporated into proteins through metabolism in the 15N-labeled culture. Except for the
different isotopologues of (NH4)2SO4 in the growth media, the two cultures were
otherwise identically prepared. Cells were harvested by centrifugation and washed twice
with ice-cold wash buffer (50 mM Tris-HCl buffer at pH 7.5 with 10 mM EDTA). Cells
were then lysed by sonication in ice-cold wash buffer and unbroken cells were removed
with low-speed centrifugation (5000 g for 10 minutes). The obtained cell lysates were
fractionated by ultracentrifugation at 100,000 g for 1 hour and the supernatants from the
unlabeled and

15

N-labeled cell lysates were labeled as the

14

N proteome and

15

N

proteome, respectively. Protein concentration in the two proteomes was determined with
Lowry’s analysis (Lowry, 1951). Standard mixtures were prepared by mixing the two
proteomes at 14N:15N ratios of 10:1, 5:1, 1:1, 1:5, and 1:10 by their total protein mass.
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Shotgun Proteomics Measurement.

The proteins in the standard mixtures were denatured and reduced with treatment of 6 M
guanidine and 10 mM dithiothreitol (DTT) (Sigma Chemical Co. St. Louis, MO) at 60 °C
for 1 hour. After six-fold dilution with 50 mM Tris-HCl/10 mM CaCl2 (pH 7.8), the
proteins were digested at 37°C with sequencing grade trypsin (Promega, Madison, WI).
The samples were then reduced with 20 mM DTT for 1 hour at 60 °C and were desalted
using C18 solid-phase extraction (Sep-Pak Plus, Waters, Milford, MA). The protein
digests were examined with LC-MS/MS using twelve-step split-phase MudPIT (MacCoss,
2002; McDonald, 2002). The samples were loaded via a pressure bomb (New Objective,
Woburn, MA) onto a 250-um-I.D. front column packed with 2 cm strong cation exchange
resin (Luna, Phenomonex) and 2 cm C18 reverse-phase resin (Aqua, Phenomonex). A
100-um-I.D. PicoFrit column (New Objective, Woburn, MA) was packed with 15 cm
C18 reverse-phase resin. The front column was connected with the PicoFrit column and
then placed in-line with a Surveyor quaternary HPLC (ThermoFinnigan, San Jose, CA).
The composition of the aqueous solvent was 95% H2O (Burdick & Jackson, Muskegon,
MI), 5% ACN (Burdick & Jackson, Muskegon, MI), and 0.1% formic acid (EM Science,
Darmstadt, Germany) and the composition of the organic solvent was 30% H2O, 70%
ACN and 0.1% formic acid. Two-dimensional LC separation was performed with twelve
salt pulses (0 mM, 35 mM, 50 mM, 60 mM, 75 mM, 100 mM, 125 mM, 150 mM, 200
mM, 250 mM, 300 mM and 500 mM ammonium acetate (Sigma Chemical Co., St. Louis,
MO) in the aqueous solvent). Each salt pulse was followed by a 2-hour reverse-phase
gradient from 100% aqueous solvent to 50% aqueous solvent and 50% organic solvent.
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LC-MS/MS analysis was performed on an LTQ linear ion trap instrument
(ThermoFinnigan, San Jose, CA) with dynamic exclusion enabled. Each full scan (4001700 m/z) was followed by five data-dependent MS/MS scans at 35% normalized
collision energy. All scans were averaged from two microscans.

Peptide and Protein Identification.

All MS/MS scans were searched with the SEQUEST program (Eng, 1994) against an R.
palustris protein sequence database (Larimer, 2004). The light isotopologues of peptides
were identified using normal amino acid masses in the SEQUEST parameter file and the
heavy isotopologues were identified using

15

N-labeled amino acid masses. OUT files

were converted to SQT files using UNITEMARE program (generously provided by Dr.
John R. Yates’ laboratory). DTASelect (Tabb, 2002) was used to filter the peptide
identifications based on Xcorr and delCN ( Xcorr > 1.8 (+1), > 2.5 (+2), and > 3.5 (+3);
delCN > 0.08). The peptides were assembled into proteins, retaining duplicate MS/MS
scans of a peptide (DTASelect option: -t 0).

Selected Ion Chromatogram Extraction.

The Xcalibur RAW files were converted into the mzXML format with the ReAdW
program (Pedrioli, 2004). An mzXML parser, RAMP, was used to access the mzXML
files. The selected ion chromatograms were extracted in the following steps. 1) The
peptide identifications were parsed out from DTASelect-filter.txt, including their amino
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acid sequence, charge state, and protein locus. 2) The m/z windows were calculated for
the two isotopologues of each peptide identification. Theoretical isotope distributions for
both isotopologues were calculated based on the sequence, the user-defined isotopic
compositions of the atoms and the user-defined atomic compositions of all residues and
their modifications. In this study, the nitrogen atoms in the heavy isotopologues were
specified to be 98%-enriched

15

N. The m/z windows for an isotopic distribution are

configured to be its major isotopes’ m/z values plus and minus the m/z tolerance; the
major isotopes were specified to be the isotopes with a relative abundance of more than
10%, and the m/z tolerance was defined to be 0.5 in this study. 3) The peptide
identifications with the same sequence and charge state were grouped, if their MS/MS
scans were acquired within a 2-minute interval. Redundant identifications from a single
chromatographic peak of a peptide were often found for either or both isotopologues of
the peptide. 4) A pair of selected ion chromatograms was extracted for the light and
heavy isotopologues of each peptide identification group. The retention time window for
both selected ion chromatograms was defined as from 2 minutes before the first MS/MS
scan to 2 minutes after the last MS/MS scan of the grouped peptide identifications.

Chromatographic Peak Detection.

The covariance chromatogram of an isotopologue pair was reconstructed from its
selected ion chromatograms with the parallel paired covariance algorithm. The parallel
paired covariance at a full scan in the covariance chromatogram is the product of the
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background-subtracted ion intensities at that full scan in the two selected ion
chromatograms:
L
H
) ⋅ ( I kH − I BG
)
Ck = ( I kL − I BG

d ≤k ≤h,

(6.1)

L
H
and I BG
are the background ion intensities of the selected ion chromatograms
where I BG

for the light and heavy isotopologues, respectively; I kL and I kH are the ion intensities at
full scan k in the m/z windows for the light and heavy isotopologues, respectively; and Ck
is the covariance of the two isotopologues’ background-subtracted intensities at full scan
L
H
and I BG
were defined to be the minimum ion
k. The background ion intensities I BG

intensities in the selected ion chromatograms for the light and heavy isotopologues,
respectively. Scan d and scan h are the first and last full scans, respectively, in the
selected ion chromatograms. The time series of I kL and I kH form the selected ion
chromatograms for the two isotopologues and, likewise, the time series of Ck forms the
covariance chromatogram of the isotopologue pair as illustrated in Figure 6.2. The
covariance chromatogram was then smoothed with 7-point quadratic Savitsky-Golay
filter (Press, 2002). The chromatographic peak for a peptide was defined as between scan
a and scan b (d ≤ a < b ≤ h) that are two local covariance minima with the smallest
interval that includes all MS/MS scans matched to this peptide (Figure 6.2). A local
covariance minimum was a scan with the lowest covariance within a seven-point
symmetric window surrounding this scan in the covariance chromatogram. Scans a and b
were the peak boundaries as labeled in Figure 6.2. The parallel paired covariance
algorithm is also capable of determining the retention time shift between the two
isotopologues. For this process, the two selected ion chromatograms would be shifted
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Figure 6.2: Selected ion chromatograms and parallel-paired covariance
chromatogram. The selected ion chromatograms for the light isotopologue
(red) and heavy isotopologue (blue) of a peptide are shown in part A and the
covariance chromatogram is shown in part B. The peak boundaries (vertical
green lines) are determined in the covariance chromatogram and transferred
to the selected ion chromatograms.
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relative to each other scan by scan until the peak height of the peptide in the covariance
chromatogram is maximized.

Peptide Abundance Ratio Estimation and Scoring.

The peptide abundance ratios and the profile S/Ns were estimated with principal
component analysis of the peak profiles. Note that the background subtraction was only
performed for peak detection. The peak profiles were constructed from the originally
extracted selected ion chromatograms. Here, we present the equations used in the
estimation and their derivation from a set of definitions and assumptions.

The detected ion intensities, I iL and I iH , of the light and heavy isotopologues at full scan
i are composed of their true signal (denoted by SiL and SiH , respectively) corrupted by
the random noise (denoted by N iL and N iH , respectively) and superimposed on the
backgrounds (denoted by BL and BH, respectively) (Lawson, 1980):
⎧ I iL = SiL + N iL + B L
⎨ H
H
H
H
⎩I i = Si + N i + B

a ≤i ≤b,

(6.2)

where a and b are the chromatographic peak boundaries. Let us assume that: i) the
backgrounds, BL and BH, hold constant across full scans; ii) the random noises, N iL and
N iH , have zero-mean; and iii) the ratio between the two signals, SiL and SiH , is constant
across scans, and defines the peptide abundance ratio, R. The third assumption, expressed
as Equation 6.3, is based on the exact co-elution of the two isotopologues:
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R = SiL / SiH a ≤ i ≤ b .

(6.3)

The constant background, BL and BH, can be eliminated from our consideration by
centering the intensities and the signals on their means. Let I 'iL and I 'iH denote the meancentered intensities and let S'iL and S'iH denote the mean-centered signals. Then
Equations 6.2 and 6.3 can be transformed, respectively, to:

⎧⎪ I 'iL = S 'iL + N iL
a≤i≤b
⎨ H
⎪⎩ I 'i = S 'iH + N iH
R = S 'iL / S 'iH

(6.4)

(6.5)

This transformation is the reason why the peak-profile-based algorithms can obviate the
background subtraction step and, therefore, eliminate the probable error in this step.

Principal component analysis is generally applied to a set of vectors. Let us define the
following vectors: the ion intensity vector I i = ( I 'iH , I 'iL ) , the signal vector
Si = ( S 'iH , S 'iL ) and the noise vector N i = ( N iH , N iL ) . Therefore, Equations 6.4 and 6.5

can be transformed to a vector form:
I i = Si + Ni ,

(6.6)

R = tan(θ S i ) ,

(6.7)

where θ S i is the direction angle of the signal vector Si (Figure 6.3). The vectors Ii are
known from the measurement, but the vectors Si and Ni are unknown and need to be
determined for calculating the abundance ratio, R, and the profile signal-to-noise ratio.
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Heavy isotopologue intensity (×105 )

Figure 6.3: Estimation of peptide abundance ratio with the principal
component analysis algorithm. Two principal components are represented
with two lines, the red line for the first principal component P1 and the
green line for the second principal component P2. The ratio between the
lengths of the two lines is plotted to be equal to the profile S/N, which
captures how elliptical the ensemble of the data points in the peak profile is.
The ion intensity vector for each data point (Ii) can be decomposed to the
signal vector (Si, the projection of Ii on P1) and the noise vector (Ni, the
projection of Ii on P2). The slope of P1 (tan(θP1)) is an estimator of the
peptide abundance ratio.
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Obviously, Si and Ni cannot be solved analytically from Equation 6.6. Instead,
determining Si and Ni is formulated as an optimization problem of finding such vectors Si
and Ni that the variance of the norm of the noise vectors, σ 2 (| N i |) , is minimized. This
optimization problem can be solved by principal component analysis of the peak profile,
as shown in Equation 6.8,
⎧ Si = (I i ⋅ P1 )P1
,
⎨
⎩N i = (I i ⋅ P2 )P2

(6.8)

where P1 and P2 are the corresponding first and second principal components of the
intensity vectors Ii. This means that the direction of all signal vectors is the direction of
the first principal component and the length of a signal vector is the dot product between
the intensity vector and the first principal component. The direction and length of the
noise vectors are determined, likewise, with the second principal component.
Geometrically, a signal vector and a noise vector are the projections of their intensity
vector on the first principal component and the second principal component, respectively
as illustrated in Figure 6.3. Principal component analysis of the intensity vectors Ii in the
peak profile calculates the principal components P1 and P2 and their associated
eigenvalues λ1 and λ2. The principal components and eigenvalues provide the estimators
for the peptide abundance ratios and profile S/Ns, as described below.

The abundance ratio is the tangent of the direction angle of the first principal component:
R = tan(θ P1 ) .
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(6.9)

The abundance ratio estimated with principal component analysis is exactly the same as
the abundance ratio estimated with linear correlation. This is because the direction of the
first principal component is exactly the same as the direction of the straight line with
minimum total squared perpendicular offset (Jolliffe, 2002), both of which are estimators
of the peptide abundance ratio.

Let us define the signal-to-noise ratio for the ion intensity vectors in the peak profile as
the ratio between the standard deviation of the length of the signal vectors and that of the
length of the noise vectors:
S / N profile ≡

σ (| S i |)
.
σ (| N i |)

(6.10)

We refer to this signal-to-noise ratio as the profile signal-to-noise ratio to distinguish it
from the chromatographic S/N, since the profile S/N is based on the peak profile, while
the chromatographic S/N is based on the ion chromatogram. The first eigenvalue, λ1, is
the variance of the projection of the intensity vectors on the first principal component,
which is the variance of the length of the signal vectors. Likewise, the second eigenvalue,
λ2 for the second principal component is the variance of the length of the noise vectors.
The profile S/N is calculated as the square root of the ratio between λ1 and λ2:
S / N profile =

λ1
.
λ2

(6.11)

The calculation of the profile S/N from the eigenvalues is the key feature of the principal
component analysis algorithm that distinguishes it from the linear correlation algorithm.
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For comparison, the peptide abundance ratios were also estimated with the peak area
algorithm. To calculate the peak area, selected ion chromatograms were smoothed with a
7-point quadratic Savitsky-Golay filter (Press, 2002). The background of a selected ion
chromatogram was set to be the straight line connecting the two ion intensities at the peak
boundaries. The peak area is the total background-subtracted intensities of a peak.

RESULTS AND DISCUSSION

In this study, standard mixtures of isotopically labeled proteomes were used to test the
proposed algorithms. Abundance ratios between the light and heavy isotopologues of all
peptides in the standard mixtures were expected to be approximately the same as the
mixing ratio of the 14N proteome and the 15N proteome. This does assume that the protein
abundance profiles should be the same for the two proteomes extracted from the
identically grown cells. Six datasets were acquired from standard mixtures, including
1:1a, 1:1b, 5:1, 1:5, 10:1 and 1:10. The 1:1a and 1:1b datasets are from duplicate
measurements of the 1:1 standard mixture.

Ion Chromatogram Extraction with Re-organized Peptide Identifications

Both the light and heavy isotopologues of peptides were considered when searching the
MS/MS scans (Table 6.1). We consider every chromatographic peak as an independent
measurement of the peptide abundance ratio. If a peptide is identified in multiple
chromatographic peaks, all identifications are retained and used for extracting the
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Table 6.1 The peptide quantification results from the six standard mixture datasets.

Standard Mixtures
14

15

N: N Log-ratio
1:1a
0.0
1:1b
0.0
5:1
2.3
1:5
-2.3
10:1
3.3
1:10
-3.3
Average

Peptide Counts
14

N ID
13,766
13,975
23,527
5,676
24,257
3,167
---

15

N ID
11,665
12,230
5,122
18,037
2,725
21,396
---

Log-ratio
#

SIC
17,574
18,472
23,256
18,855
22,770
20,945
20,312

Quantified
11,919
12,958
14,583
12,453
12,914
12,910
12,956

Median
-0.17
-0.16
1.66
-1.99
2.20
-2.80
---

* AAD: Absolute average deviation from the median
# SIC: Selected ion chromatogram
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AAD *
0.67
0.69
1.04
0.94
1.37
1.39
1.02

Log-profile-S/N
Median
2.17
2.15
2.29
2.44
2.31
2.46
2.30

AAD *
0.58
0.56
0.73
0.78
0.85
0.91
0.74

selected ion chromatograms. However, if a peptide is identified in the same charge state
at multiple retention time points across a single chromatographic peak, the different
identifications are combined and used to extract a single selected ion chromatogram pair.

The m/z windows for extracting ion chromatograms were calculated from the isotopic
distributions of a peptide’s isotopologues. The heavy isotopologues had a theoretical
isotopic distribution skewed by the incomplete enrichment of the heavy stable isotope.
Our ion chromatogram extraction algorithm has the capability of handling mass spectral
data of varying resolution. Normally, ion chromatograms are extracted from a single m/z
window for an ion species. To allow high-resolution ion chromatogram extraction, an m/z
window is opened for each major isotope in the isotopic distribution. The width of the
m/z windows can be configured to fit the measurement resolution of the mass
spectrometer. In this way the background noise between two isotopes can be notched out,
if a high-resolution mass spectrometer is used. In this study, as a linear ion trap
instrument was used, the mass tolerance was set to be ±0.5 Da and the m/z windows for
individual isotopes were merged into one m/z window per isotopologue. Our algorithm
can also be configured to extract ion chromatograms for other isotope labeling techniques,
such as SILAC, ICAT and H218O digestion.

Chromatographic Peak Detection with Parallel Paired Covariance

The selected ion chromatograms of a peptide were extracted for a user-defined retention
time window around the MS/MS scans of the peptide. Then, the exact retention time
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boundaries of the two isotopologues’ chromatographic peaks were determined by
performing peak detection in the covariance chromatogram. The covariance
chromatogram was constructed by combining the two selected ion chromatograms
(Figure 6.2). The two co-eluting peaks in selected ion chromatograms are represented by
one greatly enhanced peak in the covariance chromatogram, whereas the noise peaks
appearing in only one selected ion chromatogram are suppressed in the covariance
chromatogram (Figure 6.2). This indicates that the parallel paired covariance algorithm
multiplies the signal of the two chromatographic peaks and effectively reduces the
uncorrelated noise in the selected ion chromatograms. As a result, the signal-to-noise
ratio of the covariance chromatogram is greater than either one of the selected ion
chromatograms, and the peak representing the elution of the isotopologue pair can be
detected with greater accuracy.

A practical advantage of using the parallel paired covariance algorithm is obviation of the
need for peak detection in both selected ion chromatograms. In Figure 6.2, the peak
detection for the light isotopologues (in the red chromatogram) is difficult due to the low
peak height and high noise fluctuation. Peak detection was found to be virtually
impossible for the less abundant isotopologue of many peptides in the 1:10 and 10:1
standard mixtures. An alternative method is to determine peak boundaries only in the
selected ion chromatogram of the more abundant isotopologue, but this method ignores
the signal of the other isotopologue and requires the knowledge of which isotopologue is
more abundant prior to estimating the abundance ratio between the two isotopologues.
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As the accuracy of the peak detection is directly related to the signal-to-noise ratio of the
chromatogram, we constructed the histograms of the signal-to-noise ratio for the
covariance chromatograms (the black histogram) and the selected ion chromatograms
(the blue and red histograms) (Figure 6.4). Virtually all peptides have an improved
signal-to-noise ratio in the covariance chromatogram than in the selected ion
chromatogram of the more abundant isotopologue. The degree of improvement is related
to the signal-to-noise ratio of the less abundant isotopologue. In accord with general
chromatography protocols, a signal-to-noise ratio of 3 or greater is generally required for
a chromatographic peak to be accurately defined in its chromatogram. More peptides
exceed this signal-to-noise ratio threshold with their covariance chromatogram than with
their individual selected ion chromatogram; therefore, more peptides can have correctly
assigned peak boundaries by using the parallel paired covariance algorithm.

The parallel paired covariance algorithm is based on the assumption of the co-elution of
the two isotopologues. While this is generally true for most peptides labeled with 13C, 18O,
and

15

N, the peptides labeled with 2H can show a retention time shift between the two

isotopologues. The retention time shift can be computationally offset by shifting one
selected ion chromatogram relative to the other one. However, this extra computational
step can add additional probable error to the peptide quantification process.
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Figure 6.4: Distribution of log2 chromatographic S/N for the six standard
mixture datasets. Histograms of log2 chromatographic S/N are shown for the
two selected ion chromatograms (blue for the light isotopologue and red for
the heavy isotopologue) and their covariance chromatogram (black). The
covariance chromatogram has a higher average signal-to-noise ratio than either
of the two selected ion chromatograms. The mixing ratio between the 14N
proteome and the 15N proteome for a standard mixture is shown in each
histogram.
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Evaluation of the Peptide Abundance Ratio Estimation Accuracy

The peptide abundance ratios were then estimated by principal component analysis of the
peak profile (Figure 6.3). As the isotopologues begin eluting off the column, the trace of
the data points starts from close to the origin and moves upwards and to the right. After
the two isotopologues reach the top of their chromatographic peaks, the trace of the data
points regresses back toward the origin. Ideally, the trace of the data points should form a
straight line whose slope is the peptide abundance ratio. However, the random noise
component of the ion intensities will make the trace “wiggle” along the straight line.
Essentially, the purpose of principal component analysis is to separate the noise
component and the signal component of the ion intensities.

The accuracy of estimating peptide abundance ratios was benchmarked with the six
standard mixture datasets. The principal component analysis algorithm was compared
with a more commonly used algorithm based on peak area calculation. On average, in
each dataset, the selected ion chromatograms were extracted for ~20,000 peptides and,
after filtering the peptides with a profile S/N cutoff of 2.0, the total number of quantified
peptides was ~13,000 (Table 6.1). The filtering effectively removes the peptides that
cannot be reliably quantified by either algorithm. This profile S/N cutoff is discussed in
the next section.

The estimated abundance ratios were transformed to logarithm base-2, abbreviated as
log-ratio, and histograms of the log-ratios estimated with the principal component
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analysis algorithm and the peak area ratio algorithm were constructed (Figure 6.5).
Although all peptides in a standard mixture should have the same abundance ratio as the
mixing ratio, the log-ratio distributions spread around a center, which can be attributed to
the random error of the estimation with both methods and, probably to a less extent, to
the biological variability of the

14

N and

15

N cultures. For the four standard mixtures of

uneven mixing ratios, their log-ratio distributions have a center slightly shifted towards
zero from the log mixing ratio and have a heavier shoulder in the side toward zero. This
suggests a systematic error of the estimation with both methods. However, the log-ratio
distributions from the principal component analysis method (the blue histogram) is
located closer to the log mixing ratio with less spread around the center and a lighter
shoulder in the side toward zero, which indicates the less random and systematic errors in
the log-ratio estimation with the principal component analysis algorithm.

Two features of the principal component analysis algorithm, which are also shared with
the correlation algorithm, can contribute to the improved peptide abundance ratio
estimation (Thorne, 1984; Thorne, 1986; MacCoss, 2003). The first feature is the
obviation of background subtraction by assuming a constant background within the
chromatographic peak. In the peak area method, however, the backgrounds of the two
chromatograms have to be subtracted from their peak area. Since the automatic routine
for background estimation can be error-prone for many peptides, the errors in the
background estimation translate directly into errors of abundance ratio estimation. The
second feature is a built-in mechanism for removing random noise. The signal component
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Figure 6.5: Distribution of peptide log-ratio estimates for the six
standard mixture datasets. The histograms of the log-ratios estimated with
the principal component analysis algorithm (blue histograms) and the peak
area algorithm (red histograms) are shown for all standard mixture datasets.
Only the peptides with profile S/Ns greater than two are considered. The
log2 mixing ratio is marked with a green vertical line in each histogram.
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and the random noise component are separated into the first principal component and the
second principal component, respectively, and the first principal component is used to
estimate the abundance ratio. The peak area method can only rely on chromatogram
smoothing to remove the random noise. As the selection of a routine and its parameters
for chromatogram smoothing is fairly subjective, it would be difficult to obtain optimized
chromatogram smoothing across thousands of selected ion chromatograms with varying
peak shapes.

Compared with the peak area method, a disadvantage of the peak profile-based
algorithms is their limited applicability to the isotopologue pairs with retention time shift.
Although the retention time shift can be offset computationally, the offset can be
incorrectly estimated, which might lead to the error in the abundance ratio estimation.

Scoring of Peptide Abundance Ratios for Estimation Variability and Bias

The principal component analysis algorithm scores each estimated peptide abundance
ratio with a profile S/N. Note that profile S/N is a signal-to-noise ratio measure of the
peak profile, which is different from chromatographic S/N. Chromatographic S/N directly
impacts peak area calculation accuracy and, therefore, estimation accuracy of peak area
ratio for a peptide should be related to the two chromatographic S/Ns for the light and
heavy isotopologues. On the other hand, the principal component analysis algorithm
estimates peptide abundance ratios from peak profiles and, therefore, its estimation
variability and bias are expected to be directly related to profile S/N.
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The peptides were separated into bins by the logarithm base-2 of their profile S/N (logprofile-S/N). The bins were evenly spaced by 0.1 units between log-profile-S/Ns of 0 and
6. The log-ratio distributions were constructed in all log-profile-S/N bins. To present the
series of the log-ratio distributions, a two-dimensional heatmap histogram was plotted for
each standard mixture dataset (Figure 6.6). Each horizontal band of the two-dimensional
histogram represents a log-ratio distribution, in which the peptide count is color-coded.
The histograms show that the log-ratio distribution changes in a consistent manner with
the log-profile-S/N. At high log-profile-S/N region, the estimated log-ratios tightly
cluster close to the log2 mixing ratios (the dashed red lines in Figure 6.6), indicating
accurate and precise log-ratio estimation for peptides with high log-profile-S/N. As the
log-profile-S/N decreases, the spread of the log-ratio distribution increases, which
suggests the elevating variability of log-ratio estimation.

When the log-profile-S/N decreases below a threshold, the log-ratio distribution
gradually regresses away from the log mixing ratio and approaches the log-ratio of zero.
This shows the higher bias in the log-ratio estimation for peptides with lower log-profileS/N. Also note that the log-profile-S/N threshold for the onset of log-ratio estimation bias
is higher in the standard mixtures with larger log2 mixing ratios. This supports the
previous observation that the abundance ratio estimation is often biased for the lowconcentration peptides with large abundance difference between their isotopologues
(Ong, 2003). The less abundant isotopologue often receives a higher percentage of ion
intensity from the noise than the more abundant isotopologue. As a result, the abundance
156

Figure 6.6: Two-dimensional heatmap histograms of log-ratio and logprofile-S/N for the six standard mixture datasets. The color keys for the
frequency of peptides are shown in the right of the histograms. The log2
mixing ratios are marked with the red dotted lines. The two-dimensional
heatmap histograms show the log-ratio distributions at different log-profileS/N levels. Log-profile-S/N is inversely related to the spread of the log-ratio
distribution and its deviation from the log2 mixing ratio.
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ratio estimate becomes biased towards 1:1. For peptides with log-profile-S/Ns close to
zero probably due to the fact that both isotopologues are “buried” in the background
noise, the abundance ratios will most likely be estimated as 1:1, regardless of their true
value.

The variability of the log-ratio estimation can be measured with the standard deviation of
the log-ratio distribution. The standard deviations of the log-ratio distributions were
plotted against log-profile-S/N (Figure 6.7A). There is an apparent inverse linear
correlation between the standard deviation and the log-profile-S/N. A linear regression
model was constructed between the log-profile-S/N and the standard deviation:
σ = 1.2 − 0.2 ⋅ V ,

where σ is the standard deviation and V is the log-profile-S/N. The coefficient of
determination of the linear regression model was 0.766. The majority of residuals in the
linear regression model arise from the stratification of the data points by the mixing ratios.

The log-ratio estimation bias can be quantified with the absolute values of the averages of
the log-ratio distributions, which were plotted against the log-profile-S/N of the peptide
bin (Figure 6.7B). At the high log-profile-S/N range, the absolute averages are close to,
but slightly below, the absolute value of the log2 mixing ratios of the datasets. As the logprofile-S/N decreases, the average also regresses back to zero. A zero-intercept straight
line was fit into the data points on the track of regressing to zero and, in conjunction with
the largely unbiased average at the high log-profile-S/N region, a linear regression model
can be obtained:
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Figure 6.7: Linear models for the standard deviation and absolute average of
the log-ratio distribution. Parts A and B show the standard deviations and absolute
average of the log-ratio distributions at different log-profile-S/N levels, respectively.
The data points from the two 1:1 datasets are shown in blue, those from the 5:1 and
1:5 datasets in red and those from the 10:1 and 1:10 datasets in green. In part A, the
standard deviations are modeled with a linear model of log-profile-S/N (the black
straight line). In part B, the biased absolute averages are also modeled with a linear
model of log-profile-S/N (the black straight line). At the high log-profile-S/N region,
the absolute averages are largely consistent with the log2 mixing ratios (marked
with the horizontal lines).
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⎧1.2 ⋅ V , 1.2 ⋅ V < H
,
μ =⎨
⎩ H , 1.2 ⋅ V ≥ H

where |μ| is the absolute value of the average, V is the log-profile-S/N, and |H| is the
absolute value of the log mixing ratio or the true log-ratio. The linear regression model of
the average shows that when log-profile-S/N is zero, the average is zero; as the log-ratio
increases, the average increases proportionally until it reaches the true log-ratio and
levels off afterwards.

The bias and the variability of the abundance ratio estimation are indispensable for
making the statistical inference on the estimated abundance ratio. In isotope dilution mass
spectrometry, the variability and bias of the abundance ratio estimation are determined
experimentally by replicate measurements of the sample and calibration with standard
solutions (Sargent, 2002). These two experimental routines are of limited practicality in
quantitative proteomics, where thousands of peptides are quantified in each experiment.
These two linear regression models shown in Figure 6.7 enable the prediction of the
variability and the bias of the abundance ratio estimation from the profile S/N for
quantitative proteomic experiments. This paves the way for statistically evaluating every
peptide abundance ratio using its predicted estimation variability and bias in protein
abundance ratio estimation process (Pan, 2006a).
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CONCLUSIONS

Here we presented two algorithms for peptide quantification in quantitative shotgun
proteomics. The parallel paired covariance algorithm was developed to improve the
accuracy of assigning peak boundaries of the chromatographic peaks from a peptide. This
algorithm integrates the two selected ion chromatograms into one covariance
chromatogram. We showed that covariance chromatograms generally have a better
signal-to-noise ratio than either selected ion chromatogram and result in better peak
detection accuracy. We then used a principal component analysis algorithm to estimate
the peptide abundance ratios from peak profiles. The estimation accuracy was shown to
be better than using a peak area algorithm. More importantly, for each peptide abundance
ratio estimate, the principal component analysis algorithm provides a signal-to-noise ratio
measure of the peak profile, called profile signal-to-noise ratio. The profile signal-tonoise ratio is inversely correlated with the variability and bias of the peptide abundance
ratio estimation.
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Chapter 7
ProRata: a Quantitative Proteomics Program for Accurate Protein Abundance
Ratio Estimation with Confidence Interval Evaluation

All of the data presented below has been published as
C. Pan, G. Kora, W.H. McDonald, D.L. Tabb, N.C. VerBerkmoes, G.B. Hurst, D.A.
Pelletier, N.F. Samatova, and R.L. Hettich. ProRata: A quantitative proteomics program
for accurate protein abundance ratio estimation with confidence interval evaluation.
Analytical Chemistry. 2006 (In press)
As first author, C. Pan’s contributions to this article include algorithm development and
MS data acquisition and interpretation
INTRODUCTION

Organisms often respond to environmental or physiological stimuli by adjusting the type
and abundance of proteins in their cells. Measurement of the relative abundances of
proteins in treatment cells subjected to stimuli, compared to that in the reference cells,
provides valuable insights about protein function and regulation. Quantitative shotgun
proteomics has recently emerged as a high-throughput technique for measuring the
relative abundances of thousands of proteins between two cellular conditions (Ong,
2005a). The reference and treatment proteomes are labeled with different stable isotope
tags (Gygi, 1999; Oda, 1999; Yao, 2001; Ong, 2002) and then mixed in equivalent
amounts. In such a proteome mixture, each protein has two mass-different isotopic
variants: the light isotopologue and the heavy isotopologue (Muller, 1994), or a protein
isotopologue pair. Finally, the proteome mixture is digested and then analyzed with
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liquid chromatography–tandem mass spectrometry (LC–MS/MS) (Link, 1999). The
proteolysis turns each protein isotopologue pair into multiple peptide isotopologue pairs.
Each of the peptide isotopologue pairs is expected to have the same abundance ratio as
the protein isotopologue pair. Although multiplication of isotopologue pairs in the
mixture by proteolysis increases the complexity of the sample for LC-MS/MS analysis, it
provides multiple indirect measurements of a protein’s abundance ratio, derived from the
abundance ratios of its peptide isotopologue pairs.

To evaluate protein abundance ratios from quantitative proteomics measurements, two
types of statistical estimation should be employed: point estimation and interval
estimation. The point estimation gives an abundance ratio for every quantified protein,
which “best” approximates the true abundance ratio. Unfortunately, the point estimation
provides no information about protein quantification precision, which can significantly
vary across different proteins. Generally, a protein should have better quantification
precision if it has more proteolytic peptides quantified from mass spectral data of higher
signal-to-noise ratio. It is misleading in quantitative proteomics to treat all proteins’
abundance ratios identically, regardless of their estimation precision.

The interval estimation complements the point estimation by providing confidence
intervals for protein abundance ratios. If 90% of quantified proteins have confidence
intervals that contain their true abundance ratios, then confidence intervals are estimated
at 90% confidence level. The confidence level for the interval estimation in quantitative
proteomics is analogous to the true positive rate for protein identification in qualitative
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proteomics. More importantly, at a given confidence level, the confidence interval
intuitively reflects the quantification precision for each protein as an “error bar” of the
abundance ratio estimate.

In quantitative shotgun proteomics, each protein’s abundance ratio is estimated by
“combining” multiple peptide abundance ratios measured with LC-MS/MS. Several
computer programs have been developed for the point estimation of protein abundance
ratios, including XPRESS (Han, 2001), ASAPratio (Li, 2003), MSQuant (Schulze, 2004),
and RelEx (MacCoss, 2003). The first three programs calculate peptide abundance ratios
from ratios of peak areas in selected ion chromatograms. RelEx, on the other hand,
estimates peptide abundance ratios using a linear correlation algorithm, which reduces the
peptide abundance ratio estimation error. The average of peptide abundance ratios is then
used by RelEx, XPRESS and MSQuant to estimate protein abundance ratios. To improve
the accuracy of protein abundance ratio estimation, ASAPratio weighs the peptide
abundance ratios with their peak area and uses the weighted average to estimate the
protein abundance ratios. In these programs, the standard deviation of the peptide
abundance ratios is used as a measure of the variability of the protein abundance ratio
estimation. However, without assuming the normality of the peptide abundance ratio
distribution, the standard deviation is not directly related to the confidence interval of the
protein abundance ratio.

In the previous chapter, we scored every peptide’s abundance ratio with a profile signalto-noise ratio for the peptide’s mass spectral data (Pan, 2006b). It was observed that the
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estimation variability and bias of peptide abundance ratios in log2 scale (peptide logratios) were linearly correlated with profile signal-to-noise ratios in log2 scale (logprofile-S/Ns). This was illustrated with a standard mixture of isotopically labeled
proteomes, in which all peptides were expected to have an abundance ratio of 1:5 or a
log-ratio of –2.3. The two-dimensional heatmap histogram of peptide log-ratio versus
log-profile-S/N shows a comet-like distribution from this standard mixture (Figure 7.1).
In the high log-profile-S/N region, the peptide log-ratio distributions are tight with a
center at the expected log-ratio. As the log-profile-S/N level decreases, the horizontal
spread of the log-ratio distributions increases, indicating the elevation of variability in
peptide log-ratio estimation. At the same time, the distributions also deviate more from
the true log-ratio, indicating the increase of bias in peptide log-ratio estimation. The
change of variability and bias of the log-ratio distributions with log-profile-S/N makes it
unsuitable to treat peptides with different log-profile-S/N identically and to assume
normality for the aggregated peptide log-ratio distribution.

In this chapter, we describe a profile likelihood algorithm that yields both maximum
likelihood point estimation (Eliason, 1993) and profile likelihood confidence interval
estimation (Venzon, 1988) of protein abundance ratios. This likelihood-based approach
allows us take into account the changing estimation variability and bias of peptide
abundance ratios in the process of protein abundance ratio estimation. This improves the
accuracy of the point estimation and the precision and confidence level of the interval
estimation, as benchmarked with standard mixtures of isotopically labeled proteomes.
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Figure 7.1: A two-dimensional heatmap histogram of peptide log-ratio
versus log-profile-S/N. The color-scale (shown on the right) represents the
number of peptides at a given log-ratio and log-profile-S/N location. The
expected log-ratio for all peptides in this 1:5 standard mixture is –2.3, indicated
with the red dotted vertical line. As the log-profile-S/N level lowers, the
horizontal distribution of the peptide log-ratios spreads wider and deviates more
from the line of expected log-ratio.
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The profile likelihood algorithm is part of a computer program called ProRata, which
automates the entire data analysis process for quantitative shotgun proteomics. ProRata is
applicable to a variety of stable-isotope labeling techniques, including 15N/13C metabolic
labeling (Oda, 1999), SILAC (Ong, 2002), ICAT (Gygi, 1999) and H218O proteolysis
(Yao, 2001). Figure 7.2 shows the data analysis flowchart of ProRata. ProRata extracts
selected ion chromatograms for peptide isotopologue pairs and detects their
chromatographic peaks with a parallel paired covariance algorithm (Pan, 2006b).
Principal component analysis is then used to calculate peptide abundance ratios and
profile signal-to-noise ratios. Finally, protein abundance ratios and their confidence
intervals are estimated with the profile likelihood algorithm.

MATERIALS AND METHODS

Chemicals and Reagents.

HPLC-grade water and acetonitrile were obtained from Burdick & Jackson (Muskegon,
MI), and the 98% formic acid from EM Science (Darmstadt, Germany). All other
chemicals were purchased from Sigma-Aldrich (St. Louis, MO) unless noted otherwise.
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Mass Spectral Data

Peptide Identifications

Ion Chromatogram Extraction
Selected Ion Chromatograms
Peak Detection

Parallel Paired Covariance

Chromatographic Peaks
Peptide Quantification

Principal Component Analysis

Peptide log-ratios with log-profile-S/Ns
Protein Quantification

Profile Likelihood Algorithm

Protein log-ratios
with confidence Intervals

Figure 7.2: Data processing flowchart of ProRata. ProRata consists of
four modules, shown as blocks. The algorithm used in each module is
specified on the right. The data flow from one module to the next is shown
with the solid arrows, starting from the input data: mass spectral data and
peptide identification results.
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Standard Isotopically Labeled Proteome Mixture Preparation.

Rhodopseudomonas palustris CGA0010 strain was grown anaerobically in light at 30°C
to mid-log phase. The defined minimal growth media supplies (NH4)2SO4 as the only
nitrogen source for bacterial growth. The unlabeled culture was grown with (14NH4)2SO4.
The

15

N-labeled culture was grown identically with (15NH4)2SO4 (>98 atom percentage

excess, from Sigma-Aldrich, St. Louis, MO). The

14

were prepared from the unlabeled culture and the

15

N proteome and the

15

N proteome

N-labeled culture, respectively, as

described in Chapter 6. The total protein concentration of the two proteomes was
quantified with Lowry’s analysis (Lowry, 1951). Six standard mixtures were prepared by
mixing the

14

N proteome and the

15

N proteome at the ratios of 10:1, 5:1, 1:1, 1:5, and

1:10 by total protein mass. An aliquot of the 14N proteome was also retained for shotgun
proteomics measurement.

Shotgun Proteomics Measurements.

The proteome samples were processed by the described procedure (Pan, 2006b). Briefly,
after disulfide bond reduction and protein denaturation with 10 mM DTT and 6 M
guanidine, the proteome samples were digested with sequencing grade trypsin (Promega,
Madison, WI). The samples were then treated with 20 mM DTT for 1 hour at 60 °C as a
final reduction step. The samples were immediately desalted with Sep-Pak Plus C18
solid-phase extraction (Waters, Milford, MA) and solvent exchanged into 0.1% formic
acid in water by centrifugal evaporation. The protein digests were examined with the
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twelve-step split-phase MudPIT technique, as described previously (MacCoss, 2002;
McDonald, 2002). Briefly, the samples were first separated by twelve-step strong cation
ion exchange liquid chromatography and then by two-hour continuous gradient reverse
phase liquid chromatography. Eluted peptides were electrosprayed at 2-kV distal
electrospray voltage into an LTQ mass spectrometer (Thermo Finnigan, San Jose, CA).
Tandem mass spectrometry analysis was performed with each full scan (400-1700 m/z)
followed by five data-dependent MS/MS scans at 35% normalized collision energy.
Dynamic exclusion was enabled. All scans were averaged from two microscans.

Peptide and Protein Identification.

All MS/MS scans were searched in two iterations against a FASTA database containing
all annotated Rhodopseudomonas palustris proteins (Larimer, 2004) using the SEQUEST
program (Eng, 1994). In the first iteration, the unmodified amino acids were used and in
the second iteration the

15

N-labeled amino acids were used. The peptide identifications

from the two iterations were merged. The DTASelect program (Tabb, 2002) was used to
filter the peptide identifications and to assemble the peptides into proteins using the
following parameters: retain the duplicate MS/MS scans for each peptide sequence
(DTASelect option: -t 0), consider fully tryptic peptides only, filter with a delCN of at
least 0.08 and cross-correlation scores (Xcorrs) of at least 1.8 (+1), 2.5 (+2), and 3.5 (+3).
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Ion Chromatogram Extraction.

For each identified peptide, two selected ion chromatograms were extracted for the two
peptide isotopologues. The m/z window for the light isotopologue was calculated from
the natural isotopic envelope of the peptide. The m/z window for the heavy isotopologue
was calculated by using 98%-enriched

15

N for all nitrogen atoms. The retention time

window of the selected ion chromatograms was defined as from 2 minutes before the
MS/MS scans to 2 minutes after the MS/MS scans.

Peptide Abundance Ratio Estimation.

The chromatographic peaks of the peptide isotopologue pairs were detected with a
parallel paired covariance algorithm. The abundance ratio and the profile S/N of a peptide
were calculated by analyzing its peak profile with principal component analysis as
described in Chapter 6. Briefly, the peak profile was constructed as a scatter-plot with ion
intensities of the two isotopologues as its coordinates (Lawson, 1980). Principal
component analysis of the peak profile generated two principal components and their
associated eigenvalues. The peptide abundance ratio was estimated as the slope of the
first principal component. The profile S/N was calculated as the square root of the ratio
between the first eigenvalue and the second eigenvalue. Peptides with a profile S/N
below 2.0 were removed, due to the large estimation error of their abundance ratios.
Peptides shared among multiple proteins were also discarded, because the abundance
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ratio of a shared peptide will be a weighted average of the abundance ratios of multiple
proteins and thus cannot be used for any of the individual proteins.

Protein Abundance Ratio Estimation.

Quantified peptides were assembled into proteins. Proteins with more than two quantified
peptides were selected for abundance ratio estimation. For the point estimation and
confidence interval estimation, the profile likelihood algorithm solves a likelihood
function of protein log-ratio with a numerical method, in the absence of an analytical
method. The profile likelihood algorithm has three steps:
1. Log-ratio enumeration step: Enumerate all protein log-ratios to be considered
through discretization of a continuous log-ratio interval.
2. Likelihood calculation step: Calculate the likelihood for each considered log-ratio
to be the true log-ratio of a protein, given the abundance ratios and profile S/Ns of
multiple peptides from this protein;
3. Point and interval estimation step: Select a log-ratio with the maximum
likelihood as the maximum likelihood estimate; select two log-ratios on a
likelihood threshold as the lower and upper limits of profile likelihood confidence
interval.

Below we describe the three steps in detail and the rationale for the procedures.
Log-ratio enumeration step: The continuous interval of protein log-ratio, [–7.0, 7.0], is

discretized at the precision of 0.1 to create a discrete set of protein log-ratios, i.e. –7.0, –
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6.9, –6.8, … 6.8, 6.9, and 7.0. This set, denoted as G, enumerates all protein log-ratios
that the profile likelihood algorithm will consider for every protein. The minimum and
maximum protein log-ratios and the discretization precision are configurable in ProRata.
The maximum protein log-ratio of 7 and the minimum protein log-ratio of –7 correspond
to 128-fold up-regulation and 128-fold down-regulation in protein abundance,
respectively. These maximum and minimum log-ratios sufficiently encompass the
practical dynamic range of our instruments for quantification. The discretization
precision of 0.1 is also the protein quantification precision that can be realistically
achieved in quantitative proteomics measurements. The discretization of protein log-ratio
solution space allows for an efficient and correct numerical solution of the likelihood
function of protein log-ratio by brute force enumeration.

Likelihood calculation step: The likelihood for each protein log-ratio in G to be the true

log-ratio of a protein is calculated. Assume that the protein has n peptides with log-ratios
of R1, R2 … Rn and log-profile-S/Ns of V1, V2 … Vn. Let H be an arbitrary log-ratio from
G. Then the likelihood for H to be the true log-ratio of a protein given the log-ratios and
the log-profile-S/Ns of its peptides equals the probability of observing these peptide logratios given their log-profile-S/Ns and the protein log-ratio of H:
L(H | R1 , R2 L Rn ,V1 ,V2 LVn ) = P(R1 , R2 L Rn | V1 ,V2 LVn , H ) ,

(7.1)

where L() is the likelihood function and P() is the probability function. Assume that the
protein’s peptides are measured independently. Then the probability of observing these n
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peptides together is the product of individual probabilities of observing each of these
peptides independently:
P(R1 , R2 L Rn | V1 ,V2 LVn , H ) = P(R1 | V1 , H ) ⋅ P(R2 | V2 , H )L P(Rn | Vn , H )
n

= ∏ P(Ri | Vi , H ).

(7.2)

i =1

Theoretically, the log-ratio of a peptide is expected to be equal to the log-ratio of its
protein. However, due to the changing variability and bias of peptide log-ratio estimation,
the probability distribution of peptide log-ratio is modeled with a mixture model of
normal distribution and uniform distribution:
P(R i | Vi , H) = 85% ⋅ Pnormal (R i | μ i , σ i ) + 15% ⋅ Puniform ,

(7.3)

where Pnormal() is a normal probability function and Puniform() is a uniform probability
function. The mixture model is employed, because the uniform distribution with a weight
of 15% models approximately 15% of outlier peptides that are not well captured by the
normal distribution.

The absolute value of the mean (|μi|) and the standard deviation (σi) of the normal
distribution in the mixture model are approximated with two linear functions of the logprofile-S/N (Vi) and the protein log-ratio (H):
⎧1.2 ⋅ Vi , 1.2 ⋅ Vi < H ,
μi = ⎨
⎩ H , 1.2 ⋅ Vi ≥ H ,

(7.4)

σ i = 1.2 − 0.2 ⋅Vi

(7.5)
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The sign of the mean (μi) is the same as that of the protein log-ratio (H). The two linear
functions and their coefficients were estimated from experimental data as described in
Chapter 6. Briefly, two-dimensional heatmap histograms were constructed for six
different standard mixtures of isotopically labeled proteomes as shown in Figure 7.1. The
means and standard deviations of the peptide log-ratio distributions at different logprofile-S/N levels were calculated, from which the two linear functions were then derived.
The absolute mean linear function (Equation 7.4) captures that the bias of peptide logratio estimation deceases to zero with an increase of log-profile-S/N. The negative slope
of the standard deviation linear function (Equation 7.5) models the decrease of peptide
log-ratio estimation variability with an increase of log-profile-S/N.

In summary, the likelihood function of protein log-ratio is constructed as:
n

L(H | R1 , R2 L Rn ,V1 ,V2 LVn ) = ∏ P(R i | Vi , H)
i =1
n

= ∏ (0.85 ⋅ Pnormal (R i | μ i , σ i ) + 0.15 ⋅ Puniform )

(7.6).

i =1

The likelihood H is calculated for each protein log-ratio in the set G and transformed to
the natural logarithm scale, denoted as ln-likelihood. The calculation result of the
likelihood function can be represented graphically with profile likelihood curve. Let the
x-axis and the y-axis be log-ratio and ln-likelihood, respectively, and plot all considered
protein log-ratios with their ln-likelihood as points. The profile likelihood curve is
constructed by connecting the points adjacent along the log-ratio axis (the blue curves in
Figure 7.3). For manual data analysis, the data points representing the peptides of a
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Figure 7.3: Estimation of protein log-ratios with profile likelihood
curves. All four proteins (locus shown in the upper right corner) are
expected to have a log-ratio of –2.3. Profile likelihood curves (the blue
curves) plot the ln-likelihood (y-axis on the right) for the log-ratios (x-axis)
of proteins. Note the different ln-likelihood ranges for different proteins.
Peptide data points (the red dots) represent the log-ratio (x-axis) and the logprofile-S/N (y-axis on the left) of the quantified peptides. The confidence
intervals are shown as the green bars.
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protein (the red points in Figure 7.3) are overlaid with the protein’s profile likelihood
curve.

Point and interval estimation step: Both maximum likelihood estimate and profile

likelihood confidence interval of a protein’s log-ratio are estimated from the protein’s
profile likelihood curve. The maximum likelihood estimate of protein log-ratio is the logratio with the maximum likelihood. The confidence interval is calculated by assuming
Chi-square distribution for the likelihood ratio test as described in the standard
methodology for profile likelihood confidence interval estimation (Venzon DJ, 1988). Let
Lmax be the maximum likelihood. The confidence interval with a nominal confidence
level of (1 – α) ⋅ 100% includes all the log-ratios that have a ln-likelihood exceeding the
threshold of ln(Lmax) – 0.5 ⋅ χ12,α . The ln-likelihood threshold is ln(Lmax) – 1.96 for the

confidence interval of 95% nominal confidence level ( 0.5 ⋅ χ12, 0.05 = 1.96 ). The lower and
upper limits of the confidence interval are the minimum and maximum log-ratios with lnlikelihood exceeding the threshold, respectively. We discarded proteins with confidence
intervals that are wider than 7.

Protein abundance ratios were also estimated with the RelEx program (MacCoss, 2003)
for comparison purpose. The DTASelect result files and the Xcalibur data files were input
to the RelEx program. Data smoothing, ratio correction and chromatogram filtering were
enabled with the default settings. The protein filter of minimum peptide number of two
was also applied. RelEx was executed in two iterations, one using the light isotopologue
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for peak detection and the other using the heavy isotopologue. The results of the two
iterations are combined. The abundance ratios of the proteins quantified in both iterations
are assigned as the average of the abundance ratios estimated in the two iterations.

Software Development.

ProRata was written in C++ and compiled with the MinGW g++ compiler. The graphical
user interface was implemented using Qt library. ProRata used the RAMP (random access
minimal parser) library to access mzXML files. The histograms were constructed with R
scripts.

RESULTS AND DISCUSSION

The features of the profile likelihood algorithm were evaluated initially with individual
proteins. Then the aggregate performance metrics were determined, including the
accuracy of the point estimation as well as the confidence level and median width of the
confidence interval estimation. Finally ProRata was equipped with a graphical user
interface to enable manual interrogation of the quantification result for any given protein.
Note the following abbreviations used in this study: (a) log-ratio for the abundance ratio
in log2 scale, (b) log-profile-S/N for the profile S/N in log2 scale, and (c) ln-likelihood for
the natural logarithm of the likelihood for a log-ratio to be true for a protein. The log2
transformation for the abundance ratio is to treat up- and down-regulation of protein
abundance symmetrically and to replace a multiplication operation on the abundance
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ratios with the addition operation on the log-ratios.

Point Estimation and Confidence Interval Estimation of Protein Abundance Ratios
with Profile Likelihood Curves

The maximum likelihood point estimation and the profile likelihood confidence interval
estimation of a protein’s log-ratio is based on the protein’s profile likelihood curve, which
is constructed from the quantified peptides of the protein. Figure 7.3 shows profile
likelihood curves (blue curves) together with peptide data points (red points) for four
proteins in the 1:5 standard mixtures.

The maximum likelihood point estimate is the protein log-ratio with the maximum
likelihood, i.e. the log-ratio position of the highest peak in the profile likelihood curve.
Conceptually, the sharper the peak is, the more precise the maximum likelihood estimate
is, and, therefore, the narrower the confidence interval should be. This intuition is
captured by how the profile likelihood confidence interval is estimated. The confidence
interval at the nominal confidence level of 95% is the log-ratio range of the curve
segment above the ln-likelihood threshold (the horizontal lines shown in Figure 7.3) at
1.96 units ( 0.5 ⋅ χ12, 0.05 ) below the peak top. A profile likelihood confidence interval can
be asymmetric, with different distances from the lower and upper interval limits to the
point estimate.
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The shape of the profile likelihood curve is determined by peptide data points in a
number of ways, as illustrated in Figure 7.3 showing four proteins with an expected logratio of –2.3. First, a profile likelihood curve forms a peak at the log-ratio location with
largest density of peptide data points of high log-profile-S/N. To illustrate this, Figure
7.3A shows the profile likelihood curve of 50S ribosomal protein L9 (Locus: RPA3080).
This protein has many peptides with high log-profile-S/Ns and consistent log-ratios. This
leads to a high and sharp profile likelihood peak in the ln-likelihood range of [–260, –140]
and a narrow confidence interval of [–2.4, –1.9].

Second, the log-ratio location of a profile likelihood peak is largely determined by the
peptide data points with higher log-profile-S/N. Figure 7.3B shows a putative
oxidoreductase (Locus: RPA1290) with only two quantified peptides. The peptide with
higher log-profile-S/N has a log-ratio of –1.8 and the other peptide has a log-ratio of –3.5.
The log-ratio position of the profile likelihood peak top, i.e. the maximum likelihood
estimate, is –2.3, which is closer to the log-ratio of the peptide with higher log-profileS/N.

Third, the protein log-ratio estimation accounts for the log-ratio estimation bias in
peptides with low log-profile-S/N. Figure 7.3C shows a phosphoglycerate kinase (Locus:
RPA0943) that has a large fraction of peptide data points with poor log-profile-S/Ns and
log-ratios considerably biased towards 0. The prevalence of biased peptide log-ratios in
the low log-profile-S/N region is also shown in Figure 7.1. A simple average of all
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peptide log-ratios would give a biased estimation of the protein log-ratio. In contrast, the
profile likelihood peak is located in the log-ratio region containing the peptides with high
log-profile-S/N, which yields an unbiased estimation of protein log-ratio. The peptides
with low log-profile-S/N were used to suppress the ln-likelihood of the protein log-ratios
on the right side of the biased peptide log-ratios.

Fourth, the profile likelihood peak excludes the peptide data points that are outliers in the
log-ratio axis. Figure 7.3D shows the profile likelihood curve for a hypothetical protein
(Locus: RPA4470). Only three peptides are quantified and one of them is likely to be an
outlier with an erroneous log-ratio. The outlier creates a small profile likelihood peak, but
has no effect on the large profile likelihood peak used for protein log-ratio estimation.

In summary, the point estimate and the confidence interval of a protein log-ratio is
calculated with peptide log-ratio weighting, bias suppression, and outlier exclusion. All
of these are achieved using the likelihood function of protein log-ratio (Equation 7.6). A
weakness of this algorithm is the need to set the following parameters in the likelihood
function: (a) the proportion between the normal and uniform distributions in the mixture
model (Equation 7.3), which sets the tolerance to outliers modeled by the uniform
distribution; and (b) the parameters in the linear models for inferring the standard
deviation and the mean of peptide log-ratio distributions (Equations 7.4 and 7.5), which
set the relative weights and the expected biases of peptide log-ratios with their logprofile-S/Ns. These parameters were estimated from experimental data as described in
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Chapter 6. This weakness might be alleviated in the future by improving the likelihood
function of our algorithm or by employing other related algorithms from data fusion (Hall,
2004), pattern recognition (Marques, 2001), data mining (Larose, 2006), etc.

Benchmark of Protein Abundance Ratio Estimation Performance using Standard
Mixtures of Isotopically Labeled Proteomes

The profile likelihood algorithm was tested as a part of the program ProRata using the
standard mixtures. A widely recognized challenge in proteomics is the enormous
dynamic range between different proteins. Quantitative proteomics presents another type
of the dynamic range challenge: the potentially large abundance difference between the
two isotopologues of a protein. We refer to the former dynamic range as protein dynamic
range and to the latter one as isotopologue dynamic range. Various standard mixtures of

metabolically labeled R. palustris proteomes were prepared with different mixing ratios,
which represent the isotopologue dynamic range. The following five mixing ratios
between the 14N and 15N proteomes were used in this study: 10:1, 10:1, 5:1, 1:5, and 1:1.
The 1:1 mixture was analyzed in duplicate, and the two data sets are designated as 1:1a
and 1:1b. The protein quantification results are summarized in Table 7.1.

On average, 1,362 proteins were identified in a standard mixture (Table 7.1
Approximately 200 fewer proteins were identified from these standard mixtures than
from the proteome sample before mixing. This reduction is probably because the mixing
essentially doubled the sample complexity. Full scans from the standard mixtures contain
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Table 7.1 Summary of protein quantification results from the standard mixtures of isotopically labeled proteomes.
Standard mixture
14

15

N: N Log-ratio
1:1a
0.0
1:1b
0.0
5:1
2.3
1:5
-2.3
10:1
3.3
1:10
-3.3
Average

Protein count
Identified
1,392
1,348
1,384
1,263
1,475
1,312
1,362

Quantified
1,117
1,071
1,054
1,024
1,096
1,000
1,060

Log-ratio point estimation
Median
-0.2
-0.2
1.8
-2.1
2.5
-3.1
---

AAD *
0.318
0.361
0.481
0.390
0.561
0.639
0.458

Confidence interval estimation
Median width
1.4
1.4
1.4
1.4
1.6
1.6
1.5

* AAD: Absolute average deviation from the median

184

Confidence level
93%
92%
90%
92%
88%
87%
90%

Hypothesis testing
Significance
8%
10%
--------9%

Power
----94%
97%
96%
98%
96%

“doublet” peaks from the two isotopologues of peptides. Many MS/MS scans were
targeted to different isotopologues of the same peptide, rather than to new peptides. On
average, 1,060 proteins were quantified out of the 1,362 identified proteins. Not every
identified protein can be quantified, as quantification of a protein requires at least two
quantified peptides with relatively high profile S/Ns and consistent log-ratios.

We compared RelEx’s and ProRata’s point estimation of protein abundance ratios. RelEx
was used for comparison, because both RelEx and ProRata take the identification results
from the DTASelect program and they employ a similar strategy for calculating peptide
abundance ratios. RelEx, unlike ProRata, uses the average of peptide abundance ratios as
the protein abundance ratio estimate. To evaluate the protein quantification results, the
histogram of protein log-ratio estimates were constructed for each standard mixture. The
protein log-ratio estimates should have the same true value in a standard mixture. Hence,
the spread of the log-ratio distribution would reflect the random estimation error and the
difference between the distribution center and the true log-ratio would reflect the
systematic estimation error.

The protein log-ratio distributions for the two 1:1 standard mixtures are similar between
ProRata (blue) and RelEx (red) (Figure 7.4, top). For the other mixtures, the protein logratio distributions from ProRata (blue) are closer to the true log-ratio (green line) and
tighter than those from RelEx (red) (Figure 7.4, middle and bottom). This indicates that
the profile likelihood algorithm gives a more accurate and precise point estimation of
protein log-ratio than averaging. The median and the average absolute deviation of
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Figure 7.4: Comparison of protein log-ratio point estimation with RelEx
and ProRata. The histograms of the protein log-ratios estimated with the two
programs (blue for ProRata and red for RelEx) are constructed for six standard
mixtures. The mixing ratios in log2 scale are represented by the vertical green
lines.
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ProRata’s point estimation are shown in Table 7.1. The average absolute deviation is the
average difference of the point estimates from their median, which indicates the spread of
the distribution.

The profile likelihood confidence intervals were also estimated for the quantified proteins.
The confidence interval width for the majority of proteins was distributed between 0 and
3 (Figure 7.5). We observed that confidence intervals are generally smaller for highabundance proteins, such as ribosomal proteins, than for low-abundance proteins, such as
DNA polymerase proteins. In the 5:1, 1:5, 1:10 and 10:1 standard mixtures, there was a
distinct, small distribution of confidence intervals that are wider than 4. This distribution
largely stems from highly asymmetric confidence intervals that have a lower limit
extending to the minimum log-ratio of –7.0 or an upper limit to the maximum log-ratio of
7.0. For example, consider a dehydrogenase protein (Locus: RPA4259) in the 10:1
standard mixture. The point estimate for this protein’s log-ratio was 2.1 and the
confidence interval was [1.0, 7.0]. The profile likelihood algorithm only determined that
the log-ratio is greater than 1.0 and extended the upper limit to the maximum log-ratio,
7.0, which gave rise to a wide confidence interval.

The confidence level was benchmarked as the percentage of the true confidence intervals.
In a standard mixture, a confidence interval was determined to be true, if it contains the
median of the protein log-ratio point estimates. On average, 955 proteins out of the 1,060
quantified proteins in a standard mixture had true confidence intervals. This means that,
although the confidence interval estimation has a nominal confidence level of 95%, only
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Figure 7.5: Histograms of the width of protein log-ratio confidence
intervals. The distribution of confidence interval width reflects the varying
quantification precision of proteins in a quantitative proteomics
measurement.
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an average confidence level of 90% was obtained in the standard mixtures (Table 7.1).
The decrease of the observed confidence level from the nominal one is probably because
the peptide log-ratio probability model (Equations 7.3 – 7.5) is only an approximation to
the true distribution. The confidence level of the interval estimation can be increased at
the expense of widening the confidence intervals. This can be achieved by increasing the
value of α in the ln-likelihood threshold, ln(Lmax) – 0.5 ⋅ χ12,α , which lowers the lnlikelihood threshold (the horizontal dashed line in the profile likelihood curves shown in
Figure 7.3).

Confidence interval estimation enables hypothesis testing on the abundance change of a
protein. The hypothesis testing can be used to filter the quantified proteins and select
those with significant abundance change for further examination. Since most of the
proteins in a proteome are not affected by a treatment, the null hypothesis is that there is
no statistically significant difference in the abundance of a protein between two
proteomes. The alternative hypothesis is that there is such a difference. The null
hypothesis can be rejected for a protein if the protein’s confidence interval does not
include zero.

Two performance characteristics of a hypothesis testing method are its power and
significance. A post hoc significance test was performed using the two 1:1 standard
mixtures, in which the null hypothesis should hold for all proteins (Table 7.1). The
average significance was 9%, which means that 9% of the proteins with no abundance
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change are falsely asserted to have significant change. A post hoc power analysis was
then performed using the standard mixtures with the other mixing ratios. The average
power was 96%, which means that 96% of the proteins with abundance change are
correctly identified. The abundance change of those proteins with accepted alternative
hypothesis is only statistically significant, and the proteins should then be selected by the
biological significance of their abundance change.

Testing of Abundance Ratio Estimation for Proteins with Extremely Large
Abundance Change

The performance of the profile likelihood algorithm is sensitive to the isotopologue
dynamic range. As the abundance difference between the two isotopologues increases
among different standard mixtures, the average absolute deviation of the log-ratio point
estimation increases and the confidence level of the interval estimation drops (Table 7.1).
As the performance decrease is not very significant, we believe that the isotopologue
dynamic range can reach 10-fold abundance difference with the LTQ-MS instrument and
the ProRata program.

However, real-world biological samples might have proteins with extremely large
abundance change, such as present in one proteome and absent in the other. We tested
ProRata with an unlabeled proteome sample. In this case, all proteins only have the light
isotopologue, and their log-ratios between the two isotopologues are expected to be
infinity. Ideally, all protein log-ratios estimated by ProRata should be the maximum
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considered log-ratio of 7. A total of 961 proteins were quantified. The histogram of their
log-ratio estimates is shown in Figure 7.6. About 250 proteins have a log-ratio estimate
next to the maximum log-ratio and the log-ratio estimates for most other proteins are
evenly distributed between 2.0 and 6.0. The under-estimation of protein log-ratios is
derived from the under-estimation of peptide log-ratios, which stems from noise
fluctuations that falsely define the abundance of the non-existent heavy isotopologue.

Confidence interval estimation and hypothesis testing were also tested. The confidence
intervals for half of the quantified proteins have an upper limit at the maximum log-ratio,
which means only the lower bound can be estimated for those protein log-ratios. In this
unlabeled proteome sample, the alternative hypothesis should be accepted for all proteins
because of their change from present to absent. We found it to be the case for 97% of the
quantified proteins. This percentage agrees with the observed power of the hypothesis
testing in other standard mixtures. Therefore, although many of these proteins with very
large abundance change have considerable error in their log-ratio point estimates, most of
them can be correctly identified to have significant abundance change.

Manual Inspection of Protein Abundance Ratio Estimation through ProRata
Graphical User Interface

Point estimation and confidence interval estimation of protein log-ratios were performed
with ProRata automatically. However, there were a small percentage of proteins with
spurious estimation results. One effective way to reducing the uncertainty is to manually
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Figure 7.6: Histogram of the log-ratio estimates for proteins with extremely
large abundance change. All proteins are expected to have a very large abundance
ratio between the light isotopologue and the non-existent heavy isotopologue. 26%
of the estimated protein abundance ratios are greater than 64:1 and 90% are greater
than 4:1.
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validate the proteins of interest. ProRata is equipped with a graphical user interface to
enable interactive data interrogation and facilitate manual result validation.

ProRata’s graphical user interface has four panes in its main window, including a Protein
Table, a Peptide Table, a Text Pane, and a Graph Pane (Figure 7.7A). It was designed to

give users a hierarchical view of their proteomics measurements. All quantified proteins
are listed in the Protein Table. When a protein of interest is selected from the Protein
Table, its profile likelihood curve and sequence coverage (Figure 7.7B) are displayed in
the Graph Pane and its peptides are listed in the Peptide Table. Then a peptide from this
protein can be selected to show its selected ion chromatograms (Figure 7.7C) and MS/MS
scans (Figure 7.7D). Furthermore, the full scan at a retention time point in the selected
ion chromatograms can be viewed with the mass spectral peaks for the two isotopologues
highlighted (Figure 7.7E).

We have examined the proteins with erroneous point estimation and/or false confidence
interval estimation. These proteins usually have less than three reliably quantified
peptides. The reliably quantified peptides can generally be ascertained by inspecting their
MS/MS scans, full scans, selected ion chromatograms and peak profiles. Therefore
manual validation of the automated estimation results can provide an additional safeguard
in quantitative proteomics against yielding false information.
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Figure 7.7: Graphical user interface of ProRata. The main window of
ProRata has four panes: Protein Table, Peptide Table, Graph Pane, and Text
Pane (Part A). The Graph Pane contains two protein plots (sequence
coverage plot (Part B) and profile likelihood curve plot), three peptide plots
(selected ion chromatograms (Part C), parallel paired covariance
chromatogram, and principal component analysis of peak profile), and two
types of mass spectra (MS/MS scans (Part D) and full scans (Part E)). In the
sequence coverage plot of a protein, a peptide is represented with a vertical
segment indicating its log-ratio and its location on the protein sequence
(Part B).
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CONCLUSIONS

In this study, we applied maximum likelihood point estimation and profile likelihood
confidence interval estimation for protein abundance ratio evaluation in quantitative
shotgun proteomics with a profile likelihood algorithm. This algorithm is able to weight
peptide abundance ratios by their estimation variability, account for peptide abundance
ratio estimation bias, and suppress contribution from outliers. The algorithm was tested
with standard mixtures of isotopically labeled proteomes at various mixing ratios. We
demonstrated that the point estimation accuracy was improved using maximum
likelihood estimation. The confidence intervals were estimated at the observed
confidence level of 90%. With confidence interval estimation, hypothesis testing was
performed on protein abundance change, which was benchmarked to have a significance
of 9% and a power of 96%. The profile likelihood algorithm was also tested with an
unlabeled proteome sample to show its ability to analyze proteins with extremely large
abundance change. The profile likelihood algorithm was built into a computer program,
ProRata, which automates the entire data analysis procedure for quantitative shotgun
proteomics. ProRata’s graphical user interface allows for manual validation of protein
quantification results.
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Chapter 8
Characterization of Anaerobic Catabolism of p-Coumarate in Rhodopseudomonas
palustris by Integrating Quantitative Proteomics and Microarray

All of the data presented below is in preparation for submission

C. Pan, Y. Oda, D.A. Pelletier, B. Zhang, P.K. Lankford, N.F. Samatova, C.S. Harwood;
Robert L. Hettich. Characterization of Anaerobic Catabolism of p-Coumarate in
Rhodopseudomonas palustris by Integrating Quantitative Proteomics and Microarray.
Journal of Bacteriology (2006), (In preparation)
As first author, C. Pan’s contributions to this article include all proteomics data
acquisition and interpretation.
INTRODUCTION

Lignin constitutes almost one third of all plant dry mass, which makes lignin the second
most abundant organic compound on earth, after cellulose. Biodegradation of lignin
during decay of plant residue in natural environment is a massive biological process
within the global carbon cycle (Kirk, 1984). Lignin biodegradation is also of great
practical significance because of its application to biological treatment and reuse of
agricultural wastes. Lignin is a polymer of phenylpropanoid units, and its biodegradation
involves depolymerization and then catabolism of the derived phenolic monomers
(Sarkanen, 1971). p-Coumarate, or 4-hydroxy-cinnamic acid, is one of the main phenolic
monomers (Hartley, 1989). The degradation of p-coumarate can occur in anoxic
environments, such as aquifers, aquatic sediments, and submerged soils.

199

The purple nonsulfur phototrophic bacterium Rhodopseudomonas palustris is one of a
few known microorganisms capable of anaerobic catabolism of diverse aromatic
compounds, such as benzoate, p-coumarate, cinnamate, and vanillate (Harwood, 1997;
Diaz, 2004). A central intermediate, benzoyl-CoA, is used in degradation of many of
these aromatic compounds in R. palustris (Figure 8.1) (Harwood, 1999). Peripheral
pathways transform different aromatic substrates to benzoyl-CoA. The central benzoylCoA pathway then degrades benzoyl-CoA to acetyl-CoA (Elder, 1994; Harwood, 1999).
We hypothesize that p-coumarate is transformed to benzoyl-CoA via a peripheral
pathway consisting of CoA ligation, ß-oxidation, and dehydroxylation (Figure 8.2). The
generated benzoyl-CoA is catabolized through the known benzoyl-CoA pathway.

In this study, the gene expression profile of R. palustris grown with p-coumarate as the
sole organic carbon source was compared to those of R. palustris grown with succinate or
benzoate. As succinate is a simple dicarboxylic acid, the succinate growth condition
provides the gene expression profile of R. palustris without aromatic degradation activity.
On the other hand, the aromatic degradation activity is induced in both benzoate and
coumarate growth conditions. Benzoat-CoA ligase (RPA0661) transforms benzoate
directly to the central intermediate benzoyl-CoA. Therefore, the comparison between the
benzoate growth condition and the coumarate growth condition was expected to shed
light on the peripheral pathway from coumarate to benzoyl-CoA (Figure 8.2).

Microarray analysis has been established as a high-throughput method for gene
expression profiling at the mRNA level (Harrington, 2000). On the other hand,
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Figure 8.1: R. palustris benzoyl-CoA pathway. The degradation of benzoylCoA involves three steps: ring reduction, ring cleavage and ß–oxidation
(Harwood, 1999). The identified genes are shown for each step.
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Figure 8.2: Proposed R. palustris p-coumarate degradation pathway. The
catabolism of p-coumarate is hypothesized to proceed through the benzoyl-CoA
pathway. The side chain of p-coumarate is removed by ß–oxidation.
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proteomics is a burgeoning technology for characterization of the protein complement of
a cell. Earlier studies with proteomics have largely been qualitative, focusing on
cataloging proteins (Washburn, 2000). With recent technological development,
proteomics has turned quantitative, capable of measuring the abundance ratios of
thousands of proteins between two proteomes (Ong, 2005b). It has now become possible
to ascertain the relative expression activities of a large set of genes at both mRNA level
and protein level by integrating microarray and quantitative proteomics data.

In this study, we demonstrate the value of such integrated gene expression profiling data.
First, the gene expression profiles at both mRNA level and protein level allow the
identification of both transcriptional and post-transcriptional regulation of many genes.
Second, greater confidence was attained for many genes of interest, when they showed
consistent expression changes measured by the two independent methodologies.

MATERIALS AND METHODS

Bacterial Growth and Metabolic Stable Isotope Labeling.

Wild type Rhodopseudomonas palustris CGA0010 was grown anaerobically on different
defined mineral growth media in sealed tubes with a nitrogen gas headspace at 30 °C
with ample incandescent light illumination. (NH4)2SO4 was the only nitrogen source
available for bacterial assimilation, and was provided as (14NH4)2SO4 for the unlabeled
culture and as (15NH4)2SO4 for the

15

N-labeled culture (>98 atom percentage excess,
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Sigma-Aldrich, St. Louis, MO). 3 mM p-coumarate was supplied as the sole organic
carbon source for the unlabeled coumarate culture. 3 mM benzoate and 10 mM succinate
were supplied as the sole organic carbon sources for the

15

N-labeled benzoate and

succinate cultures, respectively. Duplicate cultures were prepared for each of the three
growth conditions. Cell growth was monitored spectrophotometrically at 660 nm and
cells were harvested in mid-log phase at OD660 nm of 0.6 by centrifugation and washed
twice with ice-cold wash buffer (50 mM Tris-HCl buffer at pH 7.5 with 10 mM EDTA).
The harvested cell pellet from each culture was divided for quantitative shotgun
measurements and microarray analysis.

Proteome Sample Preparation.

Duplicate cell mixtures of the unlabeled p-coumarate culture and the

15

N-labeled

succinate culture were prepared by mixing equal weight of cell pellets from duplicate
cultures. Duplicate cell mixtures of the unlabeled p-coumarate culture and the 15N-labeled
benzoate culture were prepared similarly. The cell mixtures were lysed by sonication in
the ice-cold wash buffer, and unbroken cells were removed by centrifugation at 5000g for
10 min. The obtained cell lysates were fractionated by ultracentrifugation at 100,000g for
1 h. The resulting supernatants were labeled as the soluble protein fraction. The pellets
were re-suspended by sonication and labeled as the membrane protein fraction. Protein
concentration for each sample was determined with Lowry’s analysis. The two fractions
from each cell mixtures were digested using the following protocol. The proteins were
denatured and reduced with 6 M guanidine and 10 mM dithiothreitol (DTT) (Sigma
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Chemical Co. St. Louis, MO) at 60°C for 1 h. The denatured proteome fractions were
diluted 6-fold with 50 mM Tris/10 mM CaCl2 (pH 7.6), and sequencing grade trypsin was
added at 1:100 (wt:wt). The first digestion was run overnight at 37°C and, after adding
additional trypsin, the second digestion was run for 5 hrs at 37°C. The samples were then
reduced with 20 mM DTT for 1 h at 60°C and were desalted using C18 solid-phase
extraction (Sep-Pak Plus, Waters, Milford, MA).

Quantitative Proteomics Measurement.

The protein digests were examined with LC-MS/MS using twelve-step split-phase
MudPIT (MacCoss, 2002; McDonald, 2002) in duplicate. The samples were loaded via a
pressure bomb (New Objective, Woburn, MA) onto a 250-um-I.D. fused silica front
column fritted into an M-520 filter union (Upchurch Scientific). The column packing
consisted of 2 cm strong cation exchange resin (Luna, Phenomonex) and 2 cm C18
reverse-phase resin (Aqua, Phenomonex). A 100-um-I.D. PicoFrit column (New
Objective, Woburn, MA) was packed with 15 cm C18 reverse-phase resin. The front
column was connected with the PicoFrit column and then placed in-line with a Dionex
Ultimate quaternary HPLC. Two-dimensional LC separation was performed with twelve
salt pulses, each of which was followed by a 2-h reverse-phase gradient. MS/MS analysis
was performed on an LTQ linear ion trap instrument (ThermoFinnigan, San Jose, CA)
with dynamic exclusion enabled. Each full scan (400-1700 m/z) was followed by three
data-dependent MS/MS scans at 35% normalized collision energy. The full scans were
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averaged from five microscans and the MS/MS scans were averaged from two
microscans.

Quantitative Proteomics Data Analysis.

All MS/MS scans were searched in two iterations against the FASTA database containing
all annotated Rhodopseudomonas palustris proteins (Larimer, 2004) using the SEQUEST
program (Eng, 1994). In the first iteration, the unmodified amino acids were used, and, in
the second iteration, the modified amino acids with 15N-labeling were used. The peptide
identifications from the two iterations were merged. The DTASelect program (Tabb,
2002) was used to filter the peptide identifications and to assemble the peptides into
proteins using the following parameters: retaining the duplicate MS/MS spectra for each
peptide sequence (DTASelect option: -t 0), fully tryptic peptides only, with a delCN of at
least 0.08 and cross-correlation scores (Xcorrs) of at least 1.8 (+1), 2.5 (+2), and 3.5 (+3).
Selected ion chromatogram extraction, peptide abundance ratio estimation and protein
abundance ratio estimation were completed with the ProRata program as described in
previous chapters.
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RESULTS AND DISCUSSION

Experimental Design and Measurement Result Overview

Both microarray and quantitative proteomics measure the abundance changes of gene
expression products between a treatment condition and a reference condition. The
treatment condition in this study was the anaerobic photosynthetic cell growth with pcoumarate as the sole organic carbon source. To identify the genes activated for pcoumarate catabolism, two reference conditions were selected, in which succinate or
benzoate replaced p-coumarate as the sole organic carbon source. Comparison of the pcoumarate condition to the benzoate condition could yield information on the pathway
from p-coumarate to benzoyl-CoA (Figure 8.2). As succinate can be readily used to
generate acetyl-CoA through the citric acid cycle, comparison of the p-coumarate
condition to the succinate condition should help elucidate the entire pathway for pcoumarate catabolism.

The experimental scheme is shown in Figure 8.3. At the cell culture step, R. palustris was
grown under three conditions with

14

N or

15

N stable isotope labeling. Two biological

replicates were prepared for each condition and analyzed independently to capture both
biological and technical variability. Each biological replicate was divided for microarray
and quantitative proteomics analysis. We found that the correlation between microarray
results and quantitative proteomics results was greatly improved by splitting the same
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Figure 8.3: Experimental scheme of integrated gene expression profiling.
The p-coumarate, succinate and benzoate cultures were prepared in biological
duplicate with metabolic stable isotope labeling. The cell pellets were divided
for quantitative proteomics measurements and transcriptomics measurements,
which yielded the relative gene expression profiles among the three growth
states.
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sample for the two measurements, as compared to using separate samples for the two
measurements (Data not shown).

Microarray analysis was performed in Dr. Caroline S. Harwood’s group (University of
Washington, Seattle) with a custom-designed GeneChip, which contained probes for all
4836 predicted genes and 3190 non-coding regions in the R. palustris genome. Each
biological replicate was analyzed with a GeneChip (Figure 8.3). RNA molecules from the
succinate and benzoate conditions contained
metabolic labeling. The

15

15

N-enriched nitrogen, as a result of

15

N

N labeling does not appear to interfere with the microarray

analysis. The reproducibility of the signal intensity measurement between biological
replicates was calculated using correlation coefficient, which exceeded 0.98 for all three
conditions (Data not shown). The relative abundances of mRNAs were derived by taking
the ratios of the signal intensities from two conditions.

The

14

N-labeled p-coumarate cell pellet was mixed with the

15

N-labeled succinate cell

pellet or benzoate cell pellet for quantitative proteomics analysis (Figure 8.3). The
measurement of the two biological replicates yielded the direct comparison of protein
abundance between the p-coumarate condition and each of the two reference conditions:
succinate and benzoate. The two direct comparisons were then combined to form the
indirect comparison between the two reference conditions. The numbers of identified
proteins and quantified proteins in each comparison were summarized in Table 8.1.
While microarray analysis can be used to determine mRNA levels for most genes in a
genome, quantitative proteomics can only quantify protein levels for a subset of genes.
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Table 8.1: Summary of quantitative proteomics results
Coumarate : Succinate

Comparison

Coumarate : Benzoate

Benzoate : Succinate

Number of
Proteins

Biological
Replicate 1

Biological
Replicate 2

Direct
Comparison

Biological
Replicate 1

Biological
Replicate 2

Direct
Comparison

Indirect Comparison

Identified

2385

2172

2012

2058

1979

1801

1500

Quantified

1859

1790

1539

1785

1730

1627

1151
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The missed proteins are generally membrane proteins, low-abundance proteins, or
proteins unexpressed in either condition. The reproducibility of quantitative proteomics
between biological replicates was measured by correlation coefficients of protein
abundance ratios in log2 scale. The correlation coefficients were 0.87 for the direct
comparison of p-coumarate and succinate and 0.84 for the direct comparison of pcoumarate and benzoate (Figure 8.4). The level of reproducibility in the log2 abundance
ratio scale was comparable between quantitative proteomics and microarray analysis.

Integration of mRNA Abundance Profiles and Protein Abundance Profiles.

The transcriptomics data and the proteomics data were cross-matched by gene locus. Due
to the incomplete coverage of the proteome, “Not Available” (N/A) values were assigned
to the absent protein log-ratios. The correlations between the mRNA log-ratios and the
protein log-ratios of the cross-matched genes are shown in Figure 8.5, which all
havepositive Pearson correlation coefficients (r2). The majority of data points were tightly
clustered around the center between the log-ratio interval of [-1, 1] along the mRNA logratio axis and the protein log-ratio axis. This shows that, at the expression fluctuation of
less than 2 fold, the mRNA change and the protein change have little correlation. The
relatively lower correlation coefficient of the benzoate-coumarate comparison is a result
of the lower number of genes with large expression changes.

Histograms of differences between the mRNA log-ratios and the protein log-ratio (Δ logratio) were also constructed for each comparison (Figure 8.5). The discrepancy between
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Protein Log-Ratio Replicate 2

Coumarate : Succinate

Protein Log-ratio Replicate 1

Protein Log-Ratio Replicate 2

Coumarate : Benzoate

Protein Log-ratio Replicate 1
Figure 8.4: Reproducibility of quantitative proteomics results. The protein
log-ratios measured from the two biological replicates were compared to
benchmark the reproducibility. The proteins with consistent log-ratios coincide
with the solid line (y = x).
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Figure 8.5: Comparison of mRNA log-ratios and protein log-ratios. The
protein log-ratios and mRNA log-ratios of quantified genes are shown as
scatter-plots for the three comparisons. And the histograms of the differences
between the protein log-ratio and the mRNA log-ratio (Δlog-ratio) were
constructed for the three comparisons.

213

Coumarate : Succinate

Gene Count

Protein Log-ratio

r2=0.67

mRNA Log-ratio

Δ Log-ratio

Coumarate : Benzoate

Protein Log-ratio

Gene Count

r2=0.31

mRNA Log-ratio

Δ Log-ratio
Benzoate : Succinate

Gene Count

Protein Log-ratio

r2=0.64

Δ Log-ratio

mRNA Log-ratio
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mRNA log-ratio and protein log-ratio of a gene can stem from the combination of
following effects (Julka, 2004):
•

Measurement errors. Both mRNA log-ratio and protein log-ratio of a gene contain
random errors from global high-throughput measurements. Strictly speaking, only
the deviation between the confidence intervals of mRNA log-ratios and protein
log-ratios is statistically significant discrepancy, which can be attributed to factors
other than measurement errors.

•

Post-transcriptional regulation. The mRNA abundance change is not directly
linked to the protein abundance change. Two additional steps can be regulated:
the protein synthesis rate from a unit amount of mRNA and the protein
degradational rate, which can together be termed as post-transcriptional regulation.

•

Sustained protein presence from transient transcriptional regulation. Generally,
mRNA molecules have a very short half-life time. Once the transcription induced
by a stimulus ends, the mRNA level would quickly return to baseline. However,
as proteins are very stable biomolecules, the proteins synthesized from this pulse
of mRNA transcripts can exist for an extended time frame. The snapshot
measurement of the mRNA level and the protein level after the transcriptional
induction can show a baseline mRNA level and an enhanced protein level.

The integrated results of transcriptomics and quantitative proteomics are summarized in
Figure 8.6. The tables show the number of genes categorized by the regulation directions
at mRNA level and protein level. All categories were color-coded to illustrate the
complementarity between transcriptomics and proteomics. The categories in yellow show
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Coumarate
CouSuc: Succinate

Protein

N/A

149 2757 224

Up

1

Null

46

36

62

1301 21

Down 46

166

Down Null

1
Up

mRNA
Coumarate
: Benzoate
CouBen

Protein

N/A

528 2743 215

Up

1

34

38

Null

181

884

11

Down

4

78

7

Down Null

Up

mRNA
Benzoate
: Succinate
BenSuc

Protein

N/A

528 2743 215

Up

2

73

50

Null

181

884

11

Down 67

54

3

Down Null

Up

mRNA
Figure 8.6: Summary of gene expression profiling results. The expression
changes of genes were categorized into up-, null- and down-regulation at the
protein level and the mRNA level. The genes not quantified by proteomics were
put into the N/A group of protein abundance regulation. The complementarities
between proteomics and transcriptomics were color-coded in the tables. Genes
in the yellow cells only have transcriptomics data. The genes in the green cells
requires proteomics data to reflect its true activity. The genes in the red cells
have consistent regulation observed by both measurements.
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the advantage of transcriptomics, which is measurement of the genes missed by
proteomics. The categories in green show the advantage of proteomics. Significant
change at the protein level can be associated with an insignificant change at the mRNA
level, and conversely a significant change at the mRNA level does not necessarily lead to
a significant change at the protein level. The categories in red contain genes with
concordant mRNA change and protein change. The consistent result from two
independent measurements gives enhanced confidence in the expression regulation of
those genes and alleviates the need for validating these genes’ expression individually
with RT-PCR, northern blotting, western blotting, etc.

Identification of cellular pathways for aromatic compound catabolism

As both coumarate and benzoate are aromatic compounds, genes with up-regulated
expression under both aromatic degradation conditions were selected and grouped into
known cellular pathways. The benzoyl-CoA pathway is the most significantly upregulated pathway (Table 8.2). The activation of this pathway in the coumarate condition
supported our hypothesis that catabolism of coumarate proceeds through the benzoylCoA pathway (Figure 8.1). However, the benzoyl-CoA pathway is less activated in the
coumarate condition than in the benzoate condition, probably because there is a rate
limiting step in generating benzoyl-CoA from coumarate. Also note the anti-correlation
between the mRNA regulation and the protein regulation of this pathway in the
coumarate-benzoate comparison. The genes in pimelyl-CoA β-oxidization were less upregulated than the genes up-stream in the benzoyl-CoA pathway. A number of genes in
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Table 8.2: Expression change of the genes in the benzoyl-CoA pathway.
Coumarate : Succinate
Reation
CoA ligation

Locus

Coumarate : Benzoate

mRNA*
Protein
Log-ratio P-value Log-ratio
CI

Benzoate : Succinate

mRNA*
Protein
Log-ratio P-value Log-ratio
CI

mRNA*
Protein
Log-ratio P-value Log-ratio
CI

Gene description

RPA0661

3.0

5.E-08

2.2

[1.9, 2.4]

1.5

7.E-06

-0.7

[-0.8, -0.5]

1.5

2.E-06

2.8

[2.6, 3.1] Benzoate-CoA ligase

RPA0657
RPA0658

3.2
4.2

6.E-10
1.E-12

4.3
3.9

[4.0, 4.7]
[3.6, 4.2]

1.8
1.1

6.E-08
1.E-06

-1.2
-1.4

[-1.3, -1.1]
[-1.5, -1.1]

1.5
3.1

4.E-06
1.E-07

5.5
5.3

[5.2, 2.9] Benzoyl-CoA reductase subunit badD
[5.0, 2.6] Benzoyl-CoA reductase subunit badE

Ring reduction RPA0659

4.8

5.E-13

4.4

[4.2, 4.6]

0.3

4.E-02

-1.7

[-1.9, -1.3]

4.5

3.E-09

6.1

[5.9, 6.3] Benzoyl-CoA reductase subunit badF

RPA0660
RPA0662

6.4
3.4

9.E-09
3.E-08

4.5
3.2

[4.2, 4.7]
[2.8, 3.6]

0.6
1.3

7.E-03
4.E-05

-1.7
-0.8

[-1.8, -1.5]
[-1.2, -0.5]

5.7
2.2

5.E-10
7.E-08

6.1
4.0

[5.9, 6.4] Benzoyl-CoA reductase subunit badG
[3.5, 4.5] Ferredoxin

RPA0650

3.9

2.E-07

N/A

N/A

0.6

1.E-02

-1.3

[-1.5, -1.2]

3.2

2.E-10

N/A

Ring cleavage RPA0653
RPA0654

4.8
4.6

5.E-10
1.E-08

3.9
3.7

[3.7, 4.0]
[3.5, 4.0]

0.9
0.6

5.E-04
2.E-02

-1.2
-1.4

[-1.3, -1.1]
[-1.5, -1.3]

3.8
4.0

5.E-06
7.E-07

5.1
5.1

N/A

Cyclohex-1-ene-1-carboxyl-CoA hydratase

[4.9, 5.2] 2-ketocyclohexanecarboxyl-CoA hydrolase
[4.9, 5.4] 2-hydroxycyclohexanecarboxyl-CoA dehydrogenase

RPA3713

1.4

2.E-04

1.6

[1.5, 1.8]

0.3

2.E-01

0.1

[0.0, 0.2]

1.0

8.E-05

1.5

[1.3, 1.7] Pimeloyl-CoA dehydrogenase small subunit

RPA3714
β-Oxidation
RPA3715

1.2
1.3

7.E-04
2.E-04

1.8
1.6

[1.6, 1.9]
[1.4, 1.7]

0.2
0.2

5.E-01
4.E-01

0.1
0.0

[0.0, 0.2]
[-0.2, 0.1]

1.1
1.1

8.E-05
2.E-05

1.7
1.6

[1.5, 1.8] Pimeloyl-CoA dehydrogenase large subunit
[1.4, 1.8] Acetyl-CoA acetyltransferase

RPA3717

1.8

5.E-05

1.4

[1.3, 1.6]

2.2

1.E-05

0.0

[-0.1, 0.2]

-0.5

3.E-02

1.4

[1.2, 1.6] Enoyl-CoA hydratase

* The mRNA data were provided by Dr. Caroline S. Harwood’s group (University of Washington, Seattle)
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fatty acid metabolism were measured to have an expression level changed by the
coumarate and benzoate catabolism. Probably a portion of pimelate molecules were
diverted to other fatty acid metabolism pathways, rather than being degraded to acetylCoA

The Calvin cycle was activated in both coumarate and benzoate conditions (Elder, 1994).
As shown in Figure 8.1, six reducing equivalents [H] are generated when a molecule of
benzoyl-CoA is degraded into acetyl-CoA. In an anaerobic condition, the reducing
equivalents cannot be oxidized with oxygen to produce ATP. As a result, the Calvin cycle
was turned on as a reducing equivalent sink and as a supplement carbon supply source in
addition to aromatic compound degradation (Elder, 1994). As the Calvin cycle and the
benzoyl-CoA pathway are coupled by the reducing equivalent, the Calvin cycle was also
less activated in the coumarate condition than in the benzoate condition.

Chemotaxis systems were also induced in both aromatic degradation conditions. Many
plant-derived aromatic compounds have been found to be chemo-attractants to bacteria
capable of those compounds’ degradation (Parales, 2002). As there was no aromatic
compound gradient in the laboratory culture condition, the induction of the chemotaxis
system was probably due to coordinate regulation with the aromatic degradation process.
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Characterization of cellular pathways for coumarate catabolism

A hypothesis to be tested in this study is that coumarate is degraded to 4-hydroxylbenzoyl-CoA and subsequently to benzoyl-CoA as shown in Figure 8.2. If the hypothesis
is true, genes required for this β-oxidization should be up-regulated in the coumarate
condition compared to both the benzoate and succinate conditions. All genes with upregulated protein level in the coumarate condition are listed in Table 8.3.

RPA1787 has approximately 50% amino acid sequence identity to known feruloyl-CoA
synthetases in Pseudomonas sp and Pseudomonas fluorescens (Overhage, 1999). The upregulated locus RPA1787 and the down-regulated locus RPA1707 are two putative
feruloyl-CoA synthetases in R. palustris genome. Considering the structural similarity
between ferulate and coumarate and the specific up-regulation of RPA1787 expression,
RPA1787 is likely the CoA ligase for coumarate catabolism (Figure 8.7). The upregulated RPA1786 was annotated as a putative 3-hydroxybutyryl-CoA dehydratase, but
it has equally strong sequence similarity to enoyl-CoA hydratases. As coumaroyl-CoA is
an aromatic enoyl-CoA, up-regulation of RPA1786 expression suggests that it is the
enoyl-CoA hydratases for coumaroyl-CoA in β-oxidization (Figure 8.7). However, there
was no highly probable dehydrogenase and acyl-CoA thiolase for the β-oxidization from
the list of genes with up-regulated mRNA level or protein level.

Interestingly, a 4-hydroxybenzoyl-CoA thioesterase (RPA1788) was up-regulated, which
would turn 4-hydroxybenzoyl-CoA to 4-hydroxybenzoate. The induction of this
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Table 8.3: Genes with up-regulated protein level in comparisons of coumarate with succinate and benzoate.
Locus

Coumarate : Succinate
mRNA
Protein

Coumarate : Benzoate
mRNA
Protein

Benzoate : Succinate
mRNA
Protein

Gene description

Log-ratio P-value Log-ratio
CI
Log-ratio P-value Log-ratio
CI
Log-ratio P-value Log-ratio
CI
RPA0665
3.0
2.E-06
2.9
[2.7, 3.2]
3.1
2.E-06
1.6
[1.3, 1.9] -0.1
7.E-01
1.4
[1, 1.7.0] Putative ABC transporter subunit, ATP-binding component
RPA0668
RPA0669

2.4
5.6

2.E-07
8.E-10

2.6
4.1

[2.4, 2.7]
[3.8, 4.4]

2.0
2.2

9.E-07
6.E-08

1.8
2.0

[1.7, 1.9]
[1.9, 2.1]

0.5
3.5

5.E-02
3.E-09

0.8
2.1

[0.6, 0.9] Putative ABC transporter subunit, substrate-binding component
[1.8, 2.4] 4-hydroxybenzoate-CoA ligase ▀

RPA0670
RPA0671
RPA0672

6.3
5.6
4.5

4.E-08
2.E-10
2.E-08

3.1
3.8
4.6

[2.6, 3.7]
[3.4, 4.2]
[4.3, 5.0]

2.5
2.5
2.6

7.E-07
4.E-09
1.E-07

1.0
1.5
2.7

[0.7, 1.3]
[1.3, 1.7]
[2.2, 3.4]

3.9
3.1
1.9

5.E-09
4.E-09
5.E-09

2.2
2.3
1.9

[1.6, 2.7] 4-hydroxybenzoyl-CoA reductase, first subunits
[1.9, 2.7] 4-hydroxybenzoyl-CoA reductase,second subunits
[1.2, 2.6] 4-hydroxybenzoyl-CoA reductase, third subunits

RPA1009
RPA1206

3.3
-0.5

3.E-11
3.E-01

3.2
1.4

[3.1, 3.4]
[1.2, 1.5]

2.0
-1.0

9.E-10
5.E-02

3.3
1.7

[3.2, 3.4]
[1.5, 1.8]

1.2
0.5

8.E-05
3.E-01

-0.1
-0.3

[-0.2, 0.1] Possible cytochrome P450
[-0.5, -0.1] Aldehyde dehydrogenase

RPA1414
RPA1782

-1.0
1.2

1.E-04
4.E-04

1.1
1.7

[0.9, 1.4]
[1.5, 1.9]

-0.7
0.3

2.E-03
2.E-01

1.2
1.4

[0.9, 1.4]
[1.2, 1.6]

-0.3
0.9

2.E-01
6.E-05

0.0
0.3

[-0.3, 0.3] MaoC-like dehydratase
[0.0, 0.5] C4-dicarboxylate periplasmic binding protein, dctP subunit,

RPA1786
RPA1787
RPA1788

4.3
4.1
2.4

7.E-06
2.E-05
1.E-03

4.1
4.3
4.1

[3.7, 4.4]
[4.1, 4.5]
[3.8, 4.4]

1.5
1.7
2.7

6.E-04
6.E-04
8.E-04

2.2
2.5
1.7

[2.1, 2.4]
[2.4, 2.6]
[1.4, 2.0]

2.8
2.4
-0.3

1.E-08
7.E-07
2.E-01

1.8
1.8
2.4

[1.5, 2.2] Putative 3-hydroxybutyryl-CoA dehydratase ▲
[1.6, 2.0] Putative feruloyl-CoA synthetase ‡
[2.0, 2.8] Possible 4-hydroxybenzoyl-CoA thioesterase ▀

RPA1789
RPA1791

0.4
1.9

2.E-01
2.E-04

1.8
2.1

[1.7, 1.9]
[1.8, 2.3]

2.5
2.1

6.E-05
2.E-04

2.1
1.4

[2.0, 2.2]
[1.1, 1.6]

-2.1
-0.1

8.E-06
5.E-01

-0.3
0.7

[-0.4, -0.2] Putative branched-chain A.A. transporter, substrate-binding protein
[0.4, 1.0] Putative branched-chain A.A. transporter, ATP-binding protein

RPA1792
RPA3011

2.2
2.5

1.E-04
2.E-08

1.9
2.9

[1.7, 2.2]
[2.6, 3.3]

2.5
2.6

7.E-05
1.E-08

1.4
4.6

[1.1, 1.6]
[4.3, 4.9]

-0.3
-0.1

8.E-02
7.E-01

0.6
-1.6

[0.3, 0.9] Putative branched-chain A.A. transporter, ATP-binding protein
[-2.1, -1.1] Unknown protein

RPA3014
RPA3101
RPA3423

0.8
-0.1
0.8

5.E-03
9.E-01
5.E-04

2.1
1.5
1.6

[1.6, 2.5]
[1.4, 1.7]
[1.3, 1.9]

4.5
0.2
0.4

7.E-09
5.E-01
2.E-02

2.2
1.5
1.6

[1.9, 2.6]
[1.4, 1.6]
[1.3, 2.0]

-3.8
-0.3
0.4

4.E-06
3.E-01
9.E-02

-0.2
0.0
0.0

[-0.7, 0.4] Two-component transcriptional regulator, LuxR family
[-0.1, 0.2] Unknown protein
[-0.4, 0.4] Unknown protein

RPA3893
RPA4092

4.0
2.8

4.E-07
5.E-08

2.3
1.8

[2.0, 2.6]
[1.7, 2.0]

3.6
2.7

6.E-07
9.E-08

1.4
1.8

[1.1, 1.8]
[1.6, 2.2]

0.4
0.1

6.E-01
8.E-01

0.9
0.0

[0.4, 1.3] Putative carboxylesterase
[-0.4, 0.3] Unknown protein

RPA4096
RPA4198

2.3
2.3

7.E-06
5.E-05

2.6
3.8

[2.0, 4.1]
[3.5, 4.0]

2.0
0.9

2.E-05
1.E-02

3.1
1.2

[2.7, 3.6]
[1.1, 1.3]

0.3
1.4

5.E-01
3.E-06

-0.5
2.6

[-1.3, 1.0] Possible multidrug efflux membrane fusion protein mexE
[2.3, 2.8] Amidohydrolase 2
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Table 8.3: Continued

▀

▲

‡
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Figure 8.7: Cellular pathways for coumarate catabolism. Coumarate is converted to hydroxylbenzoyl-CoA, which is either excreted to growth medium after removing CoA or completely
degraded to acetyl-CoA through the benzoyl-CoA pathway.
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thioesterase activity appeared to be balanced by the almost equivalent induction of the
opposing 4-hydroxybenzoate-CoA ligase activity (Table 8.3, Figure 8.7). This supports a
previously proposed hypothesis for aromatic degradation: the metabolisable aromatic
intermediates are excreted into the growth medium and subsequently absorbed for further
degradation. This hypothesis was mainly supported by the transitory presence of aromatic
intermediates in the growth medium (Sasikala, 1994). In this study, we measured the
coordinated up-regulation of both CoA ligase and thioesterase for 4-hydroxybenzoate,
which suggests that 4-hydroxybenzoate is transiently excreted during coumarate
catabolism. The cross-membrane transportation of these aromatic compounds is probably
facilitated by those up-regulated transporter proteins (Table 8.3).

CONCLUSIONS:

In this study, transcriptomics and quantitative proteomics were combined to identify the
genes probably responsible for coumarate degradation and characterize the response of
the global metabolic network to the utilization of coumarate as the sole carbon source in
R. palustris. Gene expression profiles at both mRNA level and protein level were

measured in R. palustris grown with succinate, benzoate and p-coumarate as the carbon
source. 1000 – 2000 genes were quantified by both methods in each binary comparison
sample. The induction of the benzoyl-CoA pathway suggests that coumarate catabolism
proceeds through benzoyl-CoA as an intermediate metabolite. Conversion of coumarate
to benzoyl-CoA was hypothesized to consist of the following steps: CoA ligation, βoxidization and dehydroxylation. Global gene expression profiling enabled the discovery
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of the coumaryol-CoA ligase (RPA1787), the coumaryol-CoA hydratase (RPA1786) and
4-hydroxybenzoate-CoA thioesterase (RPA1788). In addition, two destinations for the
intermediate 4-hydroxybenzoate-CoA were suggested: complete degradation through the
benzoyl-CoA pathway and transitory excretion to the growth media. It is possible that at
the beginning of the culture growth the bacteria mainly derive carbon from β-oxidization
of the side chain of coumarate and excrete 4-hydroxybenzoate that is more difficult to
metabolize. With the decline of coumarate concentration, bacteria gradually switch to
deriving carbon from the aromatic ring.
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Chapter 9
Conclusions

Tremendous progress has been made in the field of proteomics over the past five years.
Thousands of proteins have been identified and quantified from whole-cell proteomes
and sub-cellular proteomes of many organisms (Pandey, 2000; Brunet, 2003; Huber,
2003). A variety of post-translational modifications have been detected and mapped in
proteins (Cantin, 2004; Jensen, 2004). Protein interaction networks have been
reconstructed for several species (Ho, 2002; Cesareni, 2005). These achievements,
together with the advances in genomics, transcriptomics and other “omics” research, have
ushered a new era of biological research, in which hypothesis-driven research is
combined with discovery-driven research, and targeted in-depth experiments are coupled
with large-scale, high-throughput experiments.

The research work described in this dissertation was mainly devoted to development of
advanced methodologies for proteomics. Two research directions were pursued:
prototyping of various high-performance analytical platforms based on FT-ICR and
development of quantitative shotgun proteomics with advanced data analysis algorithms
enabling confidence interval estimation. Research progress was achieved with an
interdisciplinary effort in three areas of proteomics: mass spectrometry methodology
advancement, data analysis algorithm development, and biological applications.
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FT-ICR mass spectrometry provides significantly higher mass accuracy, resolving power,
and dynamic range in mass measurement than quadrupole ion trap, time-of-flight and
triple quadrupole mass spectrometers (Bogdanov, 2005). We believe that the high
performance instruments like FT-ICR hold the promise of revolutionizing the field of
proteomics by providing deeper proteome coverage, more confident protein
identifications, higher protein sequence coverages, and more accurate protein
quantification. However, the potential of FT-ICR has not been fully explored for
proteomics applications, due to the limited development of FT-ICR MS as a robust and
high-throughput MS technology. Our laboratory is equipped with a 9.4 Tesla IonSpec
FT-ICR instrument, which has been well maintained with almost 100% up-time. This
allowed us to pioneer a variety of novel proteomics measurement methods with FT-ICR
and demonstrate the great potential of high performance instruments.

Gas-phase fragmentation is an important method to interrogate the structure of an analyte
with mass spectrometry. In FT-ICR, collisionally-activated dissociation (CAD) is
typically accomplished within the analyzer cell. An alternative approach of multipole
storage-assisted dissociation (MSAD) is afforded by inducing collisional fragmentation
in the external multipole that is usually employed for ion accumulation. This MSAD
method has the potential for very efficiently dissociating large proteins. To explore the
utility of MSAD for interrogating large intact proteins (molecular masses exceeding 100
kDa) and protein mixtures in a multiplexed manner, we have investigated the means of
controlling the collisional energy and the fragmentation patterns of seven intact proteins.
With protein samples in the low micromolar concentration range, the two major
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experimental parameters affecting MSAD in the hexapole region were found to be the dc
offset voltage and accumulation time. While low-energy MSAD of intact proteins yields
fragment ions similar to SORI-CAD, high-energy MSAD induces sequential
fragmentation to yield a rich variety of singly-charged ions in the m/z 600-1200 Da
region. Each of the proteins examined in this study exhibited their own characteristic
MSAD fragmentation pattern, which could be used as a signature of the presence of a
given protein, even in a mixture. In addition, any MSAD fragment can be isolated and
dissociated further by SORI-CAD in an MS3-type experiment inside the FTICR analyzer
cell. This presents a novel way to interrogate the identities of these fragment ions as well
as obtain amino acid sequence tag information that can be used to identify proteins from
mixtures. Such MS3 measurements on a high-performance instrument could potentially
be employed in top-down proteomics to obtain sequence information directly from intact
proteins, if the data acquisition and interpretation could be automated.

In shotgun proteomics, quadrupole ion traps are generally used to interrogate peptides
with tandem mass spectrometry, and the peptides are identified by matching their MS/MS
scans with all possible sequences using a database searching algorithm. We believe that
high resolution tandem mass spectrometry can not only improve the confidence and
sensitivity of peptide identification with database searching algorithms, but also enable
discovery of amino acid substitutions, post-translational modifications, and novel
peptides through the use of de novo sequencing algorithms. A key problem in interpreting
a CAD-generated tandem mass spectrum is the separation of y and b ions from each other
and from the noise peaks. We developed a graph-theoretic approach for separation of ion
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types in high resolution tandem mass spectra. We represent each spectral peak as a node
and consider two types of edges: type-1 edge connecting two peaks probably of the same
ion types and type-2 edge connecting two peaks probably of different ion types. The
problem of ion-separation is formulated and solved as a graph partitioning problem,
which is to partition the graph into three subgraphs, representing b, y and others ions,
respectively, through maximizing the total weight of type-1 edges, while minimizing the
total weight of type-2 edges within each partitioned subgraph. A dynamic programming
algorithm was developed to solve this graph partition problem. A set of high resolution
peptide tandem mass spectra were acquired with an FT-ICR instrument to test the
algorithm. An accuracy of ~90% was achieved for the separation of b and y ions.

The complexity and dynamic range of a proteome necessitate the coupling of mass
spectrometry measurements with liquid chromatography separation. We built a nanoscale
LC-FT-MS system for shotgun proteomics measurements. The LC was interfaced with
FT-ICR with an optimized nanospray ionization source. The LC-FT-MS system has been
tested with a protein standard mixture digest and an R. palustris proteome digest. We
achieved 1–5 ppm mass accuracy, ~200,000 mass resolution, and >100 dynamic range.
The high-performance mass measurement enabled accurate m/z determination, charge
state calculation, isotopic envelope deconvolution, and detection of low-abundance
peptides. As a result, monoisotopic neutral masses have been accurately determined for a
large number of peptides. The LC-FT-MS measurement was integrated with LC-QITMS/MS measurement to enhance peptide identification confidence. Samples were
measured with both LC-FT-MS and LC-QIT-MS/MS using the same LC settings.
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Peptides observed in the two measurements are correlated by their retention times and
masses. By combining accurate mass information from LC-FT-MS and MS/MS data
from LC-QIT-MS/MS, more peptides were identified with greater confidence than with
the conventional shotgun proteomics measurement employing LC-QIT-MS/MS alone.

In these three studies, we have explored different novel measurements with FT-ICR,
including sequence tagging of intact proteins, ion type recognition from high resolution
tandem mass spectra, and LC-FT-MS for shotgun proteomics. We demonstrated that
high-performance mass spectrometry can help addressing multiple challenges in
proteomics, such as amino acid sequencing with MS/MS, high-confidence peptide
identification, deep proteome coverage, etc. However, we also found that conventional
FT-ICR instruments need improvement in the following areas to deliver their promises
for proteomics:
•

Instrument control software. As FT-ICR has mainly been used for non-biological
applications, the instrument control software for FT-ICR lacked many essential
features for proteomics measurement, including data-dependent MS/MS, direct
communication with LC systems, automated data acquisition sequence, etc.

•

Tandem mass spectrometry. In LC-MS/MS analysis of a proteome digest, many
peptides elute simultaneously; thus, it is essential to have a high MS/MS scan rate
to examine as many peptides as possible. However, FT-ICR can only acquire ~20
scans per minute, compared with ~200 scans per minute for a two-dimensional
quadrupole ion trap. And due to the lack of automatic gain control, FT-ICR has a
limited dynamic range for tandem mass spectrometry analysis.
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•

Maintainability. FT-ICR requires ultra-high vacuum in the analyzer cell, high
field

superconductive

magnets,

and

cryogenic

temperatures

for

the

superconductive magnet. As a result, the instrumentation for FT-ICR is much
more sophisticated and less rugged than other types of mass spectrometers. This
limits the use of FT-ICR in a production proteomics pipeline. Also, operation and
maintenance of FT-ICR require more specialized expertise than quadrupole ion
trap and time-of-flight instruments.
•

Cost. The price of a high-field FT-ICR instrument is three times higher than that
of a quadrupole ion trap. And FT-ICR requires routine purchase of liquid nitrogen
and liquid helium for the superconductive magnet.

Recently, two commercial hybrid high-performance instruments have been developed:
ThermoFinnigan LTQ-FTMS (Peterman, 2005) and LTQ-Orbitrap (Erickson, 2006). The
two hybrid instruments are equipped with a linear quadrupole ion trap as the first stage
and an FT-ICR or an Orbitrap as the final stage. These hybrid instruments have much
improved instrument control software and tandem mass spectrometry capability,
compared with conventional FT-ICR instruments. It is possible that the next generation
of analytical platform for proteomics will be based on such hybrid high-performance
instruments.

Quantitative proteomics is a proteomics field that attempts to determine the abundance
changes of proteins between two proteomes. Establishment of quantitative shotgun
proteomics can be attributed to the development of a variety of stable isotope labeling
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techniques. The two proteomes under comparison can be labeled with different stable
isotope tags at different stages of sample preparation: cell growth, protein processing,
proteolysis, and peptide processing. The LC-MS/MS measurement and the data analysis
for peptide and protein identification are largely the same in quantitative shotgun
proteomics as in qualitative shotgun proteomics. However, quantitative shotgun
proteomics needs new algorithms for peptide abundance ratio estimation and protein
abundance ratio estimation.

The abundance ratio between the light and heavy isotopologues of an isotopically labeled
peptide is estimated from their selected ion chromatograms. However, quantitative
shotgun proteomics measurements yield selected ion chromatograms at highly variable
signal-to-noise ratios for tens of thousands of peptides. This challenge calls for
algorithms that not only robustly estimate the abundance ratios of different peptides but
also rigorously score each abundance ratio for the expected estimation bias and
variability. Scoring of the abundance ratios, much like scoring of sequence assignment
for tandem mass spectra by peptide identification algorithms, enables filtering of
unreliable peptide quantification and use of formal statistical inference in the subsequent
protein abundance ratio estimation. We developed a parallel paired covariance algorithm
for robust peak detection in selected ion chromatograms. A peak profile is generated for
each peptide, which is a scatter-plot of ion intensities measured for the two isotopologues
within their chromatographic peaks. Principal component analysis of the peak profile is
proposed to estimate the peptide abundance ratio and to score the estimation with the
signal-to-noise ratio of the peak profile (profile signal-to-noise ratio). We demonstrate
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that the profile signal-to-noise ratio is inversely correlated with the variability and bias of
peptide abundance ratio estimation.

We then developed a profile likelihood algorithm to infer the abundance ratios of
proteins from the abundance ratios of isotopically labeled peptides derived from

proteolysis. Given multiple quantified peptides for a protein, the profile likelihood
algorithm probabilistically weighs the peptide abundance ratios by their inferred
estimation variability, accounts for their expected estimation bias, and suppresses
contribution from outliers. This algorithm yields maximum likelihood point estimation
and profile likelihood confidence interval estimation of protein abundance ratios. This
point estimator is more accurate than an estimator based on the average of peptide
abundance ratios. The confidence interval estimation provides an “error bar” for each
protein abundance ratio that reflects its estimation precision and statistical uncertainty.
The accuracy of the point estimation and the precision and confidence level of the
interval estimation were benchmarked with standard mixtures of isotopically labeled
proteomes. The profile likelihood algorithm was integrated into a quantitative proteomics
program, called ProRata, freely available to the public.

With the development of the ProRata program, we have significantly improved the data
analysis procedure for quantitative shotgun proteomics. However, quantitative shotgun
proteomics is still a relatively new field that requires further research efforts along the
following directions:
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•

Stable isotope labeling. The ideal stable isotope labeling method is metabolic
labeling, which occurs before any sample processing step and guarantees almost
complete labeling efficiency. However, it has only been applied to a limited
number of organisms and cell cultures. Although other enzymatic and chemical
labeling methods have been developed downstream in the sample processing
procedure, they all have certain disadvantages, such as incomplete labeling, side
reactions, selected labeling of a subset of peptides, etc. Novel stable isotope
labeling methods are needed to overcome these limitations.

•

LC-MS/MS measurement. Quantitative shotgun proteomics uses the full scan
mass spectra for quantification. This demands high dynamic range of the mass
spectrometers to match the protein dynamic range and isotopologue dynamic
range of an isotopically labeled proteome mixture. Therefore, a high-performance
mass spectrometer is critical to obtain high-confidence protein quantification
results in quantitative shotgun proteomics.

•

Data analysis. The accuracy of point estimation and the precision and confidence
of interval estimation for protein abundance ratios can be further improved with
advanced algorithms.

Currently, stable isotope labeling is the basis for quantitative shotgun proteomics.
Another route for quantitative shotgun proteomics is the label-free approach, in which the
proteomes under comparison can be measured in separate LC-MS/MS runs. The labelfree approach obviates the need for stable isotope labeling, but requires the construction
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of a highly reproducible LC-MS/MS analysis platform and the development of data
analysis algorithms for data quality control and measurement bias normalization.

As gene expression consists of transcription and translation, we believe that it is of great
value to integrate quantitative proteomics and transcriptomics for global gene expression
profiling. The abundance change of the mRNA product and the protein product of a gene
can reveal the gene’s regulation at the two expression levels. Combination of the results
of two independent measurements can also minimize the false discovery rate and reduce
the need for additional validation experiments.

We have demonstrated this integrated gene expression profiling with our study on
anaerobic catabolism of p-coumarate by R. palustris. Coumarate is a major phenolic
monomer resulting from lignin degradation. R. palustris is one of a few known bacteria
capable of degrading coumarate under anoxic environments. However, the cellular
pathway for coumarate catabolism was unknown in R. palustris. It was hypothesized that
coumarate is degraded into benzoyl-CoA via β-oxidization, which then proceeds through
the benzoyl-CoA pathway. In this study we attempted to identify the genes responsible
for coumarate β-oxidization and characterize the impact of coumarate catabolism on the
global metabolic network. Transcriptomics and quantitative proteomics were employed to
measure the gene expression profiles of R. palustris grown with succinate, benzoate, or
p-coumarate as the carbon source. Between 1000–2000 genes were quantified by both

methods in each binary comparison sample. The induction of the benzoyl-CoA pathway
supported our hypothesis that coumarate catabolism proceeds through benzoyl-CoA as an
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intermediate metabolite. Probable genes for coumarate CoA ligase and coumaryl-CoA
hydratase were identified. Interestingly, it was discovered that at least a portion of
coumarate molecules are partially degraded into 4-hydroxyl-benzoate, which is likely
excreted into the growth medium. Additionally, many other cellular pathways were found
to be affected by coumarate catabolism.

The whole body of research work described in this dissertation represents our effort in
multiple areas of proteomics: mass spectrometry, informatics, and biology. We have
demonstrated the great potential of high-performance mass spectrometry for proteomics,
developed a suite of much improved algorithms for quantitative proteomics data analysis,
and demonstrated the biological impact of proteomics technology. Our progress was only
one step forward in the field of proteomics, and we realize that there are many challenges
needed to be addressed in the future, but the challenges also represent exciting research
opportunities for chromatographers, mass spectrometrists, statisticians, computer
scientists, and biologists. We expect that, in the next few years, proteomics will be truly
realized for many organisms, i.e. comprehensive characterization of the primary
structures, chemical modifications, tertiary structures, cellular locations, physical
interactions, and abundances of all proteins under all cellular states of an organism. The
wealth of proteomic data for an organism will assist in elucidating the cellular functions
of all proteins encoded in the organism’s genome.

Proteomics is an integral part of systems biology, together with genomics,
transcriptomics, metabolomics and other forthcoming “omics” fields. We envision that
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systems biology research will give us a mechanistic understanding of biological
processes. Perhaps, based on this understanding, mathematical models can eventually be
constructed for the life forms on Earth.
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